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In this project a series of multinuclear complexes were successfully prepared and 
characterised using an array of analytical techniques. The use of nitrogen-donor ligands, in 
particular pyridine and ferrocenyl derivatives thereof was examined. Two main approaches 
were taken in the preparation of the ferrocenylpyridines: 
i. The ferrocenylpyridines were systematically studied by varying the position of 
substituents along the pyridyl ring in the 4-,3- and 2-positions. 
ii. The effect of placing spacer groups between the ferrocenyl group and the pendant 
pyridine was examined. 
iii. The ligands were prepared with a system of conjugated 1C bonds, allowing for an 
electronic pathway within the ligand. 
Coordination studies of the substituted pyridines (L), were carried out with rhodium, iridium, 
platinum and palladium with the preparation of the fonowing types of complexes: 
II [MCI(COh(L)] and [M(COD)(L2)]CI04 where M == Rh or Ir, COD == 1,5-cyclooctadiene. 
II [M'CI2(Lh] where M' == Pt or Pd 
These complexes were characterised using several analytical techniques such as NMR, IR 
and electronic spectroscopy. The electrochemical behaviour of the complexes was of 
particular interest and was examined using cyclic voltammetry. Additionally, the X-ray crystal 
structures of several rhodium complexes [RhCI(COh((CsHs)Fe(CsH4)CsHIN==Cpy)], 
[RhCI(COD)(3-Fcpy)] and [RhCI(COD)(3-Fc(CsH4)py)], and a palladium complex, [PdCI2(3-
Fcpyh], was determined. 
The properties and some potential applications of these complexes was further demonstrated 
by preliminary investigations into their catalytic activity through several test reactions. 
II The polymerisa.tion of phenylacetylene was studied with rhodium complexes of the type 
[RhCI(COD)L] and [Rh(COD)L2]CI04. A trend was observed between the structure of 
the catalyst and its activity. Polymers with improved yields, molecular weight and 
thermal stability were prepared. 
II The carbonylation of nitrobenzene with palladium complexes, [PdCbL2] where L == 4-
phenylpyridine and 2-, 3- and 4-ferrocenylpyridines. The derivatised pyridyl complexes 











• The hydrogenation of cyclohexene and 1-hexene with rhodium and iridium complexes, 
[M(COD)L2]CIO". where L :::: pyridine, 4-ferrocenylpyridine and 4-ferrocenylphenyl-4'-
pyridine. 
A preliminary cytotoxic screening of several complexes was also carried out based on the 
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Chapter 1: Introduction 
Historically, the synthesis and study of transition metal complexes has featured prominently in 
chemistry, in particular through applications in the fields of catalysis, materials chemistry and 
even medicinal chemistry. One of the first stable transition metal complexes, Zeise's salt 
K[PtCIs(C2H4)], was prepared as early as 1827 by a Danish pharmacist, Zeise. It took, 
however, at least 125 years to understand the true nature of the chemical bonding of ethene 
to platinum in the complex. 1 
The development of complexes containing transition metals for use in catalysis is closely 
linked to three major industrial processes developed between 1930 to 19502; the 
carbonylation of alkenes and alkynes using iron catalysts in the Fischer-Tropsch process3, 
preparation of ethene and propene polymers with Ziegler-Natta catalysts4 and the production 
of acetaldehyde from ethene by the Wacker process using palladium and copper catalysts.5 
The hydroformylation or oxo process was also developed during this time. Currently, the 
hydroformylation of alkenes is the largest industrial-scale reaction that is catalysed 
homogeneously.s Roelen discovered the reaction in 1938 and prepared propionaldehyde from 




C3-C15 aldehydes are produced by hydroformylation and converted to amines, carboxylic 
acids and primary alcohols using mainly cobalt and rhodium catalysts.s One of the current 
objectives in this reaction is to produce linear products selectively. The use of rhodium 
catalysts with bulky phosphane ligands has been reported to increase the ratio of linear to 
branched products relative to the cobalt catalysts.s 
The activity of rhodium catalysts for a variety of reactions is well-known. Wilkinson first 
prepared RhCI(PPh3h in 1965 when its activity was first noted as an efficient homogeneous 
catalyst for the hydrogenation of alkenes. 
A number of areas of chemistry have evolved from the discovery of certain key complexes. 













complex, Cr(CO),.{CR)1 in 1973.1 Carbene complexes are intermediates in olefin metathesis 
and have even been used in a model reaction for the degradation of chlorohydrocarbons in 
the Iiver.6 Olefin metathesis can be used for the catalytic conversion of propene to ethene and 
1-butene for the preparation of Cs aldehyde via the hydroformylation reaction. Several types 
of transition metal catalysts are available for olefin metathesis.6 These include Black Box 
heterogeneous catalysts with high valent transition metal halides, oxides or oxo-halides with 
an alkylating zinc or aluminium cocatalyst on an aluminium or silicon support, titanocene-
based catalysts, Shrock catalysts with tungsten, molybdenum and rhenium8 and Grubbs 
ruthenium catalysts9 (see Figure 1.1 for examples of Shrock and Grubbs' catalysts). 
Schrock's catalyst Grubbs catalyst 
Figure 1.1: Examples of olefin metathesis catalysts8.9 
Similarly, the discovery of the first sandwich complex, ferrocene,1o in 1951 led to the 
preparation of numerous other metallocenes.11 Ferrocenyl derivatives have found application 
in several areas of chemistry.6,12 Monosubstituted and 1,1 '-disubstituted ferrocenes are the 
most frequently studied type of ferrocenyl compounds. The ferrocenyl group has been 
incorporated into a range of conjugated systems and is able to be coordinated to other 
metals, due mainly to its unique chemistry. The study of ferrocene and determination of its 
relative stability led to investigations into compounds with larger ring stack arrays. The first 
triple-decker sandwich complex, [Ni(CsHsht was prepared by Werner in 1972.8 
More recently, the study of transition metals in catalysis and combinatorial chemistry has 
taken a shift in the development of green chemistry. There is a general move in chemistry in 
recent times towards clean and sustainable technology that eliminates waste and avoids the 
use of toxic reagents and solvents in the manufacture and utiiisation of chemical products. 
Rhodium complexes of ferrocenylphosphines, for example, have been useful in this regard as 
hydrogenation catalysts immobilised on alumina or silica.13 The catalyst is very active, 













Many important transition metal complexes contain phosphine donor ligands. This thesis, 
however, looks at the role of nitrogen donor ligands and their influence on the development of 
transition metal chemistry. 
1.1 Nitrogen donor coordination complexes 
Nitrogen-donor ligands have played a notable role in the development of coordination 
chemistry. Ligands with sp2-hybridised nitrogen atoms, such as pyridine, have a significant 
coordination chemistry.14 Pyridine could easily be regarded as one of the best-known 
heterocyclic nitrogen donor ligands. Pyridine is a particularly good ligand as it contains a 
nitrogen donor ring atom with a localised pair of electrons available for binding. 
When considering the uses of these ligands, it is worth noting the differences in coordination 
behaviour between the nitrogen donor ligands and the well-studied phosphorus ligands as 
well as the properties of the nitrogen donor Iigands.14 
(i) The nitrogen atoms in donor ligands are known to bond strongly to metal centres 
where the strength of the bond is dependant on their cr covalency. 
(ii) Nitrogen donor ligands generally show only a limited 'It back-bonding ability, 
making these ligands unsuitable for the stabilization of low oxidation state 
transition metals. However, Sp2 hybridised nitrogen donors such as pyridine, have 
been known to show some 'It interactions and 'It back-bonding effects between the 
nitrogen heterocycle and the metal centre.15,16 
(iii) These ligands exert a very small trans effect in comparison to other ligands used 
in organometallic chemi try, resulting in a fast rate for substitution reactions. 
(iv) The observed reactivity of nitrogen donors is generally high, particularly with alkyl 










Figure 1.2: Examples of nitrogen donor ligands complexed to palladium, rhodium and iridium16,17 
In contrast to the widespread use of phosphine donor coordination complexes in catalysis, 













towards the preparation of mixed ligand systems incorporating nitrogen donor atoms into 
these systems as well as the preparation of novel nitrogen donor ligand systems for a variety 
of applications (see for example Figure 1.2).14.18 P,N chelating ligands have been observed to 
show similar reactivity to complexes containing P,P chelating ligands. 
The chemistry of vitamin B12, its coenzyme and the cobalamines are interesting examples of 
nitrogen donor complexes. The chemistry of vitamin B12 has been studied extensively,19 
particularly through simple cobaloxime model compounds (see Figure 1.3). The study of 
these cobaloxime complexes has further application in the catalysis of organic systems.14.20 
Of particular significance is the mode of cleavage of the Co-R bonds in these types of 
complexes as well as the oxidation state of the cobalt atom with reference to the study of 
electron transfer processes.21 
B = pyridine 
Figure 1.3: Cobaloxime, a model for the vitamin B12 system where B is, for example, pyridine 
The use of nitrogen donor ligands has featured more significantly in materials chemistry. With 
an increasing demand for new materials with novel properties, there has been a move in 
polymer research towards the preparation of materials with a highly controlled architecture.22 
The emphasis in the study of dendrimers or starburst polymers, has been the development of 
new materials with novel properties that are fundamentally different from the linear polymers. 
There has been a steadily growing interest in the preparation of dendrimers containing 
transition metals. The metal centres may be incorporated either at the core, throughout the 
structure, or at the periphery (see Figures 1.4 and 1.5).23.24.25 The incorporation of nitrogen 
donor ligands such as pyridyl and bipyridyl groups is advantageous as these groups can be 













Figure 1.4: Platinum bipyridyl dendrime~4 
The majority of iron dendrimers reported have involved the inclusion of ferrocenyl groups. The 
incorporation of redox-active ferrocenyl groups into the dendritic architecture has been 
studied mainly with the aim of establishing electronic communication between the metal 
sites.26 These polymers may be useful as biosensors and as catalysts for the modification of 
electrodes.27 Figure 1.5 shows the first heterometallic dendrimer with different transition 
metals in different layers.25 
Figure 1.5: Heterometallic dendrimer with platinum and ferrocenyl centres25 
1.2 Ferrocenyl-containing nitrogen donor coordination complexes 
Recently, the study of novel multiple metal-containing complexes has reached prominence 













of polymers. It is anticipated that these complexes will have additional properties that are 
significantly different from similar organic compounds. The types of anticipated properties 
include electrical conductivity, magnetic behaviour,28 enhanced thermal stability. non-linear 
optical effects87 and superconductivity. 
The preparation of polypyridyl transition metal complexes with electronically coupled photo- or 
redox-active sensors is currently of interest for a number of potential applications. 
Comparatively simple ruthenium, osmium and rhenium complexes of 2,2'-bipyridine,29 for 
example, exhibit properties related to redox electrocatalysis and solar energy conversion.30 
Although oligopyridyl complexes with redox-active centres are known, until recently, there 
were few examples reported in which these centres were covalently coupled.31 The existence 
of covalent pathways is of interest as electron transfer processes are usually facilitated by the 
presence of these through-bond pathways.31 Oligopyridyl ligands are beneficial for the 
development of metaliosupramolecular chemistry and have provided new avenues in the 
search for new topological molecular systems.32 
Figure 1.6 shows examples of polynuclear redox-active ferrocenyloligopyridyl complexes. 
These supramolecular complexes may be assembled either as a single chelating ligand or 






M = Co, Fe 
Figure 1.6: Ferrocenyloligopyridyl transition metal coordination complexes31 •33 
The use of ferrocenyl nitrogen donor ligands is further observed in the preparation of 
ferrocenylimines. The study of ferrocenylimine complexes follows a similar trend to the 













of interest. 34 The ligands are often prepared as unsaturated oligomers or polymers. However, 
one of the disadvantages of aromatic polyimines is their relative insolubility in a range of 
common organic solvents. 
The preparation of 4-ferrocenylpyridine, as well as the 3- and 2-substituted analogues, was 
reported several years ago.35,36 However, only a limited number of coordination studies have 
been carried out with these ligands. The most notable of these described a novel synthetic 
route for the preparation of 4-ferrocenylpyridine using a nickel-catalysed Grignard reaction. 
The ferrocenylligand was coordinated to a rhenium metal centre, complex [1.6]. The complex 
was further compared to a series of rhenium-ferrocenyl and ferrocenylphosphine coordination 
complexes, [1.1]-[1.4]. Of primary interest in this work was the preparation of a series of 
organometallic complexes with pendant redox-active ligands (see Figure 1.7). The complexes 
were investigated to determine whether changes in the oxidation state of the ligand would 
result in changes in the spectroscopic properties and reactivity of the rhenium metal centre, 
essentially without changing the coordination sphere of the rhenium metal. Rhenium 
complexes were specifically chosen as rhenium-centred oxidations are generally difficult and 
these complexes are usually substitutionally inert. Spectroscopic changes were used to 
monitor redox changes in the ferrocenylligand. 
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Figure 1.1: Ferrocenyl-rhenium coordination complexes35 
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[1.3] 
A series of shifts to higher energy was observed in the infrared carbonyl stretching frequency 
upon oxidation of the rhenium complexes. This corresponded to a lowered electron density at 
the rhenium metal centre. The extent of shift was found to be dependant on the number of 













the electron density at a metal centre could be predetermined and adjusted upon oxidation of 
the ligand redox centre.35 
The preparation of a platinum complex of 3-ferrocenylpyridine together with the 
electrochemistry of the complex [1.6] was later described (see Figure 1.8).37 A platinum(lI) 
metal centre was chosen as nitrogen-donor complexes of the metal are known to be both 
thermodynamically and kinetically stable. It is interesting to note that, as with the complexes 
in Figure 1.7, both the ligand and the coordination complex exhibited redox activity. 
Figure 1.8: Platinum-ferrocenylpyridine complex37 
Of particular interest was the specific role of platinum as a linker between the ferrocenyl 
ligands. A single redox wave was observed for complex [1.6], corresponding to a two-electron 
oxidation at the platinum electrode rather than two separate consecutive one-electron 
oxidations, indicating little or no communication between the respective ferrocenyl groups. It 
would appear that the platinum metal centre inhibited electronic communication between the 
ligands in complex [1.6]. Another factor worth considering is the role played by the pyridyl 
ligand toward effective electronic communication. It was unclear as to which factor in 
particular contributed to the observed redox behaviour. The complex was simply viewed as a 
reducing agent able to release two electrons at a time. 
Considering the specific contribution various donor atoms make to electronic communication, 
it is worth taking a second look at the complexes in Figure 1.7.35 The phosphine-donor 
complex [1.4] showed a two-electron oxidation process in the form of two separate one-
electron oxidations separated by 100 mV. This indicated significant coupling between the 
ferrocenyl fragments. It would appear that the rhenium metal centre did not oppose 
electrochemical communication. However, a single two-electron oxidation was observed for 
complex [1.5]. The specific factor contributing to this observed effect was unclear. A further 














The complexes described above for the most part contain systems in which the metals are 
connected through conjugated pathways. This provides an avenue for through-bond 
electronic communication. This type of communication is expected to predominate in linear 
conjugated systems but may be diluted in complexes containing relatively long conjugated 
spacers between the metal centres.38 Furthermore, electronic communication through space 
may occur provided the metal centres are within very close proximity to allow this. The 
Significance of a conjugated system has been illustrated in complexes [1.7] and [1.8] (see 
Figure 1.9).39 
[1.7a], [1.7b] [1.8a], [1.8b] 
a: R = cr, n = 0 
b: R = py, n::: 2 
Figure 1.9: Platinum dipyridyl-ferrocene complexes used to illustrate the role of conjugated ligand 
systems on electrochemical communication39 
Investigation of the redox behaviour of complexes [1.7] and [1.8] revealed that the nature of 
the spacer between the redox active site and the dipyridyl metal-binding sites strongly 
influenced both the redox and spectroscopic properties of these complexes. The redox 
behaviour of the ferrocenyl ligands of complexes [1.7] and [1.8] were fairly similar but differed 
Significantly upon complexation to the platinum metal centre. Comparison of oxidation shifts 
showed a dramatic difference between the free ligand and coordinated complex, with a shift 
of at least +150 mV in the case of the conjugated system of complex [1.7], compared to +30 
mV in the unconjugated system of complex [1.8]. This difference in redox behaviour can be 
attributed to the conjugated system allowing through-bond communication between the 
metals. Hence, the electron-withdrawing nature of the bound platinum metal centre makes the 
ferrocene group harder to oxidise, accounting for the larger oxidation shift. 
1.3 Application of transition metals in catalysis 
The use of transition metal complexes in both heterogeneous and homogeneous catalysis is 
commonplace. Although the majority of catalytic synthetic processes occur by means of 
heterogeneous catalysis in industry, homogeneous catalysis is favoured academically. One of 
the chief advantages of homogeneous catalysis is the ability to monitor the reaction progress 













into the catalytic synthetic process, often leading to the ability to improve reaction conditions, 
yields and selectivity. A comparison between these types of catalysis is made in Table 1.1. 




Low thermal stability 
High activity 
Well-defined catalyst 




High thermal stability 
Lower activity 
Poorly defined catalyst 
Limited by diffusion processes 
The homogeneous and heterogeneous catalytic application of rhodium complexes, for 
example, is widespread (see for example Figure 1.10). The literature abounds with 
applications of highly active complexes containing this metal centre.6.40 Wilkinson's catalyst, 
[RhCI(PPh3h], is the best known of these with simple hydrogenation reactions taking place at 
ambient temperature and atmospheric pressure. Modifications of this catalyst include 
[Rh(CO)H(PPh3h], which is the active catalyst formed under hydroformylation conditions.41 
Hydroformylation is an industrially relevant and significant process that is responsible for the 
preparation of several million tons of aldehydes and alcohols annually.6 This complex is one 
of the most active homogeneous hydroformylation catalysts and is used in industrial 
processes. 
~ 66 EtOCHaCI .. SnCl4 
Figure 1.10: Example of Wilkinson's catalyst on a polymeric supportS 
Other interesting rhodium complexes are of the type [Rh(j3-diketonate)L2] (where j3-diketonate 













phosphine or phosphite). These rhodium complexes serve as catalyst precursors for a range 
of reactions such as alkene hydroboration and diboration, carbon dioxide hydrogenation, 
hydroformylation and addition of arylboronic acids to aldehydes.42 
The catalytic study of iridium complexes has similarly been investigated, most notably as 
homogeneous hydrogenation catalysts. Iridium is usually considered the least catalytically 
active of the platinum group metals. In the highly coordinatively unsaturated form, however, 
certain iridium complexes such as the catalyst precursor, Crabtree's catalyst 
[lr(COD)L(py)]PFs (where COD = 1,5-cyclooctadiene, L = phosphine and py = pyridine) may 
behave as highly active hydrogenation catalysts even for stericaliy hindered alkenes (see for 
example Figure 1.11).43 In the development of this catalyst, the presence of the coordinated 
phosphine-donor ligand was a disadvantage, as the ligand did not readily dissociate to allow 
coordination of the alkene substrate. Modification of the iridium catalyst led to the introduction 
of cyclooctadiene (see Figure 1.11).44 The labile ligand readily dissociated for coordination of 
the alkene. 
TIPSO""" 
Crabtree's catalyst = 
Ir catalyst. 
rt, CH2CI2' H2 
TIPSO""" 
Figure 1.11: Iridium hydrogenation catalyst and an example of a hydrogenation reaction with this 
catalyst43•44,45 
A further consideration is the solvent of reaction. The solvent may bind tightly to the metal 
centre, leading to hindered coordination of the olefin. This was overcome through the use of 
weakly- or non-coordinating solvents.44 Catalyst development has reached the stage where 
these complexes have been used as catalyst precursors for the hydrogenation of imines,46 a 














Aside from the importance of the metal centre in the observed catalytic activity of various 
transition metal complexes, the coordinated ligands warrant some consideration. Ferrocenyl 
phosphine donor ligands, for example, are well-known, with numerous reports of coordination 
complexes. 12 1,1'-Bis(diphenylphosphino)ferrocene (abbreviated as dppf), prepared in 1965, 
was the first example of a ferrocenyl-based phosphine ligand (see Figure 1.12).48 Ferrocenyl 
phosphine ligands have shown increased popularity since the 1980s with various academic 
and industrial catalytic applications currently cited, where the activity of the complexes has 






Palladium coordination complex of 1,1 '-bis( diphenylphosphino )ferrocene50 
The Kumada-Hayashi coupling reaction, for example,50 successfully uses PdCb(dppf) in the 
formation of a nearly quantitative yield of the desired carbon-carbon coupled product, with 
good selectivity. 50 The activity of this complex by far exceeds the activity of monodentate as 
well as some bidentate phosphine-based catalysts. Further examples of reactions where the 
use of complexes of these ligands results in increased activity, include the Suzuki coupling 
reaction ,51 the Heck coupling reaction 52 and the Stille coupling reaction 53 with palladium, 
rhodium and nickel complexes of dppf. 
Since the discovery of dppf, a variety of other ferrocenylphosphine complexes have been 
prepared as well as ferrocenes with both phosphine and nitrogen donor groups. There are 
several synthetic routes to the preparation of these non-racemic ferrocenyls, a number of 
which have applications in asymmetric synthesis.54 
The redox behaviour of ferrocenyl complexes of molybdenum, tungsten, palladium and 
platinum metal centres has also been studied using cyclic voltammetry.55 No significant 
changes were observed between ligand and complex in the case of the molybdenum and 
tungsten complexes while anodic shifts in the redox wave were observed for the other 
metals.56 The study of the electrochemical behaviour of dppf has led to attempts to increase 
the stability of the ferrocenium monocation, which is known to form during the electrochemical 
process.56 Isolation of the various complexes formed during the electrochemical process 
would lead to a better understanding of this process and potentially allow for electrochemical 
systems to be tuned for specific needs. The investigation was carried out by examining the 













substituents with a range of electronic properties. Results indicated that substituents with 
higher electron donating ability lead to the formation of the corresponding ferrocenium 
monocations with a longer lifetime. Despite this, a stable ferrocenium cation could not be 
isolated for separate examination.56 
Quite often the coordination chemistry of transition metal complexes is considered prior to 
examination of the role of the complex as a potential catalyst. A series of related ligands may 
be prepared followed by determination of their coordination chemistry with several metal ions. 
An example is the disubstituted ferrocenyl ligand, 1, 1'-bis(2-pyridyl)ferrocene, which although 
known for some years,57 has had few coordination complexes reported. Earlier work 
described the preparation of rhodium and silver complexes of this ligand but studies were 
limited simply to the preparation of these complexes and a crystal structure of the silver 
complex.58 
Since then, platinum and palladium complexes of this ligand (see Figure 1.13) have been 
prepared and their reactivity studied with regard to carbonyl insertion reactions. 59 This 
reaction forms an important part in the copolymerisation of alkenes and carbon monoxide.59 
The bidentate ligand has been reported to increase the rate of carbonyl insertion reactions. 
Structural factors, such as its conformational flexibility, as well as the tendency to coordinate 
with a large bite angle were considered in investigations of the reactivity of complexes of this 
Iigand.59 
[1.9] 
Figure 1.13: Palladium and platinum complexes of 1 ,1 '-bis(2-pyridyl)ferroceneIl9 
It is known that complexation of the late transition metals with phosphorus ligands results in 
the formation of robust complexes. Due to the harder Lewis nature of nitrogen ligands, the 
analogous complexes were not expected to be as stable. Results however, indicated that the 
insertion of carbon monoxide into the palladium-methyl bond of complex [1.9] occurred 













bidentate nitrogen ligands, as well as rigid bidentate nitrogen ligands with small bite angles. 
The 1,1'-bis(2-pyridyl)ferrocene ligand is flexible and has been known to coordinate with a 
large bite angle, evidenced by the silver complex of this ligand, [Ag(l)CI04]2 (where l ::: 1,1'-
bis(2-pyridyl)ferrocene).58 Despite the increased carbon monoxide insertion rate due to the 
presence of the ligand, the group was only weakly bound to the metal centre, preventing 
detailed kinetic studies of the reaction.59 
Modifications to systems of this type through changes in the donor atom allows for systematic 
study of this type of complex and may provide a deeper insight into the mode of reactivity of 
these and similar complexes. 
1.4 Medicinal chemistry 
Biomedical inorganic chemistry is a rapidly expanding area of chemistry. A number of the 
compounds investigated in this field have potential applications in medicine and by extension, 
offer real possibilities for the pharmaceutical industry, where traditionally organic chemistry 
has dominated. Some of the key areas of medicinal inorganic chemistry are highlighted in 
Figure 1.14.60 
Essential elements Diagnostic agents: 
Mineral supplements MRI (eg. Gd. Mn) 
(eg. Fe, Cu, Zn, Sa) X-ray (eg. Ba, I) 
~ L 
Medicinal Inorganic Chemistry: 
( Chelation therapy ) 
Targetting of the elements r Enzyme inhibitors] 
Control of toxicity 
/ ~ Radiopharmaceutica Is: 
Therapeutic agents J Diagnostic (eg. 99rnrC) 
(ag. ti, Pt, Au, Bi) Therapeutic (eg. 186Re) 
Figure 1.14: Some of the key areas of medicinal inorganic chemistry60 
The use of transition metals in medicinal chemistry has rapidly developed with the discovery 
of the antitumour properties of cisplatin.51 It is interesting to note that despite the range of 
transition metal complexes prepared and studied for their antitumour activity, only very few 
have proceeded to clinical phase trials.52 Due to the observed antitumour activity of cisplatin, 
numerous platinum complexes with similar geometry have been prepared. Several 
metallocenes, including ferrocene and titanocene complexes have been investigated for their 













insolubility in aqueous systems.52 The insolubility of ferrocene has been overcome to some 
extent by preparation of the ferrocenium cation53 or through preparation of ferrocenyl 
inclusion complexes with cyclodextrin. 
Ferrocenyl derivatives have also shown some use as antimalarial agents (see Figure 1.15).64 
These compounds are based on the antimalarial agent, chloroquine, and are investigated in a 
bid to find complexes with different structures and mechanisms of action than those currently 
employed. Recent studies have found metabolites of these complexes to be more active than 
chloroquine against the virulent causative agent, Plasmodium falciparum. 64 
NH(CH2)n-~~NMe2 
~ R ~ 
CIMN) ~ 
R = H, n = 2-6 
R = CONHBn, n = 2-6 
Figure 1.15: Ferrocenyl antimalarial agents64•55 
1.5 Non-linear optical materials 
Ferrocenyl-containing conjugated ligand systems have been extensively studied as non-linear 
optical materials since the enhanced non-linear optical behaviour of these compounds was 
first described.66 Many reports have appeared since then with similar observations on the 
properties of ferrocenyl-containing systems with high second harmonic generation 
efficiency. 57 
Reports on the study of non-linear optical properties have resulted from the preparation of 
multinuclear ferrocene-containing complexes, which tend to satisfy the requirements for non-
linear optical behaviour; these include polarizability and crystallisation in a non-
centrosymmetric space group.68 Complexes of this type generally contain metals such as 
chromium, molybdenum or tungsten as electron accepting groups, while ferrocene serves as 
an electron donor.1I8 These metals appear to enhance the observed non-linear optical 
properties. Platinum group metals such as rhodium, iridium, platinum and palladium, have 
largely been ignored for this application due to the observed greater non-linear optical 
responses from complexes containing chromium, molybdenum or tungsten.58 
The non-linear optical properties of W(CO)sl complexes (where l :::: pyridine or its 4-
substituted derivatives), for example, have been well-studied.59 The activity of complexes of 













complexes were shown to have low energy metal-to-ligand charge transfer bands as well as 
enhanced solvatochromism, both of which have been linked to enhanced polarisabilities and 
increased second-order non-linear optical behaviour. 
co 





a: n:: 0 
b: n = 1 
c: n =2 
x 




a: X = Y :::: COOMa 
b: X = CN, Y :::: COOMa 
c: X=Y=CN 
Figure 1.16: Tungsten pyridyl complexes investigated for non-linear optical properties70 
1.6 Aims of the project 
The above examples serve to illustrate the variety of factors that must be taken into account 
not only in the preparation of ferrocenyl complexes but also in considering the nature of 
electrochemical interactions. Accordingly, the ferrocenylpyridines represent an interesting 
class of compounds due primarily to their redox behaviour. The coordination of a transition 
metal to a ferrocenylpyridine may be monitored electrochemically due to the presence of the 
ferrocenyl group. 
The current investigation represents a systematic exploration into the preparation of various 
ferrocenylpyridines and their coordination behaviour with a range of platinum group metals 
such as rhodium, iridium, palladium and platinum. The motivation for the study of these 
coordination complexes is to expand the range of applications of these complexes. 
Investigations include the establishment of synthetiC methodologies for the preparation of 
several transition metal-containing complexes and determination of their respective 
spectroscopiC and redox properties. The study involves the synthesis and examination of the 
properties of ferrocenyl nitrogen-donor ligands and in particular their metal complexes, an 
area that has hitherto not been systematically examined. The complexes prepared have been 
characterised using a wide range of spectroscopic and analytical techniques and the X-ray 
crystal structures of selected complexes are reported. 
Bearing in mind the specific metals that have been targeted as part of this study, an 
investigation into several potential applications was considered. The incorporation of metals 
such as rhodium and palladium in particular, allowed for investigation of several catalytiC 













complexes prepared in this study have been carried out and comparisons made with related 
complexes reported in the literature. 
A further point of interest in terms of applications of these complexes lies in the study of their 
biological activity. Since the preparation and antitumour activity of cisplatin, cis-
diamminedichloroplatinum(II), was first reported, numerous subsequent reports have 
appeared describing the biological activity of other transition metal complexes. The 
antitumour activity of several of the complexes prepared in this study was considered in a 
preliminary investigation. 
This thesis addresses the preparation and determination of the physico-chemical properties 
of novel platinum group metal complexes containing nitrogen-donor groups, such as pyridine 
bonded to ferrocene. The effect of derivatising the pyridyl group is considered with a view to 
the determination of resulting effects on spectroscopic and electronic properties of these 
complexes. The applications of complexes of this type are also examined in several 
preliminary studies in the areas of catalysis and medicinal chemistry. 
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Chapter 2: Synthesis and Study of Substituted Pyridyl Ligands 
2.1 Introduction 
The past few decades have seen a rapid growth in the systematic study of phosphine-donor 
ligands and in particular, ferrocenylphosphine ligands for use in a variety of applications, 
mainly catalysis.1,2 The use of nitrogen-donor ligands in areas such as catalysis, materials 
science and medicinal chemistry has not enjoyed much attention and until recently has 
remained a relatively unexploited area of chemistry.:3 In the current investigation, we are 
particularly interested in Sp2 hybridised nitrogen donors with specific reference to the 
behaviour of pyridyl and substituted pyridylligands. 
Currently, pyridine and bipyridine are viewed as building blocks from which a range of ligand 
systems can be built." This is largely due to the relative ease of derivatisation of these groups. 
The redox stability of complexes of this type gains prominence when considering that a large 
number of complexes are investigated for their electrochemical activity. Transition metal 
complexes containing these ligands have uses in a variety of applications. Rhodium 
complexes with pyridyl ligands and ruthenium complexes with bipyridine, for example, are 
catalysts for the water gas shift reaction in both the homo- and heterogeneous processes.s In 
the heterogeneous process these groups act as linkers to polymer supports, anchoring the 
catalyst to a solid support. In the homogeneous process the position of substituents on the 
pyridine and bipyridine ring system  playa Significant role in activity of the catalyst. 
Many nitrogen donor ligands have gained distinction as optically active molecules upon 
coordination to both metal and organiC groups and are often noted for the brightly coloured 
complexes obtained. For example, organometallic compounds have been investigated as 
dyes for the potential rapid screening of catalysts (see Figure 2.1).s 
~ t='N+ -
~ '-J:O;" where X :: BPh", CIO". BF" or Br 
~ X'#' 
Organometallic dye Ferrocenylpyridlne ligand 














The dye molecule consists of an electron donor group such as ferrocenyl, linked through a 
conjugated pathway to an electron acceptor group such as a quarternised pyridinium. These 
highly conjugated molecules are intensely coloured but if the alkene bond in the ligand is 
reduced by catalytic hydrogenation, conjugation is lost and the dye bleached. This 
methodology would allow for the rapid screening of potential hydrogenation catalysts. In 
practise, the dye was photochemically unstable in solution.s 
Stilbene and stilbazole ligands, which contain pendant pyridyl groups, have been widely 
studied for their potential liquid crystalline properties. The incorporation of transition metals 
into complexes of this type represents an interesting development in terms of including metals 
in an ordered fluid system? Several nickel,S rhodium9 and iridium complexes have been 
reported. Initial investigations were into the preparation of rhodium complexes of the type cis-
[Rh(alkyloxy)CI(COMcyanobiphenyl)]. These complexes were thermally unstable. The 
thermal instability was attributed to the presence of a weak rhodium-nitrile bond. 
[2.1J 
R = CnH2n+1, n = 4-12 
M = Rh, Ir 
Figure 2.2: Rhodium and iridium complexes prepared with mesogenic ligand, 4-alkyloxy-4'-
stilbazole9 
Rhodium and iridium complexes with mesogenic 4-alkyloxy-4'-stilbazole ligands [2.1], yielded 
mesomorphic metal-containing complexes showing nematic and smectic A mesophases (see 
Figure 2.2). The preparation of several ferrocenyl-containing mesogens has also been 
reported in the form of both mono- and bisubstituted ferrocenes.1o In this instance, a second 
metal centre is introduced via an organometallic group rather than coordination of a given 
mesogenic ligand to a further metal centre. 
Recent developments in the study of nitrogen-containing ligand systems include the 
preparation of mixed donor systems. These for the most part contain both nitrogen- and 
phosphine-donor groups (see Figure 2.3). Despite the prevalence of phosphine-donor ligands 
in a number of catalysts, one of the disadvantages of phosphine-donor catalysts is the 
deactivation of the catalyst under a number of conditions. The inclusion of a nitrogen-donor 
group into the catalyst together with the phosphine-donor in the form of an N,P-chelate, 
resulted in the preparation of a catalyst with higher stability towards oxidation and 






















Figure 2.3: Chelating ligands containing both N- and P-donor atomsl1.12.13.14 
Ligands 
Ferrocene chemistry has developed significantly in the fifty-plus years since the preparation 
of the metailocene was first reported.15.16 Ferrocene, [2.2] is relatively stable and lends itself 
to derivatisation. The electrochemical behaviour of ferrocene shows a perfectly reversible 
redox change (see Figure 2.4) and is often used as an internal standard and is increasingly 
being viewed as the nonaqueous counterpart of the standard hydrogen electrode (SHE).17,16 
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400 200 0 -200 -400 
Potential ( mY) 
Figure 2.4: Cyclic voltammogram of ferrocene in acetonitrile with 0.1 M TBAP as background 
electrolyte, AglAgN03 reference electrode. platinum wire auxiliary electrode and 
platinum disk working electrode 
Comparing the redox activity of a substituted ferrocene with ferrocene as a standard can be 
used to monitor the effect of derivatising the metailocene. The electron-withdrawing or 
donating effect of the substituent can be readily observed as a change in the position and 
nature of the ferrocenyl redox wave. The study of the electrochemical behaviour of 
bisferrocenyl ruthenium and cobalt complexes, for example, monitored the role of the central 
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~~ 'Br~ 
[2.4] 
Figure 2.5: Bis(ferrocenyl) complexes of cobalt and ruthenium 19 
A study of the electrochemistry of these complexes revealed that the extent of interaction 
between the ferrocenyl groups of the cobalt complex [2.3], was very similar to that of the free 
ligand while the ruthenium complex [2.4], showed a marked difference. While complex [2.3] 
showed a single reversible redox wave, complex [2.4] showed two separate one electron 
redox waves, indicating interaction of the ferrocenyl groups through the ruthenium 
metallacycle. The difference in electrochemical behaviour was thought to be due to 
differences in the donating ability of the respective metal centres as well as differences in 'It 
conjugation within these systems.19 
The use of ferrocenylpyridines as ligands coordinated to various transition metal ions such as 
silver,37 gold,20 platinum17 and rhenium21 has been reported with the primary aim, initially, the 
preparation of novel coordination complexes. Due to the presence of the ferrocenyl group, the 
potential electrochemical properties of these transition metal complexes have been studied. 
These specific ligands are usually conjugated in nature, allowing for an electronic network of 
communication through a 'It-electron pathway. Figure 2.6 for example. shows the 
electrochemical resonance forms of the 4-ferrocenylphenylpyridine triosmium aikylidene 
cluster.22 As illustrated. the push-pull interaction in the conjugated ferrocenyl ligand allows 
electrochemical interaction between the respective metal centres. 
~ \. # \. ~r°), 
(OChOS~OS(CO)4 
Ground state Excited state 
Figure 2.6: Electrochemical flow illustrated in a conjugated ferrocenyl ligand coordinated to a 
triosmium alkylidyne cluste~2 
The preparation and coordination of ferrocenylpyridine ligands allows for the possibility of 













interest for the study of nonlinear optical materials,23 magnetism,24 molecular sensors25 and 
liquid crystals. 26 
2.2 Types of ligands investigated 
The ferrocenyl-containing ligands prepared in this study are for the most part conjugated in 
nature. They represent a class of ligand that exhibit independent redox activity, in that the 
redox behaviour of the ligand does not depend on further coordination to a metal ion. These 
ferrocenyl-based ligands show completely reversible redox activity, allowing them to act 
potentially as electrochemical switches when coordinated to further metal centres. 
Of particular interest would be the ability to tune the electron density of a coordinated metal 
ion without changing its coordination sphere. This would allow for remote control of reactivity 
at the coordinated metal centre. Hence, being able to tune the electron density of the 
coordinated metal ion by oxidation of the pendant ferrocenyl ligand in a system of the type 
described in Figure 2.6, for example, where the coordinated metal ion is represented by the 
triosmium trialkylidene cluster, would present an alternative to varying the substituents on the 
coordinated metal centre as well as varying substituents on the cyclopentadienyl rings of the 
ferrocene or pendant pyridyl group of the ligand. 
Several factors were considered in the ligands chosen for this work including steric and 
electronic factors. Several modes of electrochemical communication are possible. The 
systems investigated are for the most part connected through conjugated pathways and the 
primary means of electrochemical communication envisioned is through the 1t-electron 
pathway. This is not the only possible mode of communication. It can also occur through 
space but in order for this to occur, metal centres must be in close proximity to one another. 
The ligands investigated in this study for their potential electrochemical properties were 
prepared with this in mind. 
The primary aim of this study is the preparation of ferrocenyl-substituted pyridines. Given the 
possible electrochemical interactions that may be facilitated by these ligands, the effect of 
pOSitioning substituents on the pyridyl group is of Significance. Figure 2.7 shows a three-
dimensional schematic describing various ferrocenylpyridines with the ferrocenyl group as a 














Figu'e2.7: Ferrocenylpyridines investigated to determine the effect 01 substituent position on the 
pyridyl ring 
Given the possible electrochemical pathways with the ligand systems described in Figure 2.7, 
it can be observed that moving the ferrocenyt substituent from the 4-position (I) through to the 
2-position (III) not only reduces the number of bonds between the ferrocenyl substituent and 
the nitrogen donor atom but also creates a bend in the system should a metal ion be 
coordinated. Hence, a metal ion coordinated to the nitrogen donor atom to a system as 
described in II I. not onty allows for a more efficient through-bond electrochemical interaction 
but also possibly for a through-space interaction. 
It should be considered that ~mitations may arise for systems of the type described by III, 
these being stereochemical constraints which are dependant on the size of the metal ion and 
other ligands coordinated to the transition metal centre. The system described by II is a less 
sterically demanding ligand. The conjugated pathway is slightly reduced from I and depending 
on the size of the metal ion. through space communication may be a remote possibility. 
A further consideration in the preparation of coordination complexes of these ligands is 
conformational flexibility. The preparation of t, t'-disubsbtuted ferrocenytpyrldines and 
comparison of these to the monosubstituted derivatives and thw coordination complexes is 
noteworthy (see Figure 2.8). 
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Aside from the position of substituents on the pyridyl ring, the ellect of placing various 
spacers between the ferrocenyl unit and the pendant pyrfdyl ring was considered. In the 
ligands investigated, the specific nature of the spacer as well as the distance created 
between these centres was examined. Figure 2.9 is a three-dimensional representation of 
several ferrocenylpyridine ligands with systematic inclusion of various spacers. 
I shows no spacer between the ferrocenyl group and pyrfdyl ring, whereas a phenylene 
spacer in ligand VII separates these groups. A further imine bond was inserted in ligand VIII, 
producing an elongated linear ligand system. The effect of inclusion of spacer groups was 
evaluated not only with regard to the electrochemical behaviour of the ligands but also the 
effect on properties and reactivity of these compounds. 
Viti 
Figure 2.9: Ferroceny1pyridines used to investigate nature of the spacer group 
Another interesting factor that has been considered is the aromaticity of ferrocene and to 
what extent this contributes to the properties and reactivity of the complex." Comparisons 
have been made with phenylene derivatives. including 4-phenylpyridine. 
2.3 Preparation of ligands 
2.3.1 Monosubstituted ferrocenylpyridine ligands 
One of the main synthetic routes followed for the preparation of the mono-substituted 
ferrocenylpyridine ligands was via the Grignard reaction This involved a niCkel-phosphine 
catalysed cross·coupling of a Grignard reagent with an aryl halide. The use of the nickel-
catalysed Grignard reaction for the coupling of aryl groups has been reported as particularly 













synthetic routes.21 ,28 Figure 2.10 illustrates the synthetic route to 4-ferrocenylpyridine, [2.6]. A 




+ Mg 1.2-Dibromoethane 
MgBr 
Q \ )-Br 
• ~ . 
Et20 ~ Ni cat., reflux 16 h 
[2.5] 
~ 
Ni cat. = Ph2P, Nt" PPh2 
CI/ 'CI 
cis-(1,3-bis(diphenylphosphino)propane)dichloronickel 
Figure 2.10: Synthesis of 4-ferrocenylpyridine via the Grignard reaction 
[2.6] 
Bromoferrocene, [2.6], was obtained by the bromination of chloromercuriferrocene with N-
bromosuccinimide.29 The synthesis of chloromercuriferrocene was achieved through 
metallation of ferrocene with mercury(lI) acetate followed by addition of lithium chloride.29,3o 
The metaliation of ferrocene in this case yields both mono- and 1, 1'-disubstituted 
chloromercuriferrocene, which were separated by Soxhlet extraction. Unreacted ferrocene 
was removed by sublimation, yielding the unsublimed portion as chloromercuriferrocene. 
which was recrystallised to give a fine golden powder. 
Ferrocenylmagnesium bromide was formed in situ with the magnesium slowly activated by 
gradual addition of 1,2-dibromoethane in solution with [2.6] in diethyl ether. Once the 
Grignard reagent was generated, a mixture of the halogenated pyridine, together with the 
nickel catalyst. was added in diethyl ether. The reaction mixture was heated under reflux 
generating the product [2.6]. which was purified by column chromatography. The product was 
obtained as yellow flakes in good yield and purity. 
Using this synthetic route several other ligands were prepared, most notably the 
ferrocenylpyridines and ferrocenylphenylpyridines shown in Figures 2.11 and 2.12. Moving 
the position of the substituents on the pyridyl ring from the 4- to the 3- and finally to the 2-
position was performed with the intention of varying the number of bonds between the 
ferrocenyl substituent and the nitrogen donor atom, and consequently orientating the metals 
in the ligand-coordinated transition metal complexes spatially closer together. These types of 
complexes would allow electrochemical communication to occur both through bond, as well 













similarly obtained from bromoferrocene with the appropriate halogenated pyridines to give the 
desired isomer. 
Although the preparation of [2.7J has been reported via the diazonium reaction.17 the 
Grignard reaction route consistently gave a significantly higher product yield. 
Br ~N Yellow flakes, 73% 
6 ~ C,J/ ~[2.6] 
M9Bf/O ~Br ~ Q. I ~ " Brown flakes, 80% 
::"N F.e \\ U 
.6 ~ · ~[2.7] 
O~ ~N\ Orange needles, 65% 
~ [2.8] 
Figure 2.11: Preparation of ferrocenylpyrldine ligands via a Grignard reaction 
The ferrocenylphenylpyridines [2.9]-[2.11]. also demonstrate changing positions of 
substituents on the pyridyl ring but with systems incorporating a phenylene spacer group. The 
effect of the spacer group is evaluated in coordination studies with various metal ions in 
Chapter 3. It would be of interest to determine the difference in conformational position of the 
substituent along the pyridyl ring in the presence of the spacer group between the ferrocene 
and pyridyl groups in comparison to compounds [2.6]-[2.8]. 
Sr N Orange flakes, 33% 
6 6 
- ~., 
~MgBr __ --=..:.N __ -i ...... 
~ ~ ~ O~ 
[2.9] 
Orange-brown flakes, 39% 
~
, 
\. tJ Orange crystals, 38% 
F.e -
~ [2.11J 













The compounds [2.9]-[2.11], were obtained using the same synthetic route as for the 
preparation of [2.6]-[2.8], starting from 4-bromophenylferrocene. The same high yields 
obtained for compounds [2.6]-[2.8] could not be obtained for compounds [2.9]-[2.11]. The 
exact reason for this is unclear at this stage but may be related to the preparation of 
ferrocenylphenylmagnesium bromide in situ. Although compound [2.9] has previously been 
prepared via a palladium-catalysed cross-coupling reaction with an organozinc reagent,22 the 
synthetic route described here represents a relatively simple one-pot synthesis. 
2.3.2 1, 11-Disubstituted ferrocenylpyridine ligands 
The current investigation has predominantly considered the preparation of monosubstituted 
ferrocenyl ligands with several chelating compounds containing two monosubstituted 
ferrocenyl groups. Despite the fact that 1, 1'-bis(2-pyridyl)ferrocene, [2.13] was prepared over 
three decades ago,31 the coordination behaviour of the compound has not been extensively 
investigated.32,37 Studies have been limited to the preparation and X-ray crystal structure 
analysis of novel rhodium and silver complexes.37 Recent work: has seen the preparation of 
palladium and platinum complexes of [2.13]. The palladium complex has been further studied 
in carbonyl insertion reactions.32 This type of disubstituted ferrocene offers a ligand with a 
relatively flexible conformation and a large bite angle. A comparison of the properties of the 
mono- and disubstituted analogues of a given ferrocenylpyridine should be interesting in 
terms of the properties of the coordinated metal complexes. 
These compounds were prepared by a zinc chloride cross-coupling reaction with 1,1 '-
dilithioferrocene catalysed by a palladium catalyst as shown in Figure 2. 13. This methodology 
has been reported for the preparation of [2.13].32 The dilithioferrocene-TMEDA complex was 
prepared in n-hexane, as this resulted in a higher conversion to the desired dilithiated 
ferrocene than in the commonly used diethyl ether.31 
25 h Q-u 
~ TMEDA 
~Li 






Figure 2.13: Synthetic scheme for the preparation of 1 ,1' -bis(2-pyridyl)ferrocene, [2.13] 
This synthetic route was applied to the preparation of both 1, 1'·bis(2-pyridyl)ferrocene, [2.13], 













may be due to some product decomposition in solution. The compound appeared to be 
relatively unstable in chlorinated solvents in particular, compared to [2.13]. Overall the 
product yields were low with a significant amount of monosubstituted compound obtained in 
both cases. The higher yield of monosubstituted compound in both cases was attributed to 









[2.14]: Orange-brown powder; 15% 
Figure 2.14: 1,1'-Disubstituted ferrocenylpyrldine ligands prepared, [2.13] and [2.14] 
The preparation of 1,1 '-bis(3-pyridyl)ferrocene [2.15], was also attempted by this method 
without success. Only the monosubstituted 3-ferrocenylpyridine was obtained. The 
preparation of the disubstituted ferrocenes [2.13]-[2.15] was also attempted using the Stille 
cross-coupling reaction with tributyltin chloride in place of zinc chloride (see Figure 2.15).33.34 
The Stille reaction has recently seen a resurgence with the synthesis of several ferrocenyl 
compounds reported using this synthetic route.35 The Stille route initially appeared to be more 
successful for the preparation of these compounds. However, separation of the product from 
the tin by-products proved to be problematic. 
Pd(PPh3)", CuO 




l .. J ---
N [2.15] 
Figure 2.15: Preparation of a 1, 1'-disubstituted ferrocenylpyridine via a Stille cross-coupling 
reaction36 
Although the coordination behaviour of 1, 1'-bis(2-pyridyl)ferrocene [2.13] has been studied to 
a limited extent, a rhodium complex of compound [2.13] has been prepared which shows 
coordination of the rhodium metal ion not only through the nitrogen donor atom but also the 0.-
proton of the ferrocenyl cyclopentadienyl group (see Figure 2.16).37 The effect was observed 
though temperature-controlled NMR studies of the complex in solution. This type of 













would be interesting to establish whether the monosubstituted 2-ferrocenylpyridine [2.8], 
would exhibit similar coordination behaviour as well. 
30°C 
Figure 2.16: The coordination behaviour of 1, 1'-bis(2-pyridyl)ferrocene with a rhodium metal 
centre 
2.3.3 Monosubstituted Schiff-base ligands 




~#~N Q ~ Nrw' Schiff base ligands . ~ --'--- '-_______ 1IIiII -----'''---Foe -
~ [2.16] 
v 
i. 4-Aminophenylferrocene, pyridine-4-carboxaldehyde, 4A molecular sieves in MeOH; reflux 12 h; maroon flakes 900,.( 
ii. Aniline, pyridine-4-carboxaldehyde, 4A molecular sieves in MeOH; reflux 12 h; cream flakes 77% 
iii. Formylferrocene, ethylenediamine, anhyd. Mg804 in diethyl ether; stir 24 h at 25°C; yellow crystals 67% 
iv. 4-Formylphenylferrocene, ethylenediamine, anhyd. Mg804 in Et20. stir 4 days at 25°C; orange powder 18% 
v. 4-Formyl-4-biphenylferrocene, ethylenediamine, anhyd. Mg804 in Et20, stir 4 days at 25°C; orange powder 15% 
Figure 2.17: Description of ligands prepared using Schiff base condensation reaction 
The Schiff base condensation reaction provided a convenient synthetic route for the 
preparation of several compounds containing imine bonds, [2.18]-[2.20], It should be noted 
that although this synthetic route has been well-established for the preparation of the type of 
compounds shown in Figure 2.17, there are associated complications that must be taken into 













efficient dehydrating agent was added to remove water formed during the reaction. This 
established a shift in the equilibrium reaction, resulting in preparation of the compounds in 
good yields in some cases. The lower yields observed for [2.18] and [2.20] were thought to 
be mainly due to solubility of either the starting material, as was the case for [2.20], or 
solubility of the product and further separation from the starting material, as in the case for 
[2.181, rather than choice of dehydrating reagent. 
Compound [2.16] comprises a phenylene group and imine bond as spacer unit between the 
ferrocenyl group and pyridyl ring, allowing for study of an extended linear system between 
these terminal groups. Compound [2.16] has been synthesised and coordinated to various 
metal ions such as tungsten, molybdenum and osmium.38 As with most ligands investigated 
here, a conjugated pathway exists within the compound. The ferrocenyl group was observed 
to behave as an electron donor whereas a further coordinated metal ion may behave as an 
electron acceptor in a push-pull type interaction.22 Furthermore, the behaviour of complexes 
containing this ligand for non-linear optical materials has been investigated,39,40 thus 
establishing a precedent for study of complexes of this type. 
Figure 2.18 shows the preparation of compound [2.16]. 4-Nitrophenylferrocene [2.21], was 
prepared using the diazonium reaction and reduced by catalytic hydrogenation in a Parr 
hydrogenation reactor, yielding 4-aminophenylferrocene, [2.22] in good yield. 
Pd/C, H2 (g) .. 
THF 
~rCN 
T.\-f o [2.16] 
4A mol. sieves, MeOH 
reflux 12 hrs 
Figure 2.18: Preparation 4-phenylferrocenylimidopyridine via a Schiff-base condensation 
reaction39 
Compound [2.161 was readily isolated in good yield by concentration of the reaction mixture 
and COOling for at least 5 hours, after which time a further crop of product was obtained from 














Further variations on [2.16] include 4-ferrocenylphenyivinylpyridine, [2.24] (see Figure 2.19). 
This particular compound varies from [2.16] by a slight variation in the spacer group. An 
alkene bond replaced the imine bond. 
Li[NP~21, THF .. 
[2.24]: Pink-red flakes, 24% 
Figure 2.19: Synthesis of 4-ferrocenylvinylpyridine, [2.24]39 
POCl3 
reflux, 24 h 
A specific interest in this study is the role played by the ferrocenyl group. Compound [2.19], 
was prepared with this in mind, representing the spacer portion of compound [2.16]. The 
study of compound [2.19] would enable the determination and to some extent the contribution 
specific spacers play in the behaviour or activity of the ligand. 
Although most ligands investigated are conjugated, allowing for a n-electron pathway, 
compounds [2.11], [2.18] and [2.20] are not. Instead, communication between the ferrocenyl 
groups of the ligand would not readily occur through bond. Compound [2.11] can act as a 
bidentate chelating ligand and would potentially allow for an investigation into the specific role 
played by the coordinated metal ion. Coordination of a metal ion would result in the formation 
of a five-membered metallacyie as shown in Figure 2.20. Consequently, a pathway for 
communication between the ferrocenyl groups through the coordinated metal centre could 
occur, where the nature of communication would depend on the specific metal ion 
investigated. In addition, ligands [2.18] and [2.10] have been prepared with additional phenyl 
groups as spacers. This would allow for further investigations into the nature of spacer 
groups, particularly in an extended system such as [2.20]. 
Q-~=Nr-'\N=~-Q 
r=L~ \/ ~ 
~ M ~ 













The synthesis of compound [2.17] has been reported and investigated as a ligand 
coordinated to both rhodium and iridium metal centres. These complexes were reported as 
catalysts for the polymerisation of phenylacetylene.41 However, attempts at repetition of the 
synthesis of the rhodium complex proved unsuccessful under the reported reaction 
conditions. The reaction intermediates appeared to be unstable under the reported conditions 
and were observed to rapidly decompose in solution. Attempted modifications of the synthetic 
route did not yield the desired product. Further attempts to form coordination complexes with 
this ligand were not undertaken. Compounds [2.18] and [2.20] were not investigated further 
due to their relative insolubility in a range of common organic solvents. 
2.3.4 Ferrocenylphosphine ligands 
Given the predominance of phosphine donor-ligands and in particular ferrocenylphosphine-
donor ligands, two ferrocenylphosphines were included in this study for comparison in terms 
of reactivity to the ferrocenylpyridine ligands. The commercially available and well-studied 
1,1 '-bis( diphenylphosphino)ferrocene, [2.25] and ferrocenyldiphenylphosphine, the 
monosubstituted analogue, [2.26] were chosen for further complexation studies. 
Ferrocenyldiphenylphosphine42 was prepared using the Friedel-Crafts reaction according to 
the reaction scheme described in Figure 2.21. The preparation and activity of rhodium 












Figure 2.21: Preparation of ferrocenyldiphenylphosphine, [2.2St2 
[2.26J 
The conformational flexibility and catalytic activity of 1, 1'-bis(diphenylphosphino)ferrocene 
[2.25], has been studied extensively. A number of metal complexes on coordination to 
compound [2.25], have shown catalytic activity for a variety of applications. Electrochemical 
studies of ferrocenylphosphine ligands are, however, somewhat complicated. The redox 













oxidation process based on the ferrocenyl unit, followed by a chemical reaction involving the 
phosphorus substituent.43 This is often further complicated by the presence of a coordinated 
transition metal centre. 
The preparation and study of ligands [2.25] and [2.26], allows for not only an investigation 
into the properties of the donor atom but also conformational-activity studies once the ligands 
are coordinated to various metal ions. A complexed [2.25], for example, would have a 
relatively rigid conformation with a set bite angle and steric requirements, dictating the 
reactivity of the complex in turn. It has been described that the bite size and angle of the 
ligand playa role in its catalytic activity.44 A complexed [2.26] would, however, allow for some 
freedom of movement within the complex itself, as described in Figure 2.22, with however, 
greater steric hindrance. These factors were taken into account when selecting these ligands 
for further investigation. 
Ph Ph 






Q- ,rJM I" ~Ph Ph 
Figure 2.22: Comparison of coordination behaviour of [2.25J and [2.26] 
2.4 Spectroscopic properties 
2.4.1 Infrared spectroscopy 
Certain characteristic stretching frequencies were observed in all ferrocenyl compounds 
prepared. Bands at 1110 and 1005 cm-1 were observed in most cases and are characteristic 
of ferrocene. Furthermore a ferrocene C-H stretch and C-C stretch was usually found at 
3060-3100 cm'1 and 1410-1430 cm-1 respectively. An out-of-plane C-H bending band was 
also observed in the region 810-830 cm-1• Bands due to C-N stretches in pyridine derivatives 
were observed in the region 1360-1250 cm-1 and 1620-1510 cm-1 depending on the nature of 
substituents on the pyridyl ring, while compounds containing imine bonds generally showed 
stretches in the region 1660-1590 cm-1. The phosphine-donor complexes generally showed 














2.4.2 NMR spectroscopy 
The NMR spectra of the compounds in this study are of interest not only for their identification 
but also for insight into the electronic contribution of substituents. The 1H NMR spectra 
provide significant information with regard to the interactions of protons within the pyridyl ring 
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Figure 2.23 compares the 1H NMR spectra for compounds [2.6]-[2.8]. The individual proton 
resonances have been identified and in particular the ferrocenyl resonances indicated where 
Cl and ~ refer to the respective equivalent protons on the derivatised cyclopentadienyl ring 
and Cp refers to the unsubstituted cyclopentadienyl ring. The protons occurring on the pyridyl 
ring have been directly indicated on the respective 1 H NMR spectra. 
The chemical shift of the unsubstituted cyclopentadienyl ring remains for the most part 
unchanged, demonstrating that no or limited interaction between the pyridyl ring and 
unsubstituted cyclopentadienyl ring occur. However, changing the position of the susbstituent 
on the pyridyl ring has an effect on the electronic shielding of the Cl and ~ ferrocenyl protons 
(these shifts are summarised in Figure 2.24). Moving the ferrocenyl substituent along the 
pyridyl ring from the 4-, 3- and 2-positions results in chemical shifts of 4.61, 4.37 and 4.39 
respectively in the case of the ~ protons and 4.82, 4.67 and 4.92 respectively in the case Qf 
the Cl protons. 
~, 
Foe j) ~J 
[2.6] [2.7] [2.8] 
a: 4.82, f3: 4.61, Cp: 4.08 a: 4.67, f3: 4.37, Cp: 4.06 a: 4.92, f3: 4.39, Cp: 4.05 
Figure 2.24: Comparison of ferrocenyl chemical shifts for [2.6]-[2.8] 
The Cl protons of 2-ferrocenylpyridine show a sharp downfield shift, indicating more strongly 
deshielded protons, most likely due to the proximity of the electronegative nitrogen atom. 
Additionally, it is speculated that some interaction may be occurring between the Cl protons 
(shown as He and Ha, in Figure 2.25) and the nitrogen-donor atom. Only a single peak has 
been observed for the Cl protons, Ha and He' and they are considered to be equivalent with a 
situation as described in Figure 2.25 the most likely scenario. This could be determined 
through temperature-controlled NMR experiments. 













Furthermore, the pyridyl protons of [2.1] and [2.8] show individual resonances for the 
respective protons due to the position of substitution on the pyridyl ring. Based on the peak 
aSSignments in Figure 2.23, none of the protons on the pyridyl ring of these compounds are 
equivalent with proton resonances observed due to the environment of the specific proton. 
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1H NMR spectra of [2.9]-[2.11] have similarly been compared in Figure 2.26 with the various 
proton resonances assigned to the respective protons as indicated. 
Proton resonances in the 1H NMR spectra of [2.9]-[2.11] have similarly been compared in 
Figure 2.27 with specific reference to the position of the ferrocenyl protons. 
[2.9] 









a: 4.71, B: 4.35, Cp4.05 
Figure 2.27: Comparison of ferrocenyl chemical shifts for [2.9]-[2.11] 
No significant differences in the respective ferrocenyl protons were observed on comparison 
of compounds [2.9]-[2.11]. This is in contrast with the observed shifts in the similar 
compounds [2.6]-[2.8]. The presence of the phenylene spacer group appears to limit the 
extent of electrostatic interaction between the pyridyl protons and hence, nitrogen donor atom 
with that of the ferrocenyl protons, despite a conjugated system existing to connect these 
centres. 
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Figure 2.28 compares the 1H NMR spectra of the related compounds [2.19] and [2.16]. 
Chemical shifts of the various protons are considered upon introduction of ferrocene in [2.16] 
with peak shifts summarised in Table 2.1. These shifts provide some insight into the nature of 
electrostatic interactions on introduction of ferrocene. On comparison of proton resonances, 
phenylene protons 5 and 4 show the greatest shifts as expected, while only minor shifts are 
observed for the pyridyl protons, 1 and 2. The conjugated nature of the compound is clearly 
demonstrated through the significant shift observed due to the imine proton, 3, which was 
shifted downfield and deshielded due to the presence of the ferrocene group. This effect is 
also observed on comparison of the imine stretching frequencies of the compounds in the 
infrared spectra. A shift from 1595 cm'1 in [2.19] to 1623 cm,1 in [2.16] on introduction of the 
ferrocenyl group was observed. 
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The redox behaviour of various ferrocenyl compounds prepared in this study was evaluated 
using cyclic voltammetry. The observed redox behaviour of the respective complexes are all 
reported with regard to the reversible redox wave of unsubstituted ferrocene, which showed 
an Ey, at +75.5 mV under the given conditions in acetonitrile with tetrabutylammonium 
perchlorate as background electrolyte. Measurements were conducted under an inert 
atmosphere using a platinum disk working electrode, platinum wire auxiliary electrode and 
Ag/AgN03 reference electrode. 
Some typical cyclic voltammograms are shown in Figure 2.29. Overall, a reversible redox 
wave similar to the unsubstituted ferrocene was observed for all compounds. However, 
derivatisation of ferrocene gave a positive shift for all compounds studied, indicating that 
placing a substituent on the cyclopentadienyl ring of ferrocene made the ferrocene group 
harder to oxidise. The extent of shift, however, was dependant on the nature of the 
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Figure 2.29: Comparison 01 cyclic voltammograms 01 lerrocen,," compounds [2.6] and [2.9] with 
ferrocerte. [2.4] 
Table 2.2: Half-wave potentials of various ferrocenyl compounds in acetonitrile 
Compound Compound Ep.1 mV Ep< I mV E"lmv 
number 
----
[2.4] Ferroceoo +120 ," +75.5 
[2.8] 2-Fcpy +188 +121 +154.5 
[2.7] 3-Fcpy +204 +131 +167.5 
[2.6] 4-Fcpy +242 +169 +205.5 
[2.11] 2-Fc(C,H,Jpy +161 ," +126.5 
[2.10[ 3·Fc(C,H,)py +189 ,>e +132.5 
[2.9] 4·Fc(CoH,)py +182 ," +133.5 
[2.16[ Fc(CoH.)NCpy +147 '" +113 
[2.27] Fc(CGH,)OCH,Ph +11 2 ," +75.5 
A ferrocenyl compound 001 previously described has been included in Table 2.2. Compound 
[2.27]. unlike the other ferrocenyl compounds in Table 2.2. does not have a conjugaled 
network. In addition, compound [2.27] does oot have a pendant pyridyl group. The effect of 
the electron-withdrawing pendant pyridyl can be clearly observed as [2.27] shows a half-wave 
potentiaf comparable to ferrocene. Compound [2.6] showed the greatest positive shift in half-
wave potential with the effect of the pyridyl group clearly demonstrated. Comparison of 
compounds [2.6]. [2.9] and [2.16] further demonslrated the effect on the electrochemical 
behaviour of the compound by placing spacer groups between the ferrocenyl group and 












closer to that 01 unsubstituted ferrocene, This Indicated that the etectron-withdrawing effect 
became tess pronomced with the inclusion of the spacer groups. This effect is also observed 
on comparison 01 [2.7] and [2.10], as well as [2.6] and [2.11]. 
2.6 Electronic Spectroscopy 
The electronic spectra of some of the ferrocenyl compounds prepared were obtained in a 
dichloromethane solution. Spectral comparisons were made with unsubshtuted ferrocene. 
Ferrocene exhibits two bands at 326 and 443 nm, which have been assigned to 'A2,-·)'E2" 
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Figure 2.30: Electronic spectra of ferrocene, [2.4] with [2.19] and [2.161 in dichloromethane 
In most cases. on substitution of the cyclopentadienyt ring of ferrocene with conjugated 
substituents, a shift to lower energy in the cyclopentadienyl orbitals was anticipated, An 
increased mixing of ligand orbitals vvith metal d orbitals was found, An additional band occurs 
around 300 nm in the pyridyt ligands with a 11-411" transition due to the conjugated pyridyt 
substituent. 
Comparison of the major bands in the electronic spectra for various ferrocenyl and nitrogen-
donor complexes in dichloromethane is summarised in Table 2.3. The extinction coefficients 
are also reported, In most cases, although the weak transition at approximately 450-500 nm 












the other ferrocene d-d transition Imnd and was observed as a shoulder. Thus, only two 
transitions are reported for the high energy rr-4'" transition. due to the conjugated pyridyl 
substituent and for one of the ferrocene d-d transitions Overall the remaining bands show a 
bathochromic shift_ 
Table 2.3: Electron c spectroscopy data fur various ferrocenyl and nitrogen oonor oompounds in 
dfchlaromethane 
Compound Compound .... ,'nm 
number [""", I mor'.dm'.cm -'] 
------ ---------
Q '" "" [2.4] ~ [101] ["" 
9.'-O-OC",-o '" 'W [2.27] ~ - [336] [2570[ 
:;0 ·, '" [2.22] [3331 
~O"'-O '" '"' 12.16] [12109] [18113[ 
O"~" "" [2.191 [3532] 
9.-0 '" '" [2.8] [384[ [1559J Q 
""" 0 "" '" [2.7] ~" [381 [ [1530[ 
~{) '" '" [2.6J [481 [ [147D[ 
Further discussion with re~ard to relative shift of transitions is made later w~h discussion of 
complexes of several of the ferrocenyl compounds prepared here. 
2.7 Concluding remarks 
A series of ferrocenylpyridine ~gallds were Sl.lCCessfully prepared using the synthetic routes 
described above_ The properties of these compounds were further investigated using several 
spectroscopic techniques_ Some of the compounds described above were further examined 
in coordination studies with rhodiUm, iridiLrn, palladiUm and platinum, the results of which are 
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Chapter 3: Preparation of Multinuclear Complexes 
3.1 Introduction 
Transition metal complexes, particularly those containing redox-active fragments such as the 
ferrocenyl group are increasingly being investigated for a variety of potential uses such as 
those in the fields of catalysis and materials science.1 These complexes, principally those 
linked through conjugated pathways, can exhibit electrochemical behaviour that has been 
associated with unusual catalytic activity due to the availability of several different metal 
sites.2 
The possibility exists of generating chemical and physico-chemical variations in the 
coordination properties of the transition metal ion by making redox changes in attached 
redox-active fragments such as a ferrocenyl group. The tuning of electron density in the 
transition metal without changing its actual coordination sphere potentially provides an 
avenue to control reactivity at this centre.3 This premise has largely formed the basis for the 
study of the electrochemical behaviour of multimetallic complexes. Electronic interactions are 
generally studied in systems containing metals separated through a system of conjugated 
bonds, since this has been shown to facilitate interaction of the respective metal centres." 
Currently, applications of these electronic interactions are largely in the field of materials 
chemistry and have provided materials with non-linear optical properties and materials that 
can act as redox switches and redox active sensors ... ,5 Several novel bis(ferrocenyl) ligands 
have been prepared and studied as metal cation sensors,5 These complexes showed shifts in 
the redox potential of the ferrocenyl group on binding of various cations to the receptor site. 
These complexes are reported to be selective for magnesium and zinc cations. 
There are several different methodologies available for the study of redox-active complexes." 
In this investigation several pyridyl ligands have been prepared with variations in substituent 
on the pyridyl ring as well as variation in position of substitution on the ring. Electronic 
interactions between the pyridyl ligand and coordinated metal centre can be monitored by 
looking at changes in chemical shift values for the free ligand and coordinated complex in the 
NMR spectra. These shifts can be correlated to the specific coordinated metal ion and the the 













systems containing ferrocenylpyridine ligands can be evaluated on the basis of considering 
changes in the chemical shifts of the ferrocenyl cyclopentadienyl protons. 
A further means of examining these complexes is through the use of electronic spectroscopy 
and electrochemistry. Due to the conjugated nature of the systems under investigation, study 
of their intermolecular interactions is possible using electronic spectroscopy. A comparison of 
the complexes in terms of variation in wavelength shift and extinction coefficient can be 
made. This information can be considered in terms of ligand variation in systems with a given 
metal centre. Cyclic voltammetry is particularly useful in evaluating systems containing redox-
active groups such as ferrocene. Provided single crystals can be obtained, X-ray 
crystallography is a particularly useful technique for the examination and comparison of the 
investigated complexes. 
Considering the properties of the investigated ferrocenylpyridine compounds, a series of 
multinuclear complexes were prepared with several transition metal centres. The properties of 
these complexes were further evaluated in terms of electronic interactions. The crystal 
structure analysis of several of these complexes was considered and the effect of 
substituents on the pyridyl ring evaluated in terms of bond lengths and angles. 
3.2 Preparation and properties of rhodium complexes 
Rhodium(l} is known to readily form coordination complexes with 7t acceptor ligands. Most 
complexes are of the square planar type, although some five-coordinate species are known. 
Many of the square planar rhodium complexes have high catalytiC activity due mainly to the 
metal being able to increase its coordination number by accepting ligands in the apical sites.s 
This behaviour of rhodium(l) complexes has led to an extensive systematic study of 
phosphine-donor complexes of the metal. 
This has changed to some extent over recent years since pyridines and bipyridines have 
been actively sought as linkers to solid polymer supports in a bid to bridge the divide between 
homogeneous and heterogeneous catalysis. An example of this includes catalysis of the 
water-gas shift reaction. This reaction usually produces hydrogen and carbon dioxide from 
gaseous water and carbon monoxide over a solid metal oxide catalyst at high temperatures? 
Initial investigations were reported as under homogeneous conditions with a lower thermal 
environment and the use of liquid water. This allowed a mechanistic study of the reaction and 
hence, led to greater catalyst efficiency.s Once the efficiency of the rhodium pyridine-













using cis-[Rh(COMamine)21PFs complexes (where amine = 4-picoline, 2-picoline, pyridine or 
2,6-lutidine) linked to 4-vinylpyridine polymer supports were carried out leading to the 
application of this work to several other reactions such as a catalytic reduction of 
nitrobenzene to aniline, under water-gas shift reaction conditions.9 
3.2.1 Rhodium carbonyl complexes 
The rhodium(l) carbonyl dimer, dichlorotetracarbonyldirhodium [3.1], represents a convenient 
and readily obtained starting material for the preparation of numerous monomeric rhodium 
complexes. The type of complex formed from [3.1] is dependant on the nature of the ligand 
being complexed, the ratio of the metal-ta-ligand and the solvent in which the reaction is 
performed. The dimer is readily prepared from the reaction of carbon monoxide with rhodium 
trichloride trihydrate10 and was first reported in 192511 but only correctly identified in 1943.12 
Since then, the dimer has been reacted with several nitrogen-donor Iigands13 as well as 
ligands containing other donor atoms via a bridge-splitting reaction. The preparation of 
complexes retaining some carbonyl groups allows for their study using a number of physical 
methods. The position of carbonyl stretching frequencies in the infrared spectrum for 
example, provides significant information about the electron density of the rhodium metal 
centre. These properties facilitate the study of rhodium(l) carbonyl complexes. These 
complexes have a variety of catalytic applications 14 and have interesting biological activity.15 
The rhodium(l) carbonyl monosubstituted pyridyl coordination complexes in this study were 
prepared through a bridge-splitting reaction of the rhodium carbonyl dimer, [3.1]. The 
complexes were prepared using the synthetic route shown in Figure 3.1. A bridge-splitting 
reaction of the dimer was carried out in a low coordinating solvent with solvation of the 
monosubstituted rhodium leading to the formation of a monomeric species. This was followed 
by addition of the ligand with the product formed by displacement of the solvent molecule. 
DC 0% ,,/ ~ ~
Rh 
OC/ 'CI 
[3.1) [3.4]: Red microcrystals, 69% 
Figure 3.1: Synthetic route for the preparation of [3.4] 
An alternative synthetic route is also available. The rhodium carbonyl dimer may be 
substituted for the related cydooctadienyl dimer [3.7] and this leads to the formation of the 













a solution of the cyclooctadienyl complex with carbon monoxide gas. The labile 
cyclooctadienyl group is displaced by the carbonyl ligands. Due to the obvious safety 
disadvantages, the use of the rhodium carbonyl dimer provides a more convenient method for 
the preparation of the rhodium carbonyl complexes. 
The complexes [3.2]-[3.6] (see Figure 3.2) were prepared using the synthetic route shown in 
Figure 3.1. It was found that in some cases the intermediates formed in the reaction were 
unstable in solvents such as dichloromethane. Accordingly, reactions were carried out in 
pentane, as for the preparation of compound [3.2]. 
[3.2]: R ::: H; orange powder, 81% 
[3.3]: R:::: NH2; dark yellow powder, 64% 
[3.4]: R :::: Fc; red microcrystals, 69% 
[3.6]: R :::: (CH=N)-Ph; yellow crystals, 63% 
[3.6]: R :::: (CH=N)(CeH4)Fc; maroon needles, 61 % 
Figure 3.2: Rhodium carbonyl complexes [3.2]-[3.6] prepared 
Complexes [3.2]-[3.6] were obtained in good yield. The effect of derivatising the pyridylligand 
as well as the effect of the substituent on the electron density at the rhodium metal centre 
was reflected in shifts in the carbonyl stretching frequencies in the infrared spectrum. Infrared 
spectra were aU recorded as potaSSium bromide pellets with strong bands obtained at 2091 
and 2016 cm-i for complex [3.2] assigned to the carbonyl stretching frequencies of the cis-
isomer. The introduction of the amine group in [3.3] showed a shift in the bands to 2076 and 
2012 cm-1 while substitution of a ferrocenyl group in complex [3.4J. showed shifts to 2086 and 
2011 cm-i . The presence of the elongated ligands in [3.5] and [3.6] resulted in shifts of 2088 
and 2013 cm-i as well as 2080 and 2003 cm-1 respectively. Comparison of shifts in the 
carbonyl stretching frequency of [3.2] with [3.3]-[3.6] showed a shift to lower energy. This 
corresponded to an increased electron density at the rhodium metal centre. The extent of shift 
appeared to depend on the nature of the substituent on the pyridyl ring. 
A further comparison can be made between the free ligand and complex in both [3.51 and 
[3.6] by evaluating the imine stretching frequency. A stretching frequency of 1595 cm-1 was 
obtained for the free ligand in [3.5]. This shifted to 1605 cm-1 on complexation to the rhodium 
metal centre. Similarly, a shift from 1623 cm-1 to 1643 cm-i was observed on complexation in 














Comparison of carbonyl chemical shifts in the 13C NMR proved difficult as in most cases the 
peaks observed were very broad and of low intensity. In some instances, they were not 
observed at all. The carbonyl stretching frequencies observed in the infrared spectrum 
conversely, were all intense, facilitating the type of comparison described above. Minor 
chemical shifts in the 1H NMR between the free ligand and coordinated complex were 
observed mainly on the a-proton adjacent to the nitrogen-donor atom on the pyridyl ring. 
Shifts in the position of the imine bond proton in [3.5] and [3.6] were also observed on 
comparison of the free ligand with complex, with downfield shifts of 8.44 to 8.81 ppm and 8.54 
to 8.57 ppm respectively. This indicated a deshielding of these protons on complexation. 
Comparing the cyciopentadienyl1H NMR chemical shifts of the ferrocenyl groups of [3.4] and 
[3.6] as well as relative to the free respective ligands, assisted in the evaluation of the effect 
of the spacer group. Furthermore, the effect of coordinating the rhodium metal centre could 





a-H: 4.76; P-H: 4.56; Cp: 4.08 [3.4] 
oc N~~ 'Rh' -- N
or!' 'CI ~ 
[3.6] 
a-H: 4.68; P-H: 4.36; Cp: 4.06 [3.6] 
a-H: 4.82; P-H: 4.61; Cp: 4.08 (ligand) a-H: 4.68; P-H: 4.36; Cp: 4.06 (ligand) 
Figure 3.3: Comparison of 1H NMR chemical shifts (ppm) for the ferrocenyl substituents of [3.4] 
and [3.6] respectively 
The difference in chemical shift values due to the presence of spacer groups has been noted 
on comparison of the free ligands, accounting for the differences in shifts between the a-H 
and I3-H In [3.4J and [3.6]. On comparing the shifts due to the complex with that of the free 
ligand, no significant differences could be established between these specific chemical shifts 
in [3.6]. It would appear that the long-range conjugative effect between the rhodium metal 
centre and the ferrocenyl group was reduced by the presence of the spacer, despite a 
conjugated system of bonds between the two. This proposal is leant some validity when 
comparing the differences between the free ligand and complex for [3.4]. 
3.2.2 Rhodium cyclooctadiene complexes 
The development of rhodium(l) cyclooctadienyl ligand complexes has been observed since 
the preparation of the rhodium cyclooctadienyl dimer, chloro(I,5-cyclooctadiene)rhodium(l) 














cyclooctadiene and rhodium trichloride trihydrate. The cycloodadienyl dimer is known to 
readily undergo a bridge-splitting reaction on addition of an uncharged monodentate ligand. 
These types of monomeric complexes have been studied for their catalytic properties.14•17 The 
presence of the labile cyclooctadienyl ligand appears to promote catalytic activity by readily 
dissociating as part of the catalytic cycle. Some investigations have also been carried out on 
the potential application of these complexes as bacteriocidal, viricidal and anti-neoplastic 
agents.1S 
3.2.2.1 Rhodium complexes with a single N-donor ligand [RhCI(COD)l] 
Several nitrogen-donor ligands were coordinated to the rhodium metal centre using a bridge 
split in the rhodium dimer followed by addition of the ligand (see Figure 3.4). 
~
~ 
Q, N ("'- ./" # f}"Rh'CI 
~ ~ 
[3.15]: Golden yellow microcrystals, 88% 
Figure 3.4: Synthetic scheme for the preparation of rhodium cyclooctadiene complexes 
Using this synthetiC route, a series of complexes shown in Figures 3.5 and 3.6 were 
prepared. Complexes [3.8]-[3.11] compare the effect of derivatising the pyridylligand with a 
set of conjugated substituents of increasing length. They also contain ligands that are 
representative of the spacer portion of several ferrocenylligands. 
[3.8]: R == H; bright yellow crystals, 62% 
[3.9]: R :: Ph; bright yellow crystals, 80% 
[3.10): R == (CH==N)-Ph; fine yellow crystals, 83% 
[3.11]: R == (CH==CH)(CaH4)-OCsH17; light yellow powder. 67% 
Figure 3.5: Rhodium cyclooctadiene pyridyl complexes [3.8]-[3.11] 
Changes in the pyridyl proton chemical shift values were observed on variation of the 
substituent on the pyridyl ring (indicated as Ha and Hb in Figure 3.5). More pronounced shifts 
in Ha proton values were observed. Complex [3.8] showed chemical shifts at 8.76 and 7.32 
ppm while introduction of the phenylene substituent in [3.9]. showed a shift of these peaks to 
8.75 and 7.57 ppm for Ha and Hb respectively. Complex [3.10] showed a more pronounced 
shift of 8.88 and 7.46 ppm for Ha and Hb• A slight shift in the imine proton peak position to 













compared to the related carbonyl complex, [3.5] where an imine peak was observed at 8.81 
ppm. Complex [3.11] showed shifts in both sets of pyridyl ring protons to 8.60 and 7.30 ppm 
respectively. 
The direction of shifts in peak positions on comparison of free ligand and complex are similar 
for both the carbonyl and cyclooctadienyl complexes. The positional shifts were overall more 
pronounced in the carbonyl complexes. This may be accounted for by conSidering the 
synergistic effect of the carbonyl groups on the metal through significant 1t back-bonding 
interaction. 
Complexes [3.12J-[3.18J include ferrocenyl substituents on the pyridyl ring. These complexes 
were prepared in relatively good yield using the general synthetic route described in Figure 
3.4. Several structural comparsions can be made between these complexes and the effect 
considered in terms their impact on the rhodium metal centre. Complex [3.19] is a pyrrole 
with the nitrogen donor atom occurring on the cyclopentadienyl ring of the 1',2' ,3',4' ,5'-
pentamethylazaferrocene compound. 
R 
r{' a r"Rh/ 
~" 'CI 
[3.12]: R ::: Fe; orange solid, 78% 
[3.13]: R ::: (CSH4)Fe; dark red powder, 70% 




[3.15]: R::: Fe; golden yellow microcrystals, 88% 
[3.16]: R = (CSH4)Fe; orange-mustard powder, 69% 
[3.17]: R::: Fe;orange-brown powder, 31% 
[3.18]: R = (CsH4lFe; orange powder, 40% 
[3.19]: orange crystals, 62% 
Figure 3.6: Rhodium complexes with ferrocenyl nitrogen donor ligands [3.12]-[3.19] 
The 1H NMR chemical shifts of the ferrocenyl cyclopentadienyl protons serve as a good 
indication of the nature of electrostatic interactions within the complex, particularly when 
comparing those of the free ligand with that of the rhodium complex. A comparison of 
cyclopentadienyl chemical shifts for selected complexes is shown in Figure 3.7, where the 












Q"'" /N~ I ,Rh, F.e 
(~( CI 
[3.19] 
a-H: 5.33, fj-H: 4.53 [3.19] 
a-H: 4.36, fj-H: 3.98 (ligand) 
Q, N~F\~ r"Rh/'~ ~" 'CI ~ 
[3.13] 
a-H: 4.68, f3-H: 4.37, Cp: 4.05 [3.13] 







a-H: 4.69, fj-H: 4.47, Cp: 4.04 [3.12] 
a-H: 4.82, fj-H: 4.61, Cp: 4.08 (ligand) 
Q, NT\.· r':Rh/ I~-~N~ 
Q( 'CI 
[3.14] $ 
a-H: 4.66, f3-H: 4.35, Cp: 4.03 [3.14] 
a-H: 4.68, f3-H: 4.36, Cp: 4.06 (ligand) 
Figure 3.7: Comparison of 1 H NMR chemical shifts (ppm) for ferrocenyl substituents of [3.19] and 
[3.12]-[3.14] respectively 
The cyclopentadienyl protons for complexes [3.12]-[3.14] showed similar chemical shift 
values, while only [3.12] showed significant drfferences on comparison of the free ligand and 
complex. The a-H and f3-H in [3.12] showed upfield shifts relative to the free ligand, indicating 
shielding of these protons on coordination of the rhodium metal centre, similar to the related 
carbonyl complex, [3.4]. The comparable chemical shifts obtained for the free ligand and 
complex for both [3.13] and [3.14] indicated a reduced conjugative effect between the 
ferrocenyl group and rhodium metal centre due to the presence of the spacer groups. 
Complex [3.19], contrary to complex [3.12], showed significant downfield shift on 
complexation of the rhodium metal centre. This indicated deshielding of these protons. The 
complex was paramagnetic with broad signals obtained in the 1 H NMR. 
The Ha pyridyl protons shifted downfield for complexes [3.12]-[3.14] and were thus 
deshielded on complexation to the rhodium metal centre. The imine bond proton in [3.14] 
showed an upfield shift on complexation of the rhodium metal centre. The Hb pyridyl protons 
showed upfield shifts on complexation to an extent dependant on the substituent on the 
pyridyl ring for these complexes. 
Comparison of ferrocenyl proton chemical shifts for complexes [3.15]-[3.18] showed no 
significant differences between the free ligand and complex (see Figure 3.8). In general, the 
a-H's of the respective complexes were significantly downfield to suggest some deshielding 
due to the presence of the nitrogen-donor atom. The pyridyl protons for each of the 
complexes showed a downfield shift, indicating deshielding of these protons on coordination 












C2'~ N ~"'Rh/ # ~/ .......... CI F.e 
[3.1~ ~ 
a-H: 4.66, I3-H: 4.40, Cp: 4.08 [3.15J 
a-H: 4.67, I3-H: 4.37, Cp: 4.06 (ligand) 
Q-::Rh~~ ~. 'CI ~ 
~ 
[3.17] 
a-H: 4.92, I3-H: 4.39, Cp: 4.05 [3.17] 




.... \N~ r 'Rh/ ~ 
~/ .......... CI ~ 
[3.16] 
a-H: 4.69, I3-H: 4.37, Cp: 4.07 [3.16] 
a-H: 4.69, I3-H: 4.36, Cp: 4.07 (ligand) 
~ 
~"'Rh/N I Q I ~ ~ ., Af} 
~/ CI ~-..::::;,..» 
Foe 
[3.18] $ 
a-H: 4.74, I3-H: 4.23, Cp: 4.05 [3.18] 
a-H: 4.71, I3-H: 4.35, Cp: 4.05 (ligand) 
Figure 3.8: Comparison of 1H NMR chemical shifts (ppm) for ferrocenyl substituents of [3.15]-
[3.18] 
3.2.2.2 Cationic rhodium complexes [Rh(COD)L21CI04 
As part of the investigation into the preparation of novel metal-containing complexes and the 
determination of electrochemical communication between these metal centres, square planar 
rhodium(l) cationic complexes were also prepared. Cationic rhodium complexes are well-
known primarily for their application in the field of catalysis. The complexes examined in this 
study include two pyridyl ligands and in the case of ferrocenyl ligands, would constitute the 
preparation of a trimetallic complex. The role of the rhodium metal centre can be established 
in electronic communication by determining the extent of communication between the 
ferrocenyl groups. 
The cationic rhodium(l) complexes were prepared using the general synthetic route described 
in Figure 3.9. Silver perchlorate was added to a solution of the rhodium dimer in acetone, 
yielding a solvated complex of general formula [Rh(COD)(M~CO)x1CI04' The addition of a 
nitrogen-donor ligand to this complex produced a cationic complex by displacement of the 













acetone --"II [Rh(COD)(Me:zCO)JCI04 
1 
[3.26]: Dark maroon powder, 81% 
Figure 3.9: Synthetic scheme for the preparation of rhodium complexes with two pyridyl ligands 
These complexes can also be prepared by replacing the counter ion present. A variation on 
the preparation of complex [3.21] (see Figure 3.10) included preparation of the complex with 
a hexafluorophosphate counter ion. The synthesis of this complex, [Rh(COD)L21PFs [3.20] 
involved the addition of excess pyridine to the rhodium dimer in ethanol, followed by addition 
of a concentrated aqueous solution of ammonium hexafluorophosphate. The product was 
obtained as a preCipitate that was collected by vacuum filtration. The preparation of further 
complexes with this counter ion was not carried out as complex [3.20] showed similar 
properties to that of complex [3.21]. 
[3.21]: R = H; yellow crystals, 87% 
[3.22]: R = Ph; light yellOlN pOINder, 59% 
[3.23]: R ::: (CH=N)-Ph; yellOlN pOINder. 59% 
[3.24]: R ::: Fe; red-brown crystals, 96% 
[3.25]: R = (CsH4)Fe, dark red crystals, 83% 
[3.26]: R :: (CH:::N)(CsH4)Fe; maroon-red powder, 89% 
Figure 3.10: Cationic rhodium complexes [3.21]-[3.26] 
Using the synthetic route described in Figure 3.9, a series of cationic rhodium complexes 
were prepared (see Figure 3.10). Complexes were obtained in good yield through 
concentration of the reaction mixture followed by addition of solvents such as diethyl ether or 
pentane to precipitate the product. The products were purified by recrystallisation. Selected 
1 H NMR data for complexes [3.24]-[3.26] is summarised in Figure 3.11. 
Little change was observed in the chemical shifts of the ferrocenyl protons for complex [3.26] 













complex [3.26] were shifted downfield on coordination of the rhodium metal while the imine 
protons were shifted upfield on complexation. Similar trends were observed for complex 
[3.23] but with larger shifts. Complex [3.24] showed upfield shifts in the ferrocenyl protons 
with a similar trend to the neutral complex [3.12]. 
~ 
~, ~.A t,J" /N~ 
~ /Rh, ~' CI04 
~ N 'I 
- Foe 
[3.24] 0 
Ct.: 4.68, p: 4.45, Cp: 3.98 [3.24] 
Ct.: 4.82, p: 4.61, Cp: 4.08 (ligand) 
Q 
I ~.A t,J"Rh/N~ 
h/ "D-04?' ~ N \ J 
- lie 
[3.25] 0 
Ct.: 4.80, J3: 4.50, Cp: 4.14 [3.25] 
Ct.: 4.70, J3: 4.37, Cp: 4.07 (ligand) 
[3.26] 
Ct.: 4.67, 13: 4.36, Cp: 4.05 [3.26] 
Ct.: 4.68, J3: 4.36, Cp: 4.06 (ligand) 
Figure 3.11: Comparison of 1H NMR chemical shifts (ppm) for ferrocenyl substituents of [3.24]-
[3.26] 
Contrary to the observations so far, a downfield shift in the ferrocenyl protons of complex 
[3.25] was observed. This was regarded in contrast to the neutral complex [3.13] and the free 
ligand [2.9]. where no shift in these protons was observed. The similarity in the ferrocenyl 
chemical shifts for the free ligand [2.9] and complex [3.13] was attributed to the presence of 
the phenylene spacer group. The observed effects in [3.25] could be due to resonance 
effects that were amplified due to the presence of two ferrocenylligands in the complex. 
3.2.2.3 Chelatlng 1, 1'·dipyridylferrocene ligand complexes 
The rhodium complexes prepared so far have contained monosubstituted ferrocenylligands. 
Selected 1,1 '-disubstituted ferrocenylpyridines have been prepared and these complexed to a 
rhodium metal centre using a similar synthetic route to that described in Figure 3.9. The 
preparation of complex [3.28] has been reported using this synthetic route 19. Complex [3.27] 
was prepared using the same synthetic route but the solvent substituted for ethanol since 












[3.27]: Dark red crystals, 67% 
a: 4.85 and p: 4.52 [3.27] 
a: 4.55 and p: 4.34 (ligand) 
Metal complexes 
~ --tI 
~ 'Rh:- )( CIO .. 
~N: --p 
. V 
[3.28]: Orange-red crystals, 65% 
a: 4.91 and p: 4.36 [3.28] 
a: 4.91 and p: 4.36 (ligand) 
Figure 3.12: Comparison of lH NMR chemical shifts for rhodium 1.1'-dipyridylferrocene complexes 
[3.27]-[3.28] 
A downfield shift was observed for the ferrocenyl protons of complex [3.21] on complexation 
of the rhodium metal centre, in contrast to complex [3.28] where no difference was observed. 
The minimal difference in ferrocenyl chemical shifts observed for complex [3.28] was in line 
with those observed with the monosubstituted complex [3.11]. The downfield shifts observed 
in the ferrocenyl protons for complex [3.21] were contrary to the upfield shifts observed for 
the monosubstituted neutral [3.12] and cationic [3.24] complexes. Assuming that the effect of 
coordination of the rhodium metal centre is felt through the conjugative system of bonds 
through the resonance stabilising effect, it would appear that these effects differ in the 
disubstituted complexes. 
3.2.3 Phosphine-donor complexes 
Although the majority of ligands investigated in this study were nitrogen-donor, some 
phosphine-donor ligands were investigated in order to draw comparisons between the ligand 
systems and their metal complexes. Some rhodium complexes were prepared with the mono-
and bidentate ligands ferrocenyldiphenylphosphine and 1,1 '-bis(diphenylphosphino)ferrocene, 









[3.29): Orange-gOld powder. 81% [3.30): Mustard-yellow powder, 65% [3.31]: Brown crystalline solid. 99% 
a: 4.34, B: 4.28 r3.291 a: 4.89, B: 4.14. co: 4.31 r3.301 a: 4.29, B: 4.13, co: 4.04 (3.31] 













Complexes [3.29H3.31] were prepared using a similar synthetic route to the rhodium 
complexes With nitrogen..<Jonor ligands (see Figures 3.4 and 3.9) and were obtained in good 
yield. 
The 'H NMR spectrum of complex [3.29] was obtained in deuterated chloroform while 
complexes [3.30]-[3.31] were obtained in deuterated benzene. Due to solvent effects. 
chemical shifts for [3.30] and [3.31] were obtained lurther downfield than normally 
expected." However. comparison of chemical shilts for the ferrocenyi protons in complexes 
[3.30] and [3.31] clearly showed trte sigrllficant downfield shift of these protons in complex 
[3.30]. This is cOrlsisterlt With effects observed for neutral and cationic rlilrogen donor 
complexes, for example. complexes [3.12] and [3.24J. 
3.2.4 Crystal structure analysis 
X-ray crystallographic data can provide insight irlto the molecular structure and irlteractions of 
molecules within a crystal. BoI1d lel1gths and bond al1gles are obtairled which can be used in 
cOrljunction with spectroscopic data to account lor irlteractions within a molecule. 
The crystal structure of complex [3.2J has been repartecf' and is preserlted below as a model 
complex (see Figure 3.14 and Table 3.1)_ The complex has been reported as crystallisil1g 
with a triclinic space group P-1 contairling two molecules in an asymmetric unit with no 
internal coordination, The geometry around the rhodium metal cerltre is square planar 
Figure 3.14: Molecular structure with labelled mole.;ule tor complex 13.2], hydrogen atom labels 












obtained for each of the molecules. The pyridyf and phenylene rings were confirmed as 
delocalised. 
Table 3.2: Selected bond lerlgths (A) ard angtes (') fDr the two molecu les in ~symm etriG unit 01 [3.6] 
------- Molecule 1 Molecule 2 
Rh(I)-CI(I) 2.357(1) Rh(2)-C~2) 2.353(1) 
Rh( 1 )-N( 1) 2. 108(~) Rh(2)-N(5) 2.115(~ ) 
Rh(I)-C(I) 1.852(5) Rh(2)-C(28) 1.852(6) 
Rh(1)C(2) 1.857(6) Rh(2)-C(29) 1.850(5) 
O(I)-C(I) 1.133(6) O(3)-C(28) 1.098(6) 
O(2)-C(2) 1.111(6) O(4)-C(29) 1 128(6) 
N(2)-C(9) 1415(6) N(38)-C(39) 1416(6) 
N(2)-C(8) 1265(6) C(37)-N(38) 1.271(6) 
C(7)-C(8) 1467(6) C(34)-C(37) 1478(6) 
N(1)-C(5) 1.333(4) N(5)-C(32) 1.345(4) 
C(5)-C(6) 1.3H (5) C(32)-C(33) 1.367(5) 
C(6)-C(7) 1.388(5) C(33)-C(34) 1.387(5) 
C(9)-C(12) 1.386(5) C(39)-C(42) 1.395(5) 
C(12)-C(13) 1.377(5) C(42)-C(43) 1371(5) 
C(13)-C(14) 1.395(5) C(~ 3)-C(~4) 1.387(5) 
C(1 4)-C(15) 1.478(5) C(~4)-C(~ 5) 1.4H (5) 
CI(1 )-Rh(1 )-N( 1) 90.20(8) C~2)-Rh(2)-N(5) 91.22(8) 
N(1 )-Rh(l )-C( 1) 176.22(14) N(5)-Rh(2)-C(29) 177.96(15) 
C(1 )-Rh(l )-C(2) 89.09(16) C(28)-Rh(2)-CI29) 88.67(16) 
CI(1 )-Rh(l )-C(2) 179.14(13) C~2)-Rh(2)-C(29) 90.20(11) 
CI(1 )-Rh(l )-C(1) 90.62(11) C~2)-Rh(2)-C(28) 176.53(13) 
Relevant bond lengths and arJgles for complex [3.6] were fairly similar to that of complex 
[3.21- Both the spectroscopic data and crystal strllcture analysis of the complex suggested 
that despite the existence of a conjugated oolwork between the respective metals in complex 
[3.6], the extended spacer group between these centres resulted in a diminished interaction. 
In both molecules the cyclopentadienyl ferrocene rings were planar The ril1gs showed a 
marginal tilt towards each other with angles of 0.73' (0.27) and 1.93° (0.29) for the molecules. 
The cyclopentadienyl rings were oot completely eclipsed in the ferrocenyi group but were 
rotated away from each other by an angle of 7.8' and 3.0' in each of the molecules This 
degree of rotation has been related to mooosubstttution of the ferrocenyl group and to the 
nature of the substituent The phenylene rirJg showed a 25.7' rotation relative to the plane of 












Figure 3.16: Perspective view of two molecules of complex [3.6] in t~e asymmetric ullit 
The molecules are packed in a tail-to-tail conformation in the unit cell. Despite the presence 
of two molecules in the asymmetric unit and the elongated nature of the complex. there 
appears to be some order with in the crystal structure (see Figure 3.17). Despite the apparent 
proximity of molecules to each other. no significant intermolecular interactions were observed. 



















Unit ,ell dimensions 
Volume 
~L (Mo·Ku) / mm'-, 
Rellections c~lected I unique 
Goodness-of-f~ on F' 
Final R indices [1:>2sigma(I)] 
R indices (all data] 
".,,"-----
C"H ,sCIFeN2 0,Rh 
560.61 
[1.25 x [1.09 x 0.[17 mm' 
1 73(2) K 
MonoclinK; 
P2,/, 
a = 14.48[1(1) A 
b=18.780(I)A 





j; _ 111.5Cl7(1)" 
.,=00" 
23441 / 9672 [R(irJI) _ [1.051 3] 
HXl8 
Rl = [1.0430, wR2 = [1.0725 
Rl _ 0.1013. wR2 _ 0.0857 
The crystal structure of complex [3.15] was obtained from single crystals grown from a 
mixture of di'hloromethane and pentane (see Figure 3.18). The ,omplex was observed to 
crystaltise in the triclinic space group P-l. Least squares refinement of the structure gave a 
final R factor of 0.0308. Details of crystal and structure refinement data are summarised in 
Table 3.5 with selected bond lengths and angles listed in Table 34. 













The coordination geometry around the rhodium metal centre in comple;o; [3.15] is square 
planar. A torsion angle of 1290 was obtained between the pyridyl ling and the adjacent 
cyclopentadienyl ring. The cyclopentadienyl rings are planar WIth a 1.60 angle of tilt The lings 
are not completely eclipsed having a rotation angle of 5.6'. The Rh-N IJond length is 2.1 09 A. 
which is in accordance with observed bond lengths of similar complexes reported in the 
literature." 
Figure 3.19: View of molecular packing diagram of [3.15] 
The packing diagram for the crystal structure of complex [3.15] (see Figure 3 19) showed an 
ordered unit cell with molecules packing in a head·to·tail arrangement. No significant 
Intermolecular contacts were observed between the molecules in the unit cell. 
Figure 3.20: Labelled perspective view of molecular structure for complex [3.16]. hydrogen atoms 
labels omitted 
The crystal structure of [3.16] was obtained from single crystals grown in a mixture of 
dichloromethane and pentane (see Figure 3.2(/). The complex was observed to crystallise in 












0.0289. Details of crystal and structure refinement data are summarised in Table 3.5 with 
selected bond lengths and angles listed in Table 3.4 
Table 3.4: Selected bond lengths (A) and angles i") for complexes [3.15] and [3.16] 
[3.151 [3.16] 
_ .. _--------_ ... 
Rh(I)-C~I) 2.3585(10) Rt>(I)-CI(I) 2.3719(11) 
Rh(I)-N(I) 2109(2) Rt>(I).N(I) 2.1031(9) 
Rh(I)-C(I) 2.130(3) Rt>(I)-C(I) 2.116(3) 
Rh(I)-C(2) 2.124(3) Rt>(I)-C(2) 2.109(3) 
Rh(I)-C(S) 2.1()4(3) Rt>(I)-C(5) 2.131(2) 
Rh(I)-C(6) 2.1()4(3) Rt>(1 )-C(6) 2.138(2) 
N(1).C(9) 1.3~0(3) N(1)-C(13) 1.340(3) 
C(9)-C(10) 1360(3) C(13)·C(12) 1.389(3) 
N(I)-C(13) 1 343(3) N(I)-C(9) 1.343(3) 
C(13)-C(12) U66(~) C(9)-C(10) 1.376(3) 
C(12)-C(11) 1.373(~ ) C(11l-C(10) 1.371(~) 
C(11)·C(10) 1.367(~ ) C(12l-C(11) 1.397(3) 
C(10)-C(14) 1.~61(~ ) C(t2l-C(14) 1.482(3) 
C(2)-Rh(1 )-C(I) 37.64(12) C(H l-C(19) 1.390(3) 
N(I ).Rt>(1 )-C~ 1) 88.26(6) C(1 4)-C(15) 1385(3) 
C(2)-Rt>(1 )-q I) 90.19(9) C(19)-C(18) 1.381(3) 
C(9)-N(1 )-Rh(l) 11 ~ .70(17) C(15)-C(16) 1.375(4) 
C(11 )-C(1 0)-C(14)·C(15) 133.8(3) C(18l-C(17) 1.389(3) 
C(16)-C(17) 1 36~ (4) 
C(17)-C(20) 1.47~ (3) 
C(2)-Rh(1 )-C(I) 3648(11) 
N(I l-Rh(1 l-CI(I) 66.68(6) 
C(2)-Rh(1 )-CI(I) 158.17(8) 
C(9)-N(1 )_Rh(l) 122.96(16) 
C(19)-C(1 4)·C(1 2)·C(13) 26.2(~) 
C(24)-C(20)-C( 17)-C(16) 29 . 6(~ ) 
The structure of complex [3.16J showed many similarities to complex [3.15J The rhodium 
metal centre is square planar and the angle of rotation between the plane of the pyridyl and 
phenylene rings was 25° The cyGiopentadtenyl rings were found to be almost parallel to one 
another with an angle of 3.11° between the respective planes. Unlike the previous rhodium 
structures, the cyclOpentadienyi rings were eclipsed with only a l' angle of rotation The 












The crystal structure packing diagram for complex [3.16] revealed that the molecules pack in 
a highly ordered fashiOll adOpting a head-to-tail co%rmation similar to that of complex [3.15] 
(see Figure 3.21). No significant intermolecular interactions were obseTVed between the 
respective molecules in the unit cell. 
Figure 3.21: View of molecular packing diagram for [3.16] 















~ _ 6,946(I)A a _ 91,38(3)' 
b K 9.999(2) A ~ _ 99,30(3)" 
c=14.789(3)A '(=97,11(3)" 
Volume 1004,6(4) A' 
~ (Mo-Kal / mm" 1 ,663 mm ' , , 
Rellections collected 1 unk1ue 6208 1 4397 [R(int) _ 0.0315] 
Goodness-of-fit on F' 1,019 
Fir.al R ir;:jices (1)2sigma(I)] R1 _ 0.0308, wR2 = 0,0566 








a=7.003(I)A a=76,00;3) ' 
b = 10,026(2) A Il - 80.79(3)' 
c _ 17.609(4)A r - M.92(3)" 
1195.5(4)A' 
1.427 mm" , 
3405515459 [R(int) _ 0,0465] 
1,025 
Rl = 0.0289. wR2 = 0.0657 












The crystal structures of complexes [3.15] and [3.16] show similarities in their space groups, 
unit cell dimensions and ~ecular packing. Complex [3.16] has a longer o-axis to 
compensate for the added p/1enylene space group. 
3.2.5 Electrochemical study of rhodium complexes 
The study of transition metal complexes using electrochemistry has gamed increasing 
popularity. A considerable amount of information is known about reactive paramagnetic 
complexes generated by electrochemical methods," Cyclic voltammetry as well as 
chronoamperometry are ideally suited to study the reactivity of electrogenerated species.?' 
These techniques have become popular for the study of organometaltic catalytic cycles, 
modified electrodes and biochemicat. macromolecular and p/1otoelectrochemicat devices," 
The cyclic voltammogram for the rhodium complex [3.14], is shown with three key areas 
highlighted (Figure 3.22), Peak 1 is an irreversible wave due to the oxidation of rhodium(l) 
and is often very broad It is only occasionally observed. Peak 2 is a typical reversible 
ferrocenyl redox wave. Shifts in the position of this wave can be related to substituents on the 
ferrocenyl group and to the presence 01 coordinated transition metals. An irreverSible wave 
occasfonally occurs at the potential indicated by the brace labelled Peak 3 and has been 
identified as being due to the reduction of rhodium(t). when rhodium metal is deposited on the 
electrooe surface. 
, , 
" Potential (V) 
· o.~ 
Figure 3.22: Cyele voltammogram for rhodium ferrocenyl complex [3.141 
, 
'" -1.~ 
The broadness of Peak 1 makes it difficult to use this to monitor changes in the rhooium 












wave potential cf Peak 2 relative to ferrocene [2.2]' Fig(1re 3.23 displays the reversible 
ferrocenyl redox waves obtained for complexes [3.16] and [3.13] 
-[2.2] 
- [3.16] 
- [3.13] Q 
",';::::;;:;;;;::========4 0 0 [','I 
~? 





Figure 3.23: Over[ay of cydk: voltammograms for lerrocene [2.2] and complexes [3.16] and [3.13] 
Reversible redox waves were obseNed for all modium lerroceny1 complexes examined. Table 
3.7lists the half-wave potential. E" . and corresponding anodic Epo (2). and cathodic E"" peak 
potentials. Where possible. the irreversible anodic peak potential. Epo (1) corresponding to 
rhodium(l) oxidation was recorded 
Table 3.6: Electrochem k:a[ data lor several rhodium([) complexes in acetonitrile 
Complex Complex type Ligand E .. (1) Eo. (2) '" " number (mV) (mV) (mV) (mV) 
[2.2] Ferrocene +120 ." +75,~ 
[3.7] [R~COD)Clk +446 
[3.8[ RhCI(COD)l " +~29 [3.12] 4-Fcpy +377 +240 +008.5 
[3.15] 3-Fcpy +223 +148 +185.5 
[3.17] 2-Fcpy +192 +118 +155 
[3.13] 4·Fc(C.,H,)py +612 +194 +125 +159.5 
[3.16] 3-Fc(C"H4)py +165 . % +1 30.5 
[3.18] 2-Fc(C"H.)py +165 ." +127 
[3.10] Pr.(NC)py ~~ 
[3.14] • Fc(C, H, )NCpy +616 +1 51 ." +126 
[3.6[ RhC kCO),l Fc(C, H, )NCpy +1 45 ." +113.5 
[3.23] [Rh(COD)l,]CIO, 4-Fcpy +2.70 +179 +224.5 













The resonance effect i1 the conjugated rilOdium complexes was demonstrated by the 
decreased positr.e sh'lft in tile hal'-wave [Xltential observed on comparison of complexes 
[3.12]. [3.15] and [3.17]. wc,'ch was consistent v~th spectroScopiC trends. This trend was 
' urther observed in the rela~ed complexes [3.13] [3,16] and [3.18] with pheny!ene ~pacer 
groups. The effect of tile spacer grOllpS was clRarly dRmon~trated on comparison of 
cOOlplexes [3.12], [3.13] and [3.14] wtlere a gradual deGrease in E", valuR was observed 
Cr~nges in the spect~tar ligands did nat appe~r to pkly a significant role on elRctron c 
interactions as complexes [3.6] and [3,14] dispklyed sim il~r E". val L>eS 
Tt-e single reversible peak obta'ned for thR cyclic voltammograms of complexes [3.24] ard 
[3,25] indlc~ted that no electrochemical cOrTYllUn ication occurred between tre ferrocenyt 
groups of tilese trinucle~r complexes through tre rrodium metal centre Furthermcre, tile 
electronic interactkm was red l£ed compared to that of the 'leutral conlplexes [3,12] and 
[3.13] Tilese effects were ~ttributed to the resonance eFect in the conjugated conlplexes 
3.2.6 Electronic spectroscopy of rhodium complexes 
The electronic spectra of tre rrodium complexes WRrP otxainRd ;r dicc,klrometc,ane WhiR 
the bands dlJe to transitions ir the 'er'ocenyt and pyridyl groups were st;1I 'ound. a d-d 
tr~nsition due to tre presence 0' tre rhodium metal cRntrP transpired, This rhodium ,ligand 
~. metal-to-ligand cl'.argetransfer ba'ld occurrej in tre range of 350 to 550 '1m, depending on 
tile specific ligand Electroric spoc'ra 0' similar COmpleXRS in dicr.lorometc,ane sr.ow two 
strong bands at approximater,- :>00 ~nd 400 nm v~tr ar exti'lction coefficient of the order cI: 
10' mol".dm'.cm·' and a weaker band ne~r 500 nm, Wllicl' is some~'mes d:scernlble as a 
sc,ouldRr only.'" 
A comparison of tr.e major bands t0gell'.er will' extinctkm coefficients in electronic spectra for 
se~ted rl'.odium complexes in dichloramethare is summarsed in Tables 3,8 and 3,9 
Interesting comp~risons can be made betweer the single and b'-ligand complexes [3.12] and 
[3.24] as well as complexes [3.13] and [3.24] In eacc, 0' tc,ese caSRS, a shijj in thR transitions 













Table 3.1: Electronic spectral bands and extinction coefficients for a range of rhodium cyclooctadienyl 
complexes 
Complex Wavelength I nm 
number [Extinction coefficient I mor1.dm3.cm·1] 
[3.8] <?'FufNJ 366 298 
~ / 'cl [1 634] [4210] 
Q":"'/~ 450 358 308 [3.15] 
~ ... 'CI F.e [593] [2474] [4344] 
~ 
C(,. N~ 466 360 308 
[3.12] ,.. ":Rh/ F.e 
Q( 'CI $ [1 811] [5670] [14712] 
[~RK::~loo. 482 370 314 [3.24] [2760] [4880] [17249] 
Q"~ 452 362 322 [3.16] 'Rh/ ~ [1 050] [4333] [5076] ~/ 'CI 
Q' N~ 460 376 318 [3.13] ,.. "'Rh/ 
~/ 'CI 0 [1 755] [6095] [8 122] 
~ 
~"'~Q-04> 472 384 314 [3.24] CIO, ./'-~ [4887] [10080] [16192] 
0 
The highly conjugated complexes [3.10]. [3.14]. [3.25] and [3.26] in Table 3.9 all show 
relatively large extinction coefficients for each of the transitions. A comparison of complexes 
[3.14] and [3.6] showed a variation in the middle band, with complex [3.6) exhibiting a more 
intense tranSition and increased extinction coefficient with a bathochromic shift relative to 













Table 3.8: Electronic spectral band positions and extinction coefficients for a range of rhodium 
complexes 
Complex Wavelength I nm 
number [Extinction coefficient I mor1.dm3.cm·1] 
~"'~/NY-O 354 336 [3.10] [11 644] [12405] ..•. "CI 
~~/N N~ 488 358 298 [3.14] .... "CI [1 998] [9459] [9701] 
~ 
Q 
~"'''~-04> 504 364 302 [3.25] /Rh,~N CI04 
• N [7895] [14296] [13328] 
oc, / N~ 500 374 300 [3.6] Rti 
oc/ 'CI .$ [3621] [13318] [9 518] 
3.3 Preparation and properties of iridium complexes 
The chemistry of iridium(l) complexes is known to be similar to that of rhodium(I). In this 
investigation a series of iridium(!) square planar complexes were prepared. Iridium(l) 
complexes are generally regarded as less catalytically active. However, intensive 
investigation of iridium(l) complexes as hydrogenation catalysts have led to their use in the 
reduction of sterically hindered olefins.26 
3.3.1 Iridium complexes with a single N-donor ligand [lrCl(COD)L] 
Iridium complexes containing a single nitrogen donor ligand were prepared from [lrCI(COD)]2 
[3.32] using a similar synthetic route to the synthesiS of the rhodium cyclooctadiene 
complexes (see Figure 3.4). A series of iridium complexes were prepared with systematic 
changes in the ligands from a simple unsubstituted pyridyl ligand [3.33], to ferrocenyl ligands, 














\2", /NJ I):' C\' 'CI 
[3.33]: R ::: H; bright yellow powder, 77% 
[3.34J: R ::: Ph; yellow crystalline solid, 75% 
[3.35]: R ::: (CH:::N}-Ph; orange powder, 57% 
[3.36]: R ::: Fe; orange-brown solid, 51 % 
Figure 3.24: Iridium pyridyl complexes [3.33J-[3.37] 
[3.37]: Maroon powder, 52% 
In complex [3.37]. the labile cyclooctadiene ligand was displaced with carbonyl groups by 
bubbling carbon monoxide gas through a solution of the cyclooctadienyl complex. Comparing 
the ferrocenyl proton chemical shifts of the iridium complex [3.37], the related rhodium 
complex [3.6] and the free ligand [2.16]. showed no significant changes. This is in 
accordance with complexes containing extended ligand systems. The imine bond proton for 
complex [3.37] showed a slight shift on coordination of the iridium metal. A similar shift was 
observed in complex [3.6]. Some differences were observed in the carbonyl stretching 
frequencies of complexes [3.37] and [3.6] (see Figure 3.25). 
~ OC", N~_ ~ a.: 4.69,13 4.38, Cp: 4.06; v CO: 2067,1991 [3.37] 
1/ N 1\ " / ' \\ II F. a.: 4.68,13 4.36, Cp: 4.06; v CO: 2080, 2013 [3.6] 
OC 'CI ~ IC!:5\ a.: 4.68, 13 4.36, Cp: 4.06 [lIgand] 
[3.37] ~
Figure 3.25: Comparison of 1H NMR (ppm) and IR stretches (em-1) for complexes [3.37] and [3.6] 
The majority of iridium complexes decomposed or tended to show line broadening when NMR 
spectra were obtained in deuterated chloroform. The 1H NMR of complexes [3.33], [3.34] and 
[3.36] were obtained in deuterated benzene. Comparing the pyridyl proton chemical shifts of 
complexes [3.33], [3.34] and [3.36], showed deshielding of the Ha proton on derivatising the 
pyridylligand. Complex [3.36] displayed a relatively large upfield shift in the Cp protons. This 
was due to solvent effects rather than interaction of the protons with the iridium metal centre. 
The pyridyl proton chemical shifts for complex [3.35] displayed deshielding of the Ha protons 
on complexation of the iridium metal while the imine proton chemical shift remained 
unchanged, relative to the free ligand [2.19]. 
3.3.2 Cationic iridium complexes [lr(COD)Lz]CI04 
The preparation of iridium complexes containing two nitrogen donor ligands followed a similar 













The coordinating solvent, ethanol, was found to be ideal for this readion and no 
decomposition was observed. Furthermore, the produds were obtained in high yield. These 
complexes allowed for simple comparison of the effed of placing a ferrocenyl substituent on 
the pyridyl ring of an iridium complex [3.38]. 
+ AgCIO" ethanol.. [lr(COD)(EtOH)xlCIO" + AgCI 
RT 
1 ~ whereR=H,Fc 
~R 
'<' NJ (" " Ir......... CIO" Q(" 'Q 
R 
[3.38J: Yellow crystalline powder, 70% [3.39]: Reddish-pink powder, 94% 
Figure 3.26: Cationic iridium cationic complexes [3.38] and [3.39] 
Both the pyridyl and ferrocenyl protons of complex [3.39] shifted downfield on complexation 
of the iridium metal. The pyridyl shifts were more pronounced than in the related rhodium 
complex [3.24]. Furthermore the downfield ferrocenyl chemical shifts were contrary to the 
related rhodium complex [3.24], which displayed upfield shifts relative to the free ligand [2.6]. 
3.3.3 Electrochemical behaviour of iridium complexes 
The iridium complexes all display reversible ferrocenyl redox waves (see for example Figure 
3.27). Results are reported relative to the half-wave potentials of ferrocene in acetonitrile (E% 
+75.5 mV) (see Table 3.9). 
Positive shifts in half-wave potential relative to ferrocene and the free ligands were observed 
for all the iridium ferrocenyl complexes (see Table 3.9). The single reversible redox wave in 
the cyclicvoltammogram for complex [3.39] indicated that no communication occurred 
between the ferrocenyiligands through the iridium metal centre, as with the related rhodium 
complex [3.24]. The relative shift in E% value for complex [3.36] was less pronounced than for 













significant shilts than their rhodium counterparts [3.24) and [3.6). This may be due to the 
resonance conjugative effect and the electron density of the metals. 
, 
_ ____ ~_'2 
200 100 -20 
Potential (mV) 
Figure 3.27: Cyel;:; voltammogr~m for irijium complex [3.36] in acetorlitriie 
Table 3.9: Electrochemical data lor ferrocenyi iridium complexes in acetorlitrile 
Complex Complex type Ligand '. '. Complex Ligand 
number (mV) (mV) E~ (mV) E,. (mV) 
[3.36] IrCl(COD)L 4-Fcpy +253 +187 +220 +205.5 
[3.39] [lr(CODIL,ICIO, 4-Fcpy .'00 +219 +262,5 +205.5 
[3.37] IrC~CO),L Fc(CoH.)NCpy +164 .00 +1 27 +113 
3.3.4 Elect ron ic spectroscopy o f iridium complexes 
The electronic spectra 01 selected iridium complexes were recorded in dichloromethane. The 
description of electronic transitions made for the rhodium complexes holds true for the iridium 
complexes as welt, with the high energy transition at appro~imately 300 nm due to the pyridyl 
substituent and the low energy transition at appro~imately 450-500 nm due to the ferrocenyl 
dod transition. The remaining band was assfgned to an overlap of ferrocenyl as well as metal-
to-ligand charge transfer from the iridium metal centre. 
The electronic transitions for the ferrocenyl iridium complexes occur at similar jXlsltions to the 
related rhodium complexes [3.12], [3.24] and [3.6) (see Tables 3.7 and 3.8). The extinction 
coefficients for the complexes [3.39) and [3.37], are significantly higher than that lor the 
related rhodium complexes, Since similar ligands are used in both the rhodium and iridium 












Table 3.10: Electronic spectral band positions and extinction coefficients far ferrocenyl iridium 
complexes in dichloromethane 
Complex Compound Wavelength I nm 
number [Extinction coefficient I mor1.dm3.cm·1] 
~ •• ~N 466 370 306 [3.36] :Jr 
."" 'CI [1 870] [5978] [9436] 
~:::< 488 366 312 [3.39] cia. [5 149] [9500] [28371] 
OC,/N~~ 514 378 255 
[3.37] Ir N 
OC/'CI ~ [4433] [14877] [23 121] 
3.4 Preparation and properties of palladium complexes 
The preparation of complex [3.40] has been reported using the synthetic route described in 
Figure 3.28.27 This synthetic route has been reported as giving the trans isomer of the 
palladium complexes. 
EtOH-H20 1 :21 EtCH II 
RT/24 h 
Figure 3.28: Synthesis of palladium complex [3.40]27 
CI, ,..0 
Pd 
ON/ 'CI ~I 
[3.40]: Light yellow powder, 77% 
The synthetic route in Figure 3.28 is, however, limited by the solubility of the ligands and the 
duration of reaction time (at least 24 hours). To overcome these shortcomings, an alternative 







[3.42]: Red powder, 83% 













The ligands investigated were soluble in dichloromethane, whereas the palladium starting 
material was not. The palladium complexes were prepared using a biphasic system with the 
ligands in a dichloromethane solution and the palladium starting material in an ethanol-water 
mixture. The reaction mixture was stirred vigorously at room temperature to increase the 
interface of reaction between the solvent layers. A phase-transfer reaction was established 
between the layers, where the palladium product formed was found to be either soluble in the 
dichloromethane phase or formed as an insoluble precipitate. The reaction could be 
monitored as the palladium layer was observed to lighten from dark brown to colourless. 
The use of this synthetic route gave a substantial decrease in reaction time, with the longest 
reaction time being 10 hours; this constitutes a decrease of more than half the reaction time 
when compared to the synthetic route described in Figure 3.28. Complexes [3.41]-[3.45] 
were prepared using this synthetic route and were obtained in high yield (see Figure 3.30). 
r'YR 
Ck ... /!lI.~) 
Pd C"'" 'CI 
R 
[3.41]: R :: Ph; light yellow powder, 83% 
[3.42]: R = Fc; red powder, 84% 






[3.44): Mustard microcrystals, 84% 
[3.45]: Dark red microcrystals, 78% 
Figure 3.30: Palladium complexes [3.41]-[3.45] prepared using the biphasic synthetic route 
The pyridyl proton chemical shifts for all complexes display downfield shifts on complexation 
of the palladium metal centre. The proton attached to the carbon adjacent to the nitrogen 
donor atom, Ha, showed the largest shift on complexation of the palladium metal for complex 
[3.45], contrary to the observed ferrocenyl shifts where very little difference was observed 
between the free ligand and complex. Complexes [3.43] and [3.44] showed downfield shifts 
for both a-H and ~-H on complexation to the palladium metal centre (see Figure 3.31), 
contrary to trends observed with the rhodium complexes. Complex [3.42], was the only 
complex that displayed upfield shifts on complexation while complex [3.45] showed no 













CI~ ,N"v'" $ 
eo D/ 'CI 
~ [3.42] 
(/: 4.72, ~ 4.52, cp: 4.07 [3.42] 
Ct· 4.82, Ii 4.61, cp 4.08 [ligand] 
~ 
I N) 6 
CI, / eo 
~t/ 'CI 
~U ¢. [3.441 
a 4.73, p 4.46. cp: 4.18 [3.44] 
(/: 4.67. B 4.37, CP: 406 [ligand] 
Metal complexes 
[3.43] 
Ct· 4.72. Ii 4.41, cp- 4.08 [3.43] 
a: 4.70. Ii 4.37. cpo 4.07 [ligand] 
[3.45] 
a: 4.92. B 4.39, cp: 4.16 [3.45J 
Ct· 4.92_ B 4.39, CP: 4.05 ]ligand] 
Figure 3.31: Compalison of 'H NMR chemical shifts (ppm) for complexes ]3.42]-]3.45] 
The spectroscopic results indicate that the conjugative resonance effects differ in the 
palladium complexes to the rhodium complexes with the same ligands. The unusual 
behaviour may be related to the difference in geometry between these complexes with the 
trans effect potentially playing a role in the spectroscopy of the palladium complexes. 
3.4.1 Crystal structure analysis of palladium complex 
The crystal structure of the palladium complex [3.44] has been obtained. As with the rhodium 
crystal structures, the X-ray crystallographic data of this palladium complex was used to 
provide insight into the molecular structure and interactions of molecules within the crystal 
structure. Reference is made to the reported structure of complex [3.40]"" and selected bond 
lengths and angles are reported (see Figure 3.32 and Table 3.11). Complex [3.40] 
crystallises in the monoclinic space group C2/c. 
" Figure 3.32: Labelled perspective vif;w of complex [3.40]. hydrogen atom labels omitted. 












Table 3. 11: Selected bond lengths (A) arld angles (') of complex [3.4IlJ" 
Pd-CI 2.297(1) Pd-N(1 ) 2.024(6) Pd-N(2) 2.02315) 
Nll)'Cll) 1.355(6) NI2)-C(4) 1.336(6) N(2)-Pd-CI 89.17(7) 
CI-Pd-CI' 178.3(1) Nll)-Pd-CI 90.83(7) C( 4)-N 12)-C(4') 119.-417) 
Cll )-Nll)·C(1 ') 118.3(7) Cll )-N(I)-Pd 120.8(3) C(5)-CI4)-N(2) 121.116) 
C(2)-Cll)-N(I) 121.9(6) CI4)-N(2)-Pd 120.3(3) 
The crystal structure of complex [3.44] was obtained with single crystals grown from a 
mixture of dichloromethane and pentane. The complex was observed to crystallise in the 
monoclinic space group C2Jc (see Figure 3.33 for molecular structure). 
Figure 3.33: Labelled perspective view 0/ molecular structure lor complex [3.44], hydrogen atom 
labels omitted 
Table 3.12: Selected bond lengths IA) and anQles 11 for [3.44] 
Pd(1 )-Clll) 2.3053(9) N(l )-Pd(I)-N'(I) 18CLOO(14) 
Pd(l)-N(l) 2.022(2) CI( 1 )-Pd (1 )·N(t) 89.82(6) 
N(1)-Cl5) 1.343(3) Pd( 1 )-N 11 )·C(t) 122.01(17) 
N(t)-Cll) 1.347(3) Po( 1 )-N (1)-C(5) lt9.05118) 
C(5)-C(4) 1.390(4) C(3)-C( 4)-C(6)-Cl7) 15.7(4) 




Tho 3-fe rroc enyl py r idi n e ligands are equivalent from a crystallographic point of view, 
indicating a completely symmetrical structure Selected bond lengths and angles are listed in 
Table 3.12. The observed bond lengths and angles around the palladium metal centre are 
similar to that of complex [3.40]. with no particularly unusual characteristics observed in the 
molecular structure of complex [3.44]. A dihedral angle between the plane of the palladium 
metal centre and pyridyl ring of 131' was obtained. As with the rhodium complexes, the 












observed to tilt toward each other by al1 al1gle of 3.1", which indicated that the rings were 
planar. The rings were 110t completely eclipsed and observed to rotate by an angle of 5.7'. 
akin to the related rhodium comple)( [3.15] COl1taining the same ferrocel1ylligand [2.7]. The 




Figur" 3.34: View of moIecufar packing diagram along b axis of unit ceM for complex [3.44] 
The packing diagram (see Figure 3.34) of complex [3.44] showed a highly ordered crystal 
structure. As with the other crystal structures determined in this study. no significant 
intermolecular contacts were observed between the molecules in the unit cell. 







Unit cell dimensbns 
Volume 
~ (Mo-Ku) i mm" , 
Reflections collected,' unique 
Goooness-of-fit on F' 
Fir-.al R irdices [1>2sigma(I)] 








a _ 34,606(7) A 
b = 5.674(1) A 
c=13.126(3)A 
2572,8{9) A' 
2,036 mm- I , 
u ~ 00" 
~ = 93.52(3)' 
Y = 9rf 
2950,' 2950 [R(int) _ 0.=] 
1,091 
R1 _ 0.0270, wR2 _ 0,0537 












3.4.2 Electrochemistry of palladium complexes 
Cyclic voltammograms of the palladium complexes were obtained in acetonitrile with 
tetrabutylammonium perchl<Yate as background electrolyte and at a platinum disk working 
electrode (see Table 3.14), Data was recorded relati~e to ferrocene urKIer the same 
conddions (E". +75,5 mV), A single ferrocen)'l wave was observed for all palladium 
complexes. indicating that no electrochemical communication occurred between the 
ferrocenyl groops 01 the complexes throogh the palladium metal centre 
Table 3.14: Electrochemic6ll dala lor lerrocenyl palladium complexes [3.42]-[3.45] in acetonttrile 
---
Complex Complex type Ligand E", (mV) E", (mY) Complex Ligand 
number E,!. (mY) E" (mY) 
--- ----" 
[3.42] PdCI,L, ~"Fcpy H53 +187 +220 +205,5 
[3.43] ~·Fc(C,H.Jpy ~176 +107 +1~1,5 +133,5 
[3.44] 3-Fcpy ,'" +190 +223 ~167,5 
[H5l 2-Fcpy ,'~ ," ,"' ~1545 .. ,,--------- ---_._-----_._ .. - -------
With the exception 01 complex [3.451 all samples displayed a positive potential shift in E", 
value indicating that the ferrocenyl groop became harder to oxidise on coordination 01 the 
palladium metal centre_ Complex [3,44] offered the largest positive E~ value as well as moot 
significant shift on companson of free ligand [2.7] and complex_ This is unl~e the rhodium 
complexes, where the rhodium complex with ligand [2.6] showed the largest E,. shifts_ 
Although the half-wa~e potential for complex [3.45] is puzzling, it is consistent with its 
spectroscopic propertles_ 
3.5 Preparation and properties of platinum complexes 
The preparation of platinum(lI) square planar complexes has been well-documented largely 
owing to the serendlpitoos disco~ery of cisplat!n, cis-d,amminedichloropiatinum(II)," Since 
the preparation of cisplatin, a signifICant number 01 related platinum complexes have been 
synthesised in a bid to disco~er further platinum complexes exhibiting similar or enhanced 
antitumour activity, 80th the cis and trailS isomers of complex [3.46] ha~e been prepared and 












EtOH-H20 1:21 EtOH ... CI, /\ ) 
Pt 0 RT/24 h 
CI/ 'N~ J 
[3.46]: White powder, 72% 
Figure 3.35: Synthesis of platinum complex [3.46J 
The platinum complexes in this study. complexes [3.46]-[3.50], were prepared using the 
synthetic route described in Figure 3.35. This methodology is similar to that described for the 
synthesis of the palladium complex [3.40] where the product was formed as a precipitate over 
time.31 
Figure 3.36: Platinum complexes [3.46J-[3.50J 
[3.46]: R = H; white powder, 72% 
[3.47]: R = Ph; cream powder, 75% 
[3.48]: R = (C=N)-Ph; mustard-yellow powder, 70% 
[3.49]: R = Fe; orange-red powder, 72% 
[3.50]: R ::: (CsH4)Fc; dark red microcrystals, 65% 
The preparation of the ferrocenyl complexes [3.49] and [3.50] were repeated using the 
biphasic route devised for the related palladium complexes (see Figure 3.29). Both synthetic 
routes generated the same product with similar yields but with variations in reaction time. On 
average the biphasic synthetic route proceeded the fastest with reaction times of the order of 
5-10 hours, as opposed to 24 hours using the former route. 
The complexes were all obtained in good yield. It has been reported that the synthetic route 
described in Figure 3.35 produces complexes exclusively in the cis-configuration.31 •32 1H NMR 
data follow a similar trend to the rhodium complexes. Downfield shifts were observed for the 
pyridyl protons on complexation of the platinum metal, for all complexes. No shifts were 
observed in the ferrocenyl protons for complex [3.50] while upfield shifts were observed for 
complex [3.49]. 
3.6 Preparation and properties of a cobaloxime complex 
As a separate pOint of interest, the preparation of a ferrocenyl cobaloxime complex is 
reported. The study of cobaloximes is extensive. This class of compound was used as a 
model for the study of vitamin B12 several decades ago.33 The related pyridine complex, [3.51] 
has previously been prepared. Complex [3.52] was prepared through displacement of the 












Dowex ion-exchange resin,. (Co}(Me)(H
2
0) 60°C. [{Co}(Me)]2 
Methanol-H20 7:1 
Since both ligands are pyridyl and show similar basicity, a simple displacement of the pyridyl 
group did not present a feasible route. The pyridyl group in complex [3.61] was first removed 
by displacement with a water molecule with a strongly acidic ion-exchange resin. The water 
molecule was removed by drying the hydrated compound under vacuum, leading to the 
formation of a light sensitive dimer. The dimer was reacted with an excess of the ferrocenyl 
ligand [2.16], in a bridge-splitting reaction to form complex [3.62]. 
Complex [3.62] can be compared to the related rhodium [3.6] and iridium [3.31] complexes 
containing the ferrocenylligand [2.16]. A spectroscopic study of complex [3.62] revealed that 
little to no interaction occurred between the ferrocenyl group and cobalt centre, despite the 
presence of a conjugated pathway, similar to the rhodium and iridium complexes. Unlike the 
chemical shifts for the ferrocenyl protons, the pyridyl and imine bond protons did show a slight 
shift upfield on complexation of the cobalt metal centre, indicating some shielding of these 
protons on complexation. 
The electronic spectra of complexes [3.6], (3.31] and [3.62] were determined in a range of 
solvents and shifts in the central metal-to-ligand charge transfer band compared to the free 
ligand, [2.16] (see Figure 3.38 and Table 3.15). Electronic stUdies of tungsten and 
molybdenum complexes of ligand [2.16] have been reported.25 These complexes were found 
to be solvatochromic when comparing electronic spectra recorded in a range of solvents of 
differing polarity. The most notable differences were recorded in the metal-to-ligand charge 
transfer band. The result~ listed in Table 3.15 reveal that on increasing solvent polarity. small 
shifts in the metal-ta-ligand charge transfer band transpired to a shorter wavelength. These 
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Figure 3.38: Electronic spectra comparing rhodium [3.6], iridium [3.37] and cobaloxime [3.52] 
complexes of the ferrocenylligand [2.16] in acetonitrile 
Table 3.15: Solvatochromism of the metal-to-ligand charge transfer band 
Complex Solvent 
number C6H6 THF MeCN MeOH 
[2.16] ~NrCN 
~ 
350 350 346 350 
OC,)I/~~ 
[3.6] Rh N 364 364 364 358 
OC/ 'CI 6 
[3.37] OC'I/N~N--G-9 





[3.52] \/ ~ 368 360 344 346 H3C-p,-N ~ 
N N N 
1111 0 c-c 
H3c! 'cH3 
The solvatochromic behaviour of transition metal complexes has been linked to their potential 
non-linear optical properties.25 Based on the results listed in Table 3.15, complex [3.52] 
shows the largest shifts in the metal-to-ligand charge transfer band. Complex [3.52] warrants 
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Chapter 4: Some Catalytic Applications of MultimetaUic Complexes 
4.1 Introduction 
The development of homogeneous catalysis is closely linked to the development of 
organometallic chemistry. leading to many advances in organic synthesis. The preparation of 
transition metal complexes has greatly aided in this process with new classes of compounds 
readily obtained through the use of these catalysts.1 Transition metal complexes have long 
been used since the early pioneering work during the 1930 to 1950's. Early applications of 
these complexes include the carbonylation of alkenes and alkynes by metal carbonyls, 
polyethene and polypropene preparation by Ziegler-Natta catalysts and acetaldehyde 
preparation from ethene by the Wacker process using palladium and copper catalysts.2 
The study of homogeneous catalysis has certain advantages over heterogeneous catalysis. 
The reactions occur under milder conditions while the selectivity of the catalytic system can 
be tuned by changes in the ligand or solvent.3 In theory, deSigning a homogeneous catalyst 
for a specific need is possible. Limitations of homogeneous catalysis include separation of the 
catalyst from the reaction mixture on completion of the reaction and stability of the complexes 
at extremely high temperatures.1 
The use of nitrogen donor ligands has received increasing prominence over the past few 
years but has still not enjoyed the type of systematic investigation that has been done for 
phosphorus-donors. Nitrogen-donors are often used in chelating ligands containing both 
phosphorus- and nitrogen-donors in the form of pincer ligands. The P,N-ligands do not differ 
significantly from the related P,P-ligands. Some differences have been noted in the reactivity 
of metal complexes containing these Iigands.4 Nitrogen-containing optically active ligands 
have also made Significant contributions to the field of asymmetric catalysis.s 
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Nitrogen-donor ligands have been used in several areas of catalysis, either as solely 
nitrogen-donor or together with other donor groups such as phosphorus. Several areas of 
asymmetric catalysis where nitrogen donor complexes have shown activity include 
hydrogenation and reduction, transfer hydrogenation, hydrosilylation, cyclopropanation, Diels-
Alder reactions, aldol condensations, alkylation of aldehydes, conjugate addition reactions, 
Grignard coupling, aUyJic alkylation and various oxidation reactions.5•6•7 
The primary objective of this research was the preparation of novel metal-containing 
complexes with a view towards investigation of interactions between the metals. Preliminary 
investigations into the potential catalytic activity of several complexes in this study were 
carried out. The specific catalytic applications examined were based on the activity of similar 
complexes reported in the literature. 
Three catalytic applications are presented. The polymerisation of phenylacetylene has been 
reported with rhodium and iridium catalysts. Current investigations include the use ferrocenyl 
rhodium and iridium catalysts. The study of the ferrocenyl complexes suggests that linear 
complexes would be better suited to the preparation of high molecular weight polymers. This 
supposition was investigated through variations in the catalyst ligands. Complexes were 
examined comparing the activity of catalysts with a systematic increase in the spacer groups. 
Studies into the carbonylation of nitrobenzene were based on the reported activity of a 
palladium pyridyl complex, PdCI2PY2. The effect of introducing a substituent on the pyridyl 
ligand was considered together with the position of the substituent. The contribution of steric 
and electronic factors on the activity of the catalyst was considered. The activity of rhodium 
and iridium complexes as hydrogenation catalysts is well-known. The activity of rhodium and 
iridium pyridyl complexes was examined with variations in the ligand and catalyst ratio. 
4.2 Polymerisation of phenylacetylene 
4.2.1 Introduction 
The examination of polymeriC acetylene materials has gained popularity recently due to their 
electrical conducting properties.s The interaction of polymers with small gaseous molecules 
such as oxygen, nitrogen dioxide and ammonia, have been investigated.9 It was found that 
this interaction may result in electrical conductivity. As such, the polymers were investigated 
for their potential application as sensors and field-effect transistors. Polyphenylacetylene and 
its derivatives have shown conducting properties and undoped polyphenylacetylene is known 













dioxide and methane. The polymer has been further investigated for the potential preparation 
of humidity sensors. 
4.2.2 Polymerisation catalysts for the preparation of polyphenylacetylene 
The polymerisation of derivatised acetylenes is reported using a variety of methods such as 
those incorporating radical, cationic and coordination mechanisms. It was found that transition 
metal catalysts utilising metals such as chromium, molybdenum and tungsten, polymerise 
acetylenes mainly through a coordination mechanism.10•11,12 Initial studies into the 
polymerisation of acetylenes utilised Ziegler-Natta type catalysts when trans-polyacetylene 
was first prepared by Natta in 1958.16 Since then, the catalytic activity of other transition metal 
complexes has been studied. The use of these complexes is not without its disadvantages 
where low molecular weight (Mw) polymers of the order of 3 000 have been prepared. High 
reaction temperatures and long reaction times are often required and dimers and cyclic 
trimers have been known to form as by-products. Despite this, the use of transition metal 
complexes to catalyse polymerisation reactions still remains popular since these complexes 
allow an examination of the polymerisation reaction under a host of different conditions 
including temperature, solvent and catalyst ratio. 
The use of tungsten and molybdenum catalysts have been reported, where initial results 
showed Mw of 5000-15000 for polyphenylacetylene.13 The reaction was optimised by varying 
the solvent, yielding polymers of up to Mw 100 000.13 The activity of cationic rhodium 
complexes of the type [Rh(COD)(L)]PF6 where COD is 1,5-cyclooctadiene and L is 2,2'-
bipyridine, 1,10-phenanthroline or 2,9-dimethyl-1,10-phenanthroline has been reported.9 
These catalysts produce highly stereoregular polymers but with low Mw of the order of 9 000. 
The activity of the zwitterionic complex, Rh+(COD)BPh4- under hydrosilation conditions was 
reported to yield stereoregular cis-polymers with Mw of up to 35 000.14 The highest reported 
Mw achieved was of approximately 4.3 x 106 with a [Rh(norbornadiene)CI]2 complex. 15 The 





Figure 4.2: Ferrocenylligands used in catalytic rhodium and iridium complexes6 
Cationic and neutral rhodium and iridium ferrocenyl complexes of the type [M(COD)(LL)]CI04 













Mw of 47 000-95 000.8 The cationic rhodium complex of [2.17] was reported as the most 
successful overall in terms of yield, cis content, molecular weight and polydispersity. 
However, attempts by us to reproduce the cationic rhodium complex with the ferrocenylligand 
[2.17]. were unsuccessful. Comparisons were carried out with the rhodium complex of 
ferrocenylligand [2.25]. 
4.2.3 Polymer stereochemistry 
Three possible stereochemical isomers can be formed in the polymerisation of 
phenylacetylene (see Figure 4.3). These isomers are differentiated by their unique 
physicochemical and spectroscopic properties, greatly facilitating their identification.8,16 
H*~ 
Ph H 
Ph H Ph H Ph 
cis-cisoidal cis-transoidal trans-cisoidal 
Figure 4.3: Stereochemical isomers of polyphenylacetylene 
The cis-cisoidaJ isomer can be differentiated from the remaining two isomers based on its 
insolubility in benzene; the remaining isomers are completely soluble in the solvent. The cis-
cisoidaJ and cis-transoida/ isomers show similar spectroscopic behaviour in both NMR and 
infrared spectroscopy, differentiating them from the trans-cisoidal isomer. 
The cis-cisoidal and cis-transoidal isomers show a band at 740 cm-1 in the infrared spectrum, 
which is related to the cis content of the polymer. The trans-cisoidal isomer does not exhibit 
this band but instead a band is found at 1265 cm-1 and 970 cm-1• These bands are due to a 
trans C-H out of plane deformation vibration. A further band occurs at 895 cm-1 in the cis-
isomers and its absorption can be correlated to the 740 cm,l band. 
The ratio between the absorption bands at 1500 and 1450 cm'1 provides insight into the 
stereochemistry of the polymer. A ratio of 1.00 or smaller, together with a strong absorption 
band at 740 cm·1 can be correlated to the cis content of the polymer, whereas a ratio of 
greater than 1.00 with no band at 740 cm-1 is related to the trans content of the polymer. 
Some polymers with a ratio of greater than 1.00 but weak absorptions at 740 cm-1 occur when 













Similariy, the 1H NMR spectrum of the polymer allows for differentiation between the 
respective isomers8 . 1H NMR studies have reveated that aside from chemical shift differences 
in the aromatic protons of the isomers, a peak can be anticipated at approximately 5.82 ppm 
due to the olefinic proton occurring in the cis-cisoidal and cis-transoidal isomers. This peak is 
a characteristic of the cis isomer and can be related to the intensity of the 740 cm-1 band 
found in the infrared spectrum. The trans-cisoidal polymer has either a small or no 5.82 ppm 
peak and displays a wide weak resonance in the 3-4 ppm region due to the aliphatic protons. 
4.2.4 Catalytic polymerisation studies 
The catalytic polymerisation of phenylacetylene was investigated with a series of rhodium 
complexes (see Table 4.1). The catalytic activity of the nitrogen donor complexes was 
compared to several phosphine donor complexes, [3.29], [3.30] and [3.31]. The nitrogen 
donor complexes were selected for a comparison of structural changes in the ligand and to 
determine its influence on the activity of the catalyst. 
Catalyst, MeOH (>=< ) 
23 aC, 24h ... Ph - H n 
Table 4.1: Comparison of catalytic activitt 
NComplex····'·,··· .... ··''''Catalyst ························ .... ··Ligs·nif·· .. · .... · .... ···yj"eidb N···cis··conientc·· .... ·w··M~·············-········· Mw 
number (%) (%) 
....... ... ....... ..... ............................ 
[3.8] RhCI(COD)L Pyridine 65 99.7 7591 48241 6.3 
[3.9] (CsH5)py 66 99.3 7476 48623 6.5 
[3.10] (CeH5)NCpy 65 96.7 7717 47113 6.1 
[3.14] Fc(CsH4)NCpy 75 99.7 8673 53085 6.1 
[3.16] 3-Fc(CsH4)PY 60 96.6 7044 49591 7.0 
[3.13] 4-Fc(CeH4)PY 74 93.5 7831 51599 6.6 
[3.30] FcPP~ 56 91.3 2886 27847 9.6 
[3.21] [Rh( COD )L2]CI04 Pyridine 50 100 8452 47473 5.6 
[3.25] 4-Fc(CsH4)PY 62 91.3 4774 45523 9.5 
[3.26J Fc(CsH4)NCPY 64 98.8 11693 68415 5.8 
[3.31] FcPP~ 25 84.4 3364 36109 10.7 
[3.29] [Rh(COD)L]CI04 Dppf 62 100 2903 33803 11.6 
"aReaCiio'n"oonciiiions:"if'3'moT'%"In'MeO'H'C1"'S'mij;'24'hrsai:i3llC"'" ...... -..... -.-..• -.-.-.-...... -'-..... "".~, .·.·.·.·.·_·~_·_·_· .... _·.·.·.·.· ... ·_-.· ... ·_·_·_·_· ... -.·A-....... . ..... '-•.•.•. -." ... -.•. ~ ..•. ~~ .. -.•... -..... ~. 
b Isolated yield 













The yield, cis content, number average molecular weight (Mn), weighted average molecular 
weight (Mw) and the polydispersity (ratio of Mw and Mn) of each polymer sample was 
determined (see Table 4.1). 
The activity of the catalysts can be evaluated in terms of, 
(i) Polymer yield: Average polymer yields were obtained for all catalysts, with complex 
[3.31] producing very little polymer. The temperature of the reaction played a 
significant role in the polymer yield. Fluctuations in temperature affected the yield to 
the pOint that the temperature was maintained constant with a thermal bath. 
(ii) Cis content of the polymer: All the rhodium catalysts examined produced polymers with 
a fairly high cis content. Complex [3.31] yielded the lowest cis content. The 
spectroscopic data indicated that the polymer was partially isomerised to the trans 
conformation. 
(iii) Mw: Complex [3.26] produced the largest polymer. The size of the polymer appeared to 
be related to the length of the catalyst. The more linear extended ferrocenyl rhodium 
complexes such as complexes [3.13] and [3.14] produced larger polymers compared 
to complex [3.8]. This was confirmed by comparison of complexes [3.13] and [3.16]. 
The rhodium phosphine catalysts produced the smallest polymers. 
(iv) Polydispersity: A lower value indicates a more uniform distribution of polymer. The 
polydispersity values were high for all polymer samples. The polymer was observed to 
form almost immediately on addition of the catalyst to a solution of the monomer for all 
catalysts investigated. This rapid formation of polymer was attributed to the elevated 
polydispersity values. The polydispersity of complex [3.29] was Significantly higher 
than reported.s This could indicate that the increased values are due to the reaction 
conditions employed in this study. 
(v) Activity of the nitrogen and phosphine donor complexes: The nitrogen donor 
complexes were significantly more active than the phosphine donor complexes with 
better yields, Mw values and polydispersity. 
4.2.5 Spectroscopic properties 
The physico-chemical properties of the polymers carry significant information about the 
stereochemistry of the isomers. The polymers prepared with the catalysts investigated in this 
study exhibited similar 1H and 13C NMR and infrared spectra (see Figures 4.4 and 4.5). The 
1H NMR peak distribution indicated mainly cis-isomer polymers. In all cases a strong peak 
was observed at 5.8 ppm in the 1H NMR spectrum. Two further peaks at 6.9 and 6.6 ppm 













poIymef!; prepared have predominantly cis-lransoidal character, A similar pattern was 
observed in the "c NMR spectrum with a peak due to the olefinic protons observed at 127 
ppm and peaks at 139 and 142 ppm due to the aromatic protons 
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Figure 4.4: 'H arid "c NMR &pectra ,n CDC!, of polypnenylacetylene, catalysed by 
RhCl(COD)( 4_FcPhpy), complex p.13] 
The catafyst was effectively removed from the polymer, No trace of it was detected In the 'H 
and ·" C NMR spectra. An the catalysts and the monomer were completely soluble in 
methanol while tile polymer was not, facilitating separation of Ihe polymer. 
A strong absorption band at 740 em-' was observed in all the polymer samples, Medium to 
weak bands were Observed al 1380 and 895 cm", These bands confinned the cis 
eonfonnahon of the polymers The Irans conformation bands, in p;!rtlcular 1265 em-' were 
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Figure 4.5: IR spedrum 0/ polyphenylacetylene prepared using [Rh(COO)(pyJ,)CIO. ~ s c>Ullyst 
~ ~ 
Cataly$t. MeOH, (e~~)" 23 'c, 2~ h 
Table 4.2: Determination of the cis content of pofymer. 
-_ .. _._._. ------ ... _ ..• _ .. _._._-_. -----
Complex CaUlfyst Ligand 1500 vs 1450 'f, Cis content Polym .. r 
number ratio (from fR) from NMR' colour 
[3.8J RhCI(COD)L Pyridine 1,05 '" Yellow [3.9J (c"H,)py '" 99.3 Yellow [3.10J (c"H,)NCpy 1 ,05 00,' Yellow 
[3.14] Fc(C,H,lNCpy W; 99,7 Yellow 
[3.16] 3·Fc{c"H.)py 1 ,09 00,' Yelklw 
[3.13] 4·Fc(C,H.)py W; 935 Yellow 
[3.30] FcPPh, 102 "" Yellow [3.21] [Rh(COD)I.,]CK), Pyridine "" "'" Yellow [3.25] 4-Fc(C,H.)py 122 913 Yellow·l)rown 
[3.26] Fc(C,Ho)NCpy 1.05 98.8 Yellow 
[3.31J FcPPh, 103 '" Brown [3.29] [Rh(COD)L]CK), C"" 1.03 '00 Yellow =----_.,,------ - -
Calcul~ted according to reference 16 
Ratios of approxim~tely 1 were obtailled for the 1500 and 1450 em" absorbaflCe bands, 
These values were cOl1Si~tent with the calculated cis content of the polymers and their 
spectroscopic properties. Comple~ [3.25] gave ~ slightly higher value but this may be related 













4.2.6 Thermal analysis 
The thermal behaviour of the polymers prepared using the catalysts in this stlJdy are very 
similar. The results are all consistent with the predominantly cis-conforma~on of the polymers 
(see Figure 4.6). 
100 , 
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Figure 4.5; TGA and DSC for p<llyphenyfacteylene obtained with RhC~COD)(4-F"Phpy) as 
catalyst 
The TGA in Figure 4.6 displays the thermal stability [If the polymer. The polymer [lnly starts to 
decompose from 265 'C. A residual of 5 % is reached at 500 °c. TIle DSC shows three peaks 
related to the cis-conformation of the polymer. The first two peaks are exotherms at 196 and 
226 'C. Peak 1 corresponds to a cis-trans iSO!1lerisati[)ll while peak 2 corresporlds to various 












several occasions for this type of polymer.s,H The endotherm, peak 3, occurring at 259°C is 
characteristic of thermal decomposition of the cis-polymer. 
The characteristic peaks in the DSC occur in all the polymers prepared. Table 4.3 lists the 
exothermic and endothermic temperatures obtained for the polymers. A comparison of the 
thermal data of these polymers can be used to draw a correlation between the catalyst and 
the properties of the polymer. 
Ph-.....;.;;;;;;;;;;;;;;;;;;;;;..-H Catalyst, MeOH ... ( >=<) 
23°C,24h Ph H n 
Table 4.3: DSC thermal data for polyphenylacetylenes prepared using rhodium catalysts 
Complex Catalyst ligand Temperature f'C) 
number 
Peak 1 Peak 2 Peak 3 
[3.8] RhCI(COD)L Pyridine 183 203 220 
[3.9] (C6H5)PY 200 235 255 
[3.10] (CeH5)NCpy 163 174 182 
[3.14] Fc(CsH,.)NCpy 157 220 255 
[3.16] 3-Fc(CsH,.)py 171 236 250 
[3.13] 4-Fc(CsH,.)py 196 226 259 
[3.30] FcPPh2 164 209 261 
[3.21] [Rh(COD)L2JCI04 Pyridine 160 213 250 
[3.25] 4-Fc(CsH4)py 161 269 280 
[3.26] Fc(CsH4)NCpy 160 270 316 
[3.31] FcPPh2 158 182 255 
[3.29] [Rh(COD)L]CI04 Dppf 184 222 258 
Complex [3.26] produced the most thermally stable polymer with the highest onset 
decomposition temperature recorded. Complex [3.10] produced the least thermally stable 
polymer. The crystallisation and isomerisation temperature vary with the catalyst. 
4.2.1 General remarks 
Although the mechanism of the polymerisation reaction has not been determined in this work, 
the most generally accepted mechanisms for the catalytiC polymerisation of acetylenes are 
presented. 
The linear polymerisation of phenylacetylene occurs through two main pathways. Firstly, a 













cyclooct8diene by solvent in the catalyst precursor. A species of the type [Rh(Lh(solventht 
or [RhCI(L)(solvent)21 is formed in solution, followed by oxidative addition of phenylacetylene 
to rhodium, yielding a hydridoacetylenic species. The coordination is followed by a migratory 
insertion, leading to the formation of a vinylic rhodium intermediate species, ultimately leading 
to the formation of the polymer (see Scheme 4.1). Ziegler-Natta catalysts as wen as some 
nickel and palladium transition metal complexes are known to follow this type of mechanism 







® = polymeric chain 
M=Rh 
Scheme 4.1: Direct four-centre acetylene insertion mechanism for formation of acetylenic 
polymer18 
The second main pathway involves the formation of a metal carbene complex with an 
intermediate vinylic metallacycle. A key intermediate step involves the rearrangement of a 
monomer unit within the diacetylenic complex. This is formed by stepwise addition of a 
second monomer to the metal carbene complex. The metallacycle can be prepared through a 





. '" HC==CH .. 
® :: polymeric chain 













In terms of the formation of the polymer, the main difference between the mechanisms 
involves the carbon bonds of the monomer. The insertion mechanism (Scheme 4.1) predicts 
that the carbon bonds of the monomer will end up doubly bonded to one another while the 
metallacycle mechanism (Scheme 4.2) predicts that although the carbons of the monomer 
unit end up next to each other, they will be singly bonded to one another. 
4.3 Carbonylation of nitrobenzene 
4.3.1 Introduction 
The range of products formed from the carbonylation of nitrobenzene and other nitro-
compounds makes the process of both academic and industrial significance. Isocyanates, 
carbamates, ureas, azoarenes and azoxyarines, amines, amides, oximes and some 
heterocyclic compounds represent a range of compounds prepared by this process. Ureas 
and carbamates are important products and intermediates in the preparation of fertilisers 
while isocyanates are intermediates in the preparation of polyurethanes, pesticides. synthetic 
leather, adhesives and coatings. 19 Carbamates and ureas have the most industrial 
applications as they can be converted to other compounds such as isocyanates. These 
compounds are readily prepared in carbonylation reactions catalysed by palladium systems. 
Figure 4.6: Carbonylatlon of nitrobenzene with selected products listed 
4.3.2 Palladium catalysts 
Palladium complexes have been reported as among the most active catalysts for the 
carbonylation of nitrobenzene.2o These complexes are divided into several categories with 
reactions involving the addition of a Lewis acid, complexes containing nitrogen-donor ligands 
and finally phosphine-donor complexes.20 The former two categories are of relevance to this 
investigation. The activation of palladium complexes of the type PdCI2 or PdCI2PY2 by a Lewis 
acid such as a metal oxide or chloride was amongst the first reported. These catalysts 
produce ureas and carbamates in good yield. However, only limited mechanistic information 
is available for carbonylation reactions involving palladium complexes. Problems such as 
reproducibility often arise and may be linked to the corrosive nature of the co-catalysts used. 













The conditions employed in the current investigation were based on the work of Skupiliska 
and oo-workers,21.22 where the use of the corrosive Lewis acids was replaced with iron and 
iodine. 
The presence of nitrogen-donor ligands such as phenanthroline and pyridine has been 
credited with promotion of the carbonylation reaction. 19 The addition of excess pyridine, for 
example, has been reported to stabilise the palladium system against precipitation of the 
metal while chelating ligands such as 2,2'-bipyridine were reported as deactivating the 
catalytic system.19 
4.3.3 Comparison of catalytic activity 
The current investigation was based primarily on the work of Skupiliska and oo-workers.21 ,22 A 
palladium complex of the type PdCbpY2 was used to catalyse the carbonylation of 
nitrobenzene. The efficient conversion of nitrobenzene into mainly aniline and 
ethylphenylcarbamate has been reported, with the carbamate fonned in higher yield (see 
Figure 4.7). 
PdCI2PY21 Fe 1121 pyridine in EtCH 10 
180°C 14MPa 12 h 
PdCI2PY2 I Fe 1121 pyridine: 0.17/10 I 0.4/6.2 mmol 
Figure 4.1: Carbonylation of nitrobenzene with reaction conditions and main products as 
reported by Skupinska and co_workers21 •22 
Iron powder and Iodine were added in place of the corrosive Lewis acid to stabilise the 
catalyst and minimise plating. The iron was added in as fine a fonn as possible. The addition 
of iodine was reported to promote the conversion of amines fonned to urea derivatives under 
relatively mild conditions.23 Pyridine was added to stabilise the palladium system against 
precipitation of the metal. Ethanol was used as both a solvent and reagent, acting as a source 
of hydrogen for the fonnation of aniline by hydrogenation of nitrobenzene.2'$ 
The palladium system was reported as extremely active with substrate conversions in the 
region of 100 % at 180 aC and at least 70 % at 150 aC. The activity of several related 
palladium complexes in this study was evaluated as carbonylation catalysts (see Figure 4.8 
and Table 4.4). The palladium complexes were chosen to compare the effect of derivatising 


















r"~/ 'CI [3.40]: R = H 
A.J [3.41]: R:: Ph 
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[3.42]: R ::: Fe 





PdCI2L2 I Fe 112 I pyridine in EtCH 
Et-N OEt NH2 
4MPa/2 h 
ill 6 6 + 
Table 4.4: Summary of carbonylation results catalysed by palladium pyridyl complexes8 
Entry Complex Catalyst ligand Nitrobenzene Carbamate 
number conversion (%)b formed (%)b 
1 [3.40] PdCI2L2 Pyridine
c 95.6 84.0 
2 [3.40] Pyridine 74.8 57.0 
3 [3.41] 4-Phpy 97.5 94.8 
4 [3.42] 4-Fcpy 75.4 73.2 
5 [3.44] 3-Fcpy 96.1 90.4 
6 [3.45] 2-Fcpy 93.4 90.4 
II PdCI2L2/Fell2/pyridine (0.42125/1/15.5 mmol) in ethanol (50 ml) with nitrobenzene (0.2 mol) 
for 2 h at 4 MPa and 150 DC 
II GC determined yields 
C Reaction temperature 180 DC 
The catalyst system with complex [3.40]. entry 1. was reported as highly efficient under these 
conditions with nearly 100% substrate conversion. 22 However. significant plating was 
observed and the reaction was repeated at 150 DC. Although the plating problem was 
eliminated. a lower substrate conversion was obtained at this temperature (see entry 2). The 
subsequent reactions were carried out at 150°C (see entries 2-6). The modified palladium 














Results for the complexes studied at 150°C are summarised graphically in F(gure 4.9. 
Complexes [3.41]. [3.44] and [3.45] clear1y display increased efficiency in formation of the 
main carbamate product. relative to complex [3.40]. It would appear that derivatising the 
pyridyl ring is linked to the increased activity of the complexes. 
The activity of the palladium complexes is due to a combination of steric and electronic 
effects. The significance of the substituent position on the pyridylligand is displayed through 
comparison of the catalytic efficiency of complexes [3.42], [3.44] and [3.45]. Complexes 
[3.44] and [3.45] were more active than complex [3.42]. This result indicates that steric 
considerations do not playas significant a role 
1 ~", 










Figure 4.9: Comparison of catalyst activity as a function of product yield over reaction time 
The efficiency of the modified palladium complexes was not solely based on the rate of 
product formation. The reaction was further evaluated with comparisons of substrate 
conversions and major product formation. A series of graphs are presented in Figt.Jre 4.10 
comparing the relative amount of substrate converted to that of major product formed for each 
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Figure 4. 1Cl: (a)·(e) Catalytic activity of various palladium complexes 
The carbonylation of nitrobenzene proceeds through the intermediate formatioo of anitine. 
The presence of aniline was detected as the reaction progressed in all the catalyst systems 
examined. However. complex [3.40] produced the largest amount of aniline and other mHlor 
side-products on termination of the reaction. The remaining palladium complexes efficiently 
converted the aniline to carbamate, with complex [3.41] the most efficient. 
4.3.4 General remarks and conclusions 
Complex [3.41] showed the highest activity and selectivity for carbamate formation with very 
small amounts of side-products detected. It is difficult at this stage to speculate on the nature 
of the relationship between the structure and activity of the catalyst. as a clear trend cannot 












ligands enhanced the activity of the catalyst system under less vigorous conditions than 
reported.22 More extensive examination of these promising catalytic systems is required. 
4.4 Hydrogenation studies of i-hexene and cyclohexene 
4.4.1 Introduction 
Hydrogenation, both homogeneous and heterogeneous, is an industrially relevant and 
significant process. Millions of tons of cyclohexane for example, are obtained annually from 
the hydrogenation of benzene.2 Cyclohexane is used for the preparation of nylon. A 
significant number of other unsaturated compounds such as dehydroamino acids used for the 
preparation of L-dopa, a drug used for the treatment of Parkinson's disease and (8)-
phenylalanine, used for the sweetener aspartame, are produced by catalytic hydrogenation 
reactions.2 The hydrogenation reaction, in both homogeneous and heterogeneous versions, 
forms part of several other important processes such as hydroformylation, hydrogenation of 
unsaturated fats, liquefaction of coal through arene hydrogenation, hydrogenation of 
butadiene rubbers and hydrodesulfurisation of crude oil through hydrogenolysis.7,25 
Rhodium phosphine complexes have long been known for their activity as hydrogenation 
catalysts.26 Wilkinson's complex, RhCI(PPh3h is one of the most widely used of these.25,27 
Iridium complexes have also been extensively studied for their activity as hydrogenation 
catalysts.2l1,29,3o Crabtree's catalyst, [lr(COD)(py)(PCY3)]PFe,31 ,32 where COD = 1,5-
cyclooctadiene, py = pyridine and PCY3 = tricyclohexylphosphine, is one of the best known 
homogeneous iridium hydrogenation catalysts. Crabtree's catalyst contai'ns both nitrogen-
and phosphine-donor ligands; where the activity of the catalyst is considered to arise from the 
presence of the phosphine ligand in the catalyst. 
The preparation and study of homogeneous hydrogenation catalysts containing exclusively 
nitrogen-donor ligands has, however, only been investigated to a limited extent. The success 
and development of catalysts containing phosphine-donor ligands has surpassed the 
development of catalysts containing exclusively nitrogen-donor ligands. Developments in the 
study of homogeneous catalysts have included the incorporation of nitrogen-donor ligands in 
a phosphine-ligand complex, as illustrated with Crabtree's catalyst. In most cases the 
incorporation of the nitrogen-donor group in the catalyst confers stability on the complex 



















R ::::: Ph, R' ::::: Xylyl 
R::::: Ph, R' == Cyclohexyl 
ferrocenylphosphine ligand 
Figure 4.11: Ferrocenylphosphine ligands used in various hydrogenation catalysts34 
Catalysis 
The use of ferroc:enyl ligands in the preparation of rhodium and iridium hydrogenation 
catalysts has gained prominence with the preparation of ferroc:enyl diphosphine Iigands.33 
1,1 '-Bis(diphenylphosphino)ferrocene (abbreviated to dppf) is one of the best known 
ferroc:enyl ligands (see Figure 4.11). A relationship exists between the structure and activity of 
the catalyst where the structure of the ligand may be readily adapted to a specific 
transformation. In principle, these ligands lend themselves to being tuned to the needs of a 
specific conversion. 34 
The hydrogenation of unsaturated compounds is a clean reaction where few side products 
are formed. The hydrogenation of simple alkenes such as 1-hexene and cyclohexene 
presents a relatively uncomplicated system with which to study and compare the catalytic 
activity of potential hydrogenation catalysts. The complexes examined are of the type, 
[M(COD)L2]CI04 where M ::: Rh or Ir, COD ::: 1,5-cyclooctadiene and L ::: pyridine or a 
derivatised pyridylligand. 
4.4.2 Comparison of catalytic activity 
The catalytic activity of several rhodium and iridium complexes was determined as 
hydrogenation catalysts under a range of conditions by varying the central metal, altering the 
ligand and changing the catalyst ratio. The activity of the complexes was examined under 
ambient conditions of room temperature (maintained at 24°C) and atmospheric pressure. 
The hydrogenation of 1-hexene and cyclohexene served as test reactions. These substrates 
were chosen to compare the activity of the catalysts for terminal and internal alkenes. 
Catalysis runs were carried out in dichloromethane. The solvent was chosen for its low 
coordinating ability, limiting competition between the solvent and alkene for coordination to 
active sites of the metal.35 The use of dichloromethane as solvent is not entirely usual since 
the solvent is known to act as a poison, oxidising classical homogeneous catalysts. The 














Table 4.5: Effect of catalyst and catalyst ratio on 1-hexene conversions 
Entry Complex Catalyst ligand Ratio catalyst 1-Hexene 
number to substrate conversion (%) 
1 [3.21] [Rh(COD)L2]CI04 Py 1:100 13.3 
2 [3.24] 4-Fcpy 1:100 8.0 
3 [3.25] 4-Fc(CeH4)PY 1:100 2.8 
4 [3.21] Py 1:50 26.7 
5 [3.24] 4-Fcpy 1:50 6.9 
6 [3.38] [lr(COD)l2]CI04 py 1:50 48.3 
7 [3.39] 4-Fcpy 1:50 29.5 
a Reaction conditions: Solvent:: dichloromethane, 24 bC, atmospheric pressure, 24 h 
Although the selected complexes were not very active under the chosen reaction conditions. 
the iridium complexes, particularly complex [3.38]. displayed the greatest catalytic activity 
(see Table 4.5). Results indicated that the derivatisation of the pyridyl ligand is linked to a 
decrease in the activity of the catalyst for both metals. 
Studies into the hydrogenation of cyclohexene were carried out under similar reaction 
conditions, catalyst to substrate ratios and variations on ligands. The results are summarised 
in Table 4.6. 
o Catalyst, H2 .. CH2CI2, 24°C, 24h o 
Table 4.6: Effect of catalyst and ratio on cyclohexene conversionll 
Entry Complex Catalyst Ligand Ratio catalyst Cyclohexene 
number to substrate conversion (%) 
8 [3.21] [Rh(COD)l2]CI04 Py 1:100 18.0 
9 [3.24] 4-Fcpy 1:100 6.4 
10 [3.25] 4-Fc(CeH4)py 1:100 2.8 
11 [3.21] Py 1:50 4.4 
12 [3.24] 4-Fcpy 1:50 3.1 
13 [3.38] [lr(COD)L2]CI04 py 1:50 2.1 
14 [3.39] 4-Fcpy 1:50 4.5 













The complexes examined for the hydrogenation of cyclohexene showed very low activity. A 
significant amount of catalyst was found decomposed and deposited in the reaction mixture 
for all complexes examined on termination of the experiments. 
On comparison of the activity of the catalysts in Tab/es 4.5 and 4.6, it would appear that the 
iridium complexes are slightly more active catalysts. The catalysts appear to be more suited 
to the hydrogenation of terminal alkenes, as expected, since terminal alkenes are more easily 
hydrogenated. The complexes were, however, not very active hydrogenation catalysts under 
the given reaction conditions. 
4.4.3 General remarks 
Although mechanistic studies were not carried out, a possible mechanism for the 
hydrogenation of the alkenes is presented diagrammatically in Scheme 4.3. This catalytic 
cycle is in line with similar complexes36 where the labile cyclooctadiene in the catalyst 
precursor dissociates in the initial stages and is hydrogenated, generating the active catalytic 
species in situ. 
The mechanism proposes the formation of a dihydride upon oxidative addition of H2 to the 
rhodium(l) metal centre. The reaction proceeds by insertion of the alkene to the metal hydride 
bond with a migratory insertion followed by reductive elimination. The use of a low or non-
coordinating solvent eliminates competition between the alkene and solvent for coordination 
to the metal. Steric effects playa role in the alkene insertion step. Depending on the nature 
and bulk of the catalyst and its ligands, terminal alkenes are preferentially hydrogenated. 

















Some differences were observed on variation of ligand systems in the complexes examined. 
This supports the premise that the ligand remains coordinated to the metal rather than 
dissociates during the course of the catalytic reaction. 
4.5 Conclusions 
The catalytic activity of several complexes in this study was investigated in three different 
catalytic applications - the polymerisation of phenylacetylene. carbonylation of nitrobenzene 
and hydrogenation of i-hexene and cyclohexene. Where possible, reactions were modelled 
on the reactivity of similar complexes described in the literature. 
The catalytic polymerisation of phenylacetylene was investigated with several rhodium 
complexes with systematic variation in the ligands of these complexes. This preliminary study 
indicated the existence of a relationship between the structure of the catalyst, its activity and 
the physico-chemical properties of the polymers. The results indicated that a linear rhodium 
catalyst with ferrocenylligand leads to the formation of higher molecular weight polymers with 
greater stability. Further investigations would be needed to optimise the performance of the 
catalysts to increase the molecular weight of the polymer as well as decrease the 
polydispersity . 
The carbonylation of nitrobenzene was investigated with a series of palladium complexes and 
the activity of these compared to a similar complex described in the literature. The preliminary 
study revealed the enhanced activity of the palladium complexes. These complexes displayed 
greater activity and selectivity for the formation of the major product. 
The hydrogenation studies were not as successful under the reaction conditions investigated. 
Rhodium phosphine complexes are known to be particularly active but this was not the case 
with the nitrogen-donor complexes examined. 
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Chapter 5: Potential Biological Activity 
5.1 Introduction 
The use of metals in the treatment of various illnesses dates as far back as between 2500 and 
2000 BC with the ancient Chinese using gold medicinally for the treatment of various 
ailments. The medicinal use of metals has occasionally been observed through time. 
Paracelsus in the fifteenth century used a variety of metals such as iron, cadmium, mercury, 
arsenic and antimony to treat various diseases including syphilis and cancer.1 Ussauer in the 
nineteenth century gave Fowler's mixture, an arsenic mixture, to patients with leukaemia.1 
Currently, the mercury compound, mercurochrome is still used in first aid. 
It was, however, in the twentieth century with the serendipitous discovery of the anti-cancer 
compound, cis-diamminedichloroplatinum(U), also referred to as cisplatin,2,3,4 that significant 
developments in the investigation of other types of non-organic cytostatic drugs took place. 
The development of medicinal bioinorganic chemistry has been rapid with significant 
contributions of inorganic compounds to the pharmaceutical industry.s The toxicity of metals 
such as gadolinium,s technetium7 and rhenium,s for example, have been adjusted to the point 
where the metals act as diagnostic agents and radiopharmaceuticals. Designed ligands allow 
these metals to be targeted to specific organs. 
The current investigation involves a preliminary study into the antitumour activity of several of 
the metal complexes prepared during this study. The complexes investigated were divided on 
the basis of transition metal centre. Several platinum, palladium, rhodium and iridium 
complexes comparing the effect of derivatised ligand systems were examined with this 
purpose in mind. 
5.2 Metal complexes in cancer therapy 
Some of the metai-containing complexes that have been investigated for their potential anti-
tumour activities are shown in Figure 5. 1. 
Metallocene complexes are particularly active against a number of tumours, and some 













the observed anti-cancer properties of the metal complexes in Figure 5. 1, aside from the 
platinum complexes, titanocene dichloride is one of the first metal complexes to be tested at 
the preclinical stage against a range of human carcinomas. 
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Figure 5.1: Some transition metal complexes proven to be active in experimental tumours1 
Ferrocene through the ferrocenium cation, is known to exhibit antineoplastic activity against 
Erlich ascites murine tumour.s The radical ferrocenium ion is known to interact readily with 
radical precursors and a host of biologically important electron donors. As such, several 
cisplatin-type ferrocenyl platinum complexes have been prepared and their potential 
antitumour activity investigated (see for example Figure 5.2).9 













It has been noted that unsubstituted ferrocene, although not displaying any antitumour activity 
due to its lack of solubility in an aqueous medium, once inserted into a target cell, could be 
converted into ferrocenium ion. It has been suggested that the ferrocenyl group acts as an 
iron carrier and the different redox states of the iron are responsible for its anticancer activity 
through the formation of radical metabolites that are responsible for biological damage in the 
cancer cell. 10 
5.3 Metal complexes investigated 
A preliminary investigation into the antitumour activity of several metal-containing complexes 
prepared during the course of this study (see Figure 5.3) was carried out in the form of 
cytotoxicity assays on two separate cancer cell lines - human oesophageal (WHC01) and 
cervical (ME180) cancer cell lines. SeverallCso values are reported. 
R 
Q." a r ':~ M = Rh, Ir q( 'CI 
Figure 5.3: Metal complexes examined for antitumour activity 
5.3.1 Cytotoxicity determinations 
Cytotoxicity determinations can be regarded as an introductory course to anticancer activity. 
Many platinum group metal complexes are reportedly active against a range of tumours.1 The 
complexes investigated in this study were examined for their efficacy against two different 
cancer cell lines, with comparison of activity for each of the cell lines. 
The cytotoxicity results are displayed in bar charts with absorbance readings reported for a 
range of drug concentrations (0-50 !-Ig/ml). The 0 IJg/ml reading corresponds to the blank 
reading without cells or drug. The optimal situation would be to have a significantly lower 
absorbance reading at 1 IJg/ml, indicating an extremely active compound. 













(i) The amount of protein present, which corresponds to the living cell number. This 
decreases with increasing drug concentration if the complex is cytotoxic, 
displaying a lowered absorbance reading. 
(ii) The solubility of the complex in the aqueous medium. If some crystalline insoluble 
complex remains in the cell well, interference in the absorbance reading can 
occur. This would be indicated by an abnormal distribution in the readings. 
5.3.1.1 Platinum complexes 
The use of platinum in antitumour drugs has been well established and cisplatin is the most 
prominent member of this class of drugs.1 Cisplatin is a widely used and effective cytostatic 
drug for the treatment of solid carcinomas.11 The drug is known to be 70-90 % effective in 
cases of testicular cancer and also highly effective against ovarian cancers. It contributes to 
the treatment of head and neck cancers, bladder cancer and lymphomas. Despite the 
success of cisplatin, some tumours have developed natural as wen as acquired resistance to 
the drug. Severe side effects such as renal impairment, neurotoxicity and ototoxicity are 
known to occur with prolonged use of the drug. These effects may only be partially reversed 
upon termination of treatment. 1 
Since the discovery of cisplatin, numerous platinum-containing compounds have been 
prepared and their efficacy investigated with a view to the reduction of side effects and 
toxicity.9,12,14,17 Carboplatin, diammine(1, 1 '-cyclobutanedicarboxylato)platinum(lI) has shown 
promise in this regard (see Figure 5.4).13 
cisplatin carboplatin 
Figure 5.4: Platinum-containing anti-cancer drugs 
The trans-PtCI2(pY)2 complex is reported to be highly active against several carcinomas such 
as Erlich's murine tumour, while the cis-isomer is not,14 One of the possible reasons cited for 
this difference is steric constraints where the cis-isomer may be too sterically hindered for the 
complex to bind to DNA. 
The cytotoxicity of several pyridyl platinum complexes was examined (see Figure 5.5). These 
complexes are reported as being in the cis-conformation based on the reported spectroscopic 
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Figu'e 5. 5: PI<l:'m,m coroplexes in.'estig"ted <lS <In:itum"Lr "genls 
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Figure 5.6: Cytotoxicity results for ci8-p!atnum c=ple,es [3,46] p.47] and [3.49] for (al WH CCl 1 
<lno (bj MEISe 
Complex [3.46] appeared to soow some acllvily for Ixlth CanCer cell lines (see Figure 5.6) [I 
was considered that a[ttlOugh speGtrosc:op<G evidence indiCilted that the complex was in the 
c;i5-Gonforrn~tion. it could be adopting the tralls·co~formation urtder certain cortditions. t,[1 the 
complexes ex~milled displayed some activity whiie Gom~ex [3.47] appeared to be the most 
active for bottl ce[1 !ines_ 
5.3.1.2 Palladium complexes 
The antitumour ~ctivity of several pa[iildium([[) compiexes has beee reported ~g~inst 
Sarcoma 180 The pa[iildium complexes were less <!Ctive th~n related p[~tinllm complexes 
Url{Jer the s~me coeditions_ ".-' These reports sheAA' the pa[[ad'lum complexes as having at 
best marginal success, 
Despite tilis, the cytotoxicity of a series of palladium complexes was uetermired (see Figl.lrf) 
5.7). Complexes were compared with structural differences ie the pyridy[ ]igarl{Js. The role 
p[~yed by sutstituents 011 the pyridy[ ligand was evaluated togethw with the position of 
subsfltutkln. The compiexes are relXlrted i~ the Imfls-conform~tion based on reporled 
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[3.40] [3.41] [3.42] [3.44] 
BiJlogiccJ aciidy 
c:=J 5O>!9ir.1 
c:=J 1 a~glml 
c::::::J 1 ~glml 
_ O~Q.lrTlI 
Figure 5.8: C)'totoxlc-Ay resu.ts tm trall.';-pa!ladiu,,-, complexes [3.40]-[3,42] [3.44] for i: a) WHC01 
a'"id lb'; MI'I80 
The complexes displayed similar distribution patlems fOf both cell lines (see Figure 58), 
Complex [3.40] appeCired to be the most active by far, The results indicated thClt derivatislng 
the pyndyl ring leads to a lowered activity in the complex. This could be due to deactivation of 
the ring due to the presence of the substituents or to steric constraints The aooormCiI 
distribution patterns for complexes [3.42] and [3.44] was due to the precipltCition of the 
complex in the cell well 
5.3.1.3 Rhodium complexes 
The antitumour properties of rtlodium(ll) complexes In the form of inorganic. binucieclr and 
caged complexes were first dijscovered in 1975' These complexes were mainly rtlodium{li\ 











inhibitioo of tumour growth. Rhodium(l) and iridium{l) square planar cyclooctadienyl 
complexes of the type [RhCI(COD){NH,)] and [RhCI(CQO)(plperdine)]" as well as 
acetylacetonato complexes of the type [M(acac)(COO)] where M = Rh(l) or Irll) have also 
been examined """" These comple~es exhibit antitumour activity against Erlich asdtes 
tumour, leukaemia L1210 and sarcoma t80, Most recently, investigations into rhodium(l) 
acetylacetooato complexes have gained renewed interest (see Figllre 5,9).>' 
R ~ CF" eel,. CH" Ph and Fe 
Figure 5.9: Rhodium co~lexe$ examined a$ articancer agenl$" 
Rhadium(l) carbonyl complexes of the type [Rh(COhL] where L " sulfooamide derivatives 
have shawn &Orne activity_ These complexes inhibit the growth of leukaemia P38a, Erlich 
tumour and advanced 816 melanoma." Reports have indicated that despite the heavy-metal 
character of rhodium, rm nephrotoxicity was observed with these complexes,,,,1 
r"Y' 
~::Rh<~ 
[3-6] R = H 
[3_9] R" Ph 
[3.13] R - {CoH.IFc 
[3_14] R = {C=NHCoH. IFc 
r;"Rh/U R 
~/ 'CI 
[3.15]R - Fe 





Figure 5.10: Rhodium oomplexes, [RhCI(CODIL] investigated as iII1titumour agents 
The antllumour activity of several rhodium cyclooctadienyl complexes was compared based 
on structural differences (see Figure 5_10)_ The role played by the position and nature of 
substituent OIl the pyridylligand was evaluated_ A rhodium carbonyl complex was included for 
exaninatioo based OIl the reported activity of similar romplexes 
Several rhodilJl1 complexes showed signifICant activity for both cancer cell lines (see Figure 
5, 11), Comple~ [3.15] seems to be particularly active, while complex [3.16] displayed specific 
activity for WHeOt and complexes [3.4] and [3.14[ were more active on MEt80, Based on 
the results for complex [3.8[, II would appear that derivalisatkln of Ihe pyridy1lf;jand is related 



























c:J 1 O~g.'ml 
_ 1~"lml 
_ O:J~iml 
Figure~. 11, Cytotoxicity r.'Jlb or r'>odium cample."s br (ai WHC01 and (b) MI:::180 
However, H1R m"lor;ty of tile rhodium complexes were only partially soluble in the aqueous 
environmRnt Catkmic rllOdium complexes were further examined in an attempt to OVRrcome 
the problRm SRveral rhodium cationic complexes were investigated with compari!'.O!l of thR 
Jerivatised pyridylligands and the effRct on thR cytotoxidiy cons d cred (see Figure 5.12) 
[~.21] R-II 
]3.2~] f< = f-e 
]3.25] R" (C, II,;"--," 
]3.26] f< = iC=N1C"Hdc 
Complexes [3.24] and [3.26] displayed the most signif~a nt activity for both cancer cRli lines 
wllile complex [3.21] seemed to be inactive (see Figufe 5. 13). This could il1{jicate that placing 
a (ferrOCRnyl) substituent on the pyrkJ'y1 ring leads to e~llanced activity of the complexes. 1 he 
solubility problems were not completRly overcomR. as the complexes remained partially 
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[3.26] 
Figure 5.13: Cytatoxicity rewlt" far rhoou m Gomplu~ s. [R~: COD: L.,] CkJ. for :") 'WHCO 1 a,j (b) 
~E'80 
5.3.1.4 Iridium complexes 
The stlldy of tile antitulll(lur activity of iridium(!) comple.es is close" linked to that oj the 
related rh<x:tium(tl cornple,es. As with the r~ated rh<x:tium complexes, the metal has been 
reported as readil\' undergoing oxidative additKln under physiological CClnditions leading to the 
formatkln (ll an active iridium(1111 complex 
Two iridium CClm:'llexes were examined lor their cyt(lt(l.ic activity with differeoce5 in the 
substituent on the py(ldyl ring I ~ and (see Figure 5.14) 
p.34] R = p~ 
[3.3£] R~,cc 
Figu,"" ~.14 IroJ ium COI'1'I€X€5 inv€"ig~tec! ~s "":itutn(J,~ ag~ rt5 
A comparison 01 tile cytotOXK:lty results revealed that neither iridium complex was particularly 




















Figure 5.15: Cytotoxicity of indium complexes. [lrCI(COD)L] for (a) WHCOI and (b) MEt80 
5.3.2 Determination of selected IC5() values 
The Ie", ~alues of selected complexes was obtained. The determination of cytotoxicity arid 
the IC," ~alue represents the f.-st screenirlg stage for caocer therapy drugs. The selection of 
complexes was ~mited by the solubility of the complex in an aqueous medium. Thus, the IC"" 
values for selected complexes could on~ be determined as the exact concentration of drug 
had to be known (see Table 5.1) 























The determination of IC!jO values for complexes [3.14] and [3.15] was attempted due to their 
significant cytotoxic actiVity. However, one of the key problems associated with these 
complexes was solubility in an aqueous medium. Large amounts of precipitate were observed 
at a range of the concentrations investigated and an endpoint could not be effectively 
obtained. Despite the potential of several of the ferrocenyl complexes examined, the 
insolubility of the complexes prevented further examination. 
5.4 General remarks and conclusions 
One of the key issues described in the literature with reference to the study of metal-
containing antitumour agents is the relatively random manner in which complexes are 
selected for investigation. Attempts were made to compare the activity of complexes 
displaying structural similarities. The rhodium complexes, for example, displayed enhanced 
activity for complexes with derivatised pyridyl ring ligands. 
One of the chief problems associated with several of the complexes examined, lies in the 
insolubility of the complexes in an aqueous medium. Given that solutions of the complexes 
are administered to biological systems, the choice of solvent is limited. Similar problems 
related to the insolubility of ferrocenyl systems have been reported. The preparation of 
ferrocenium salts of the complexes or cyclodextrin inclusion complexes could potentially 
stabilise the complexes and render them soluble in an aqueous medium. The use of 
cyclodextrins for this purpose has been reported where anticancer studies were conducted 
with ferrocene. 1o Recently, the preparation of 4-ferrocenylpyridine as well as a rhenium 
complex thereof, (4-ferrocenylpyridine)methyltrioxorhenium, has been reported as 
cyclodextrin inclusion complexes.24 
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Conclusions & future work 
Chapter 6: Conclusions & Future Work 
6.1 Project overview 
In this project a series of multinuclear complexes were successfully prepared and 
characterised using an array of analytical techniques. The electronic and electrochemical 
properties of the complexes were determined and these related to the structure of the 
complexes. The application of these complexes was further investigated through 
determination of the anticancer properties and catalytic activity of the complexes. The 
catalytic activity of the complexes was determined through several test reactions. 
In the current investigation into the preparation of novel multinuclear complexes, several 
approaches were taken. 
• A series of pyridyl complexes was successfully prepared. The ligands studied for 
complexation, were all in the form of derivatised pyridyl ligands where the nature of the 
substituent was considered together with the position of substitution on the pyridyl ring. 
The effect of spacer groups between the ferrocenyl group and pyridyl ring was examined. 
Both monosubstituted and 1, 1'-disubstituted ferrocenylpyridines were synthesised. 
• Viable synthetic routes for both ligand and complex preparation were studied where 
these complexes were prepared in good isolated yield. The ligands prepared were 
complexed to a series of platinum group metals - rhodium, iridium, palladium and 
platinum, in the form of mono-, bi- and trinuclear complexes. The complexes were fully 
characterised using NMR, infrared spectroscopy. elemental analysis, mass spectrometry, 
electronic spectroscopy and cyclic voltammetry. The X-ray crystal structure of selected 
complexes was determined. 
• Electrostatic changes between the free ligand and metal complexes were monitored 
using a number of spectroscopic techniques and related to the substituent on the pyridyl 
ring and its positon. The extent of electrochemical interaction in the ferrocenyl complexes 
was evaluated, where changes in redox potential was reported relative to the 
standardised ferrocene redox potential. 
• Results indicated that the length of spacer group affected the extent of interaction 












Conclusions & future work 
communication. The most pronounced electrochemical interaction was obtained for the 
linear rhodium binuclear complex [RhCI(COD)(4-Fcpy)]. The extent of shift of redox 
potential indicated a strong interaction between the metals in this complex. The 
interaction was further displayed through the spectroscopic comparison of the free ligand 
and complex. 
• The resonance effect appeared to limit electrochemical interaction in the ortho and meta 
ferrocenylpyridine complexes. The electrochemical interactions for these complexes was 
not as pronounced in these complexes relative to the para-substituted 
ferrocenylpyridines. 
6.2 Catalysis 
Several catalytic reactions were investigated with the metal complexes prepared in this study. 
Certain trends were discernible from these investigations. Where possible, the activity of the 
catalysts was correlated with the structure of the complex taking into account steric and 
electronic effects. 
• The polymerisation of phenylacetylene was investigated with several neutral and cationic 
rhodium complexes. The activity of nitrogen-donor complexes was compared to several 
ferrocenylphosphine complexes. The nitrogen-donor ligands were more active, displaying 
increased polymer yield, polymer molecular weight and thermal stability with comparable 
polymer isomer formation. Certain structure-activity relationships were speculated since 
results indicated that catalysts with linear extended ligands showed the best activity in 
terms of higher molecular weight and more thermally stable polymer. The rhodium 
catalysts examined gave the cis-isomer of the polymer almost exclusively. There is 
potential for the further investigation of these complexes. Modifications to this type of 
system would include extension of the linear ligand framework. One of the key areas to be 
addressed includes the polydispersity. 
• The carbonylation of nitrobenzene was catalysed with palladium complexes. 
Derivatisation of the pyridyl ring in the palladium complex PdCl2(pyh lead to enhanced 
activity under relatively milder reaction conditions than that reported in the literature. The 
derivatised palladium complexes displayed greater selectivity for the formation of the 
major product. The results indicated that the position of substitution on the pyridyl ring of 
the ligand makes a difference to the activity of the complex. The palladium complex, 













nitrogen into a glass storage vessel with Teflon stopcock. All other commercial reagents were 
used as obtained without further purification. 1',2',3',4',5'-Pentamethylazaferrocene was 
prepared according to the method of Fu3 and obtained courtesy of Dr P. Beagley, 
Organometallic Research Group, University of Cape Town. 
Rhodium, iridium, platinum, and palladium were obtained as chloride salts on loan from 
Johnson-Matthey and ferrocene obtained commercially from Sigma Aldrich. 
Thin layer chromatography was performed on aluminium backed silica gel or aluminium oxide 
60 F254 plates in a variety of solvent systems using the ascending technique. Plates were 
analysed under ultraviolet light. Column chromatography was conducted either on silica gel 
60, particle size 0.063 mm - 0.200 mm (70 - 230 mesh ASTM) or neutral alumina, particle 
size 0.063 mm - 0.200 mm (70 - 230 mesh ASTM). Columns were generally prepared with 
1 :100 ratio product to chromatographic material. 
7.1.1 Instrumentation 
Melting points were determined on a Kofler hotstage microscope (Reichart Thermovar). 
Microanalyses were obtained on a Carlo Erba EA 1108 elemental analyser. Fast atomic 
bombardment (FAB) and high resolution (EI) mass spectra were recordered on a VG-70SEQ 
mass spectrometer at the mass spectrometry unit, Cape Technikon. In all cases the isotopic 
distribution was checked against the theoretical distribution. 
Infrared spectra were recorded on a Perkin Elmer Paragon 1000 FT-IR spectrometer, with 
solid samples prepared as potassium bromide disks and solution samples in sodium chloride 
solution cells. Thermal analyses were conducted on Perkin Elmer ThermograVimetric 
analyser TGA7 and Differential Scanning Calorimeter DSC7. 
NMR spectra were recorded on either a Varian Unity-400 CH: 400 MHz; 13C: 100.6 MHz) or 
Varian Mercury-300 CH: 300 MHz; 13C: 75.5 MHz) spectrometer at ambient temperatures. 1H 
NMR spectra were referenced internally using reSidual protons in the deuterated solvent 
(CDCb: 0 7.27; CsDs: 0 7.24, CD30D: 0 5.84, CD3COCDs: 0 2.09) and values reported relative 
to tetramethylsilane (0 0.00). 13C NMR spectra were Similarly referenced internally to the 
solvent resonance (CDCI3: 0 77.0; CsDs: 0 128.1, CD30D: 0 49.1, CD3COCD3 : 0 30.60 and 













UV-Vis spectra were recordered on a Hewlett Packard 8452A diode array spectrophotometer 
in a range of solvents. Cyclic voltamograms were obtained on a BAS 100B electrochemical 
analyser with a one compartment three-electrode system consisting of a Ag/AgN03 (0.01 M) 
reference electrode, platinum wire auxiliary electrode and platinum disc working electrode. 
Samples (1-2 mM) were prepared and run under argon at ambient temperature, in anhydrous 
acetonitrile with tetrabutylammonium perchlorate (0.1 M) as background electrolyte. Solutions 
were saturated with argon by bubbling for several minutes prior to each run. The system gave 
ferrocene Ey. :::: +75.5 mY. The platinum disc working electrode was polished between runs. 
Gas chromatography was conducted on a Carlo Erba Strumentazione Fractovap 4200 series 
dual column modular gas chromatograph fitted with a Phenomenex Zebron ZB-1 column. 
Gel-permeation chromatography was conducted at Stellenbosch University with a Waters 717 
autosampler, Waters 619 flow unit, Waters 410 differential refractometer, Waters 600E 
system controller, Waters 515 HPLC pump, Valveco 8-port switch valves for high and low 
temperature HPLC applications and Wyatt technology laser photometer. The programme was 
controlled using Milienium™ software. 
X-ray diffraction data was collected at 173 K using Nonius Kappa CCD with 1.5 kW graphite 
monochromated Mo radiation. The strategy for data collection was evaluated using 
COLLECr.4 Several sets of data were collected with both a 1990 phi scan and omega scans 
to collect cusp data. The data was scaled and reduced as well as treated for absorption by a 
semi-empirical method using DENZO-SMN.5 Unit cell dimensions were refined on all data. 
The structure was solved and refined using SHELX97.6•7 Molecular graphics were generated 
using ORTEP-III,8 PLA Tar.! and X-Seed,10 a graphical interface for the SHELX program. 
Biological studies were carried out by Dr D. Hendricks at Medical Biochemistry, University of 
Cape Town. 
Preparation of ferrocenyl precursors, ligands and their coordination complexes 
7.2 Synthesis of ligands 
1.2.1 Chloromercuriferrocene11 ,12 
A solution of mercuric acetate (5.26 g, 16.5 mmol) in methanol (45 ml) was 
added dropwise to a solution of ferrocene (6.25 g, 33.0 mmol) in benzene (30 
















least 10 hours. A solution of lithium chloride (1.48 g. 35.0 mmol) in ethanol-water 1:1 (10 ml) 
was added slowly to the reaction mixture, changing it from dark brown to light orange. Upon 
further stirring for 2 hours at room temperature, an orange suspension was observed. The 
reaction mixture was set to reflux for an hour. fonowed by filtration of the crude residue under 
vacuum. The residue obtained was purified by Soxhlet extraction with dichloromethane, 
followed by sublimation to remove unreacted ferrocene. Recrystallisation of the unsublimed 
portion yielded the product as a fine golden powder (2.92 g, 42%), mp 194-195 DC (dec.) (lit. i3 
194-198 DC dec.). Vmax (KBr)/cm'
1 3091, 1653, 1409, 1324, 1105,1020,999,823 and 493; 1H 
NMR (5H (300 MHz; solvent CDCI3): 4.47 (2H, t, J = 1.7 Hz, CSH4), 4.23 (5H, s, CsHs), 4.11 
(2H, t, J = 1.7 Hz, CSH4); 13C NMR (5e (75 MHz; solvent CDCI3): 73.01 (CSH4). 70.38 (CSH4) 
and 68.98 (CSH5). 
7.2.2 lodoferrocene11 
A solution of iodine (4.52 g, 35.6 mmol) in dichloromethane (100 ml) was added 
slowly to a solution of chloromercuriferrocene (5.00 g, 11.87 mmol) in 
dichloromethane (300 ml) at room temperature under nitrogen. The reaction 
mixture was further stirred for several days, concentrated under vacuum and 
subjected to flash chromatography. The filtrate was w shed with sodium thiosulfate (10 % 
aqueous solution), followed by water. The organic fractions were collected, dried over 
anhydrous magnesium sulfate and the solvent removed in vacuo. The residue obtained was 
subjected to column chromatography on silica with petroleum ether (40-60 DC) as eluant. The 
product was obtained as yellow crystals (1.90 g, 51%), mp 44-45 DC (lit,i1 44-46 DC). Vmax 
(KBr)1 cm,i 3090, 1600-1700, 1412, 1105, 1018, 1000 and 820; 1H NMR (5H (300 MHz; solvent 
CDCI3): 4.35 (2H, t, J = 1.7 Hz, CSH4), 4.12 (5H, s, CsHs), 4.09 (2H, t, J = 1.8 Hz, CSH4); 13C 
NMR (5e (75 MHz; solvent CDCI3): 74.85 (CSH4), 71.42 (CsHs) and 69.20 (CSH4). 
7.2.3 Bromoferrocene11 
A solution of N-bromosuccinimide (1.10 g, 6.2 mmol) in anhydrous N,N'-
dimethylformamide (20 ml) was added slowly to a cold (-0 DC) stirred solution of 
chloromercuriferrocene (2.10 g, 5.0 mmol) in anhydrous N,N'-dimethylformamide 
(40 ml). under nitrogen. The reaction mixture was further stirred at this 
temperature for at least 3 hours. A sodium thiosulfate (10 % aqueous) solution was added to 
the dark green reaction mixture, forming a lighter green suspension that was poured into 500 
ml of cold water. The resulting green solution was extracted several times with hexane. The 













and the solvent removed in vacuo. The crude orange residue obtained was subjected to 
column chromatography on alumina and the product eluted with hexane. The product was 
observed as orange-yellow crystals (0.79 g, 60%), mp 32-34 °C (1it. 11 31-32 °C). 1H NMR OH 
(300 MHz; solvent CDCI3): 4.51 (2H, t, J::: 1.8 Hz, CSH4), 4.32 (5H, s, CsHs), 4.18 (2H, t, J::: 
1.8 Hz, C5H4); 13C NMR Oc (75 MHz; solvent CDCI3): 75.48 (CSH4), 72.32 (CsHs) and 69.02 
(CSH4). 
7.2.4 4.Bromophenylferrocene 13,14 
A mixture of 4-bromobenzeneboronic acid (0.64 g, 3.21 mmol), ~ ~ 
iodoferrocene (0.50 g, 1.60 mmol), barium hydroxide (0.71 g, 2.24 ~Br 
F.e 
mmol) and palladium acetate (0.12 g, 0.53 mmol) in degassed 90 % ~
ethanol (250 ml) was vigorously shaken for 30 minutes. The mixture 
was set to reflux while stirring under nitrogen (49 hours). The solvent was then removed in 
vacuo and the residue taken up in diethyl ether and filtered. The filtrate was washed with 
water, dried over anhydrous sodium sulfate and the solvent removed in vacuo. The residue 
obtained was purified by column chromatography over silica gel. The product was eluted with 
hexane-dichloromethane 8:2 and collected as bright red crystals, which were recrystallised 
from hexane (0.08 g, 15%), mp 122-123 °C (lit,13 125°C); (Found: M+ 339.9551. C1sH13BrFe 
requires M+ 339.9550). Vmax (KBr)1 cm-
1 3086, 3050, 2926, 2853, 1588, 1510, 1446, 1406, 
1383,1279,1103,1088,1067,1050,1030,1001,884,819, 712, 644, 516, 498 and 478; 1H 
NMR OH (300 MHz; solvent CDCI3): 7.41 (2H, d, J ::: 8.5 Hz, CSH4), 7.34 (2H, d, J ::: 8.5 Hz, 
CSH4), 4.62 (2H, t, J ::: 1.8 Hz, CSH4), 4.34 (2H, t, J ::: 1.7 Hz, CSH4), 4.04 (5H, s, CsHs); mIz 
(EI) 340 (M+, 100%),260 (3), 205 (23), 203 (10),202 (9). 
7.2.5 4-ferrocenylphenol16 
A cold aqueous solution of sodium nitrite (8.01 g, 0.12 mol) was added 
slowly to a cold (0 0c) solution of dilute hydrochloric acid (60 ml, 2 M) 
and 4-aminophenol (12.00 g, 0.11 mol) in a 2-necked round-bottom 
flask. The mixture was stirred at this temperature for at least 30 
~ )-OH 
~ 
minutes. The diazonium salt that formed was added to a cold solution of ferrocene (18.60 g, 
0.10 mol) in diethyl ether (450 ml). The reaction mixture was gradually warmed to room 
temperature overnight and nitrogen gas formed as the reaction progressed. The two-layer 
reaction mixture was poured into a separating funnel and the aqueous layer was extracted 
with diethyl ether. The organic fractions were combined, washed with water, dried over 













obtained was initially passed over a silica gel flash column to remove decomposed material, 
followed by column chromatography over silica gel. The product was eluted as a red band 
with diethyl ether. 4-Ferrocenylphenol was obtained as an orange crystalline solid (8.80 g, 
32%), mp 162-164 DC (1it. 1S 164-166 DC); (Found: M+ 278.0393. ClsH14FeO requires M+ 
278.03940). Vmax (KBr)1 cm-1 3515,1651,1609,1528,1269,1175,840 and 815; lH NMR OH 
(300 MHz; solvent COCh): 7.38 (2H, d, J::: 8.5 Hz, CSH4), 6.79 (2H, d, J::: 8.2 Hz, CSH4), 4.76 
(1H, s, OH), 4.56 (2H, t, J::: 1.8 Hz, CSH4), 4.27 (2H, t, J::: 1.7 Hz, CSH4), 4.03 (5H, s, CsHs); 
mIz (EI) 278 (M+, 100%), 157 (11) and 121 (10). 
7.2.6 4-Benzyloxy-4' -phenylferrocene 16 
A mixture of 4-hydroxyphenylferrocene (0.30 g, 1.08 mmol), 
benzyl bromide (0.18 g, 1.08 mmol), potassium carbonate 
(0.89 g, 6.47 mmol) and sodium iodide (0.97 g, 6.47 mmol) 
in acetone (50 ml) was heated under reflux while stirring under nitrogen for 46.2 hours. The 
reaction mixture was then concentrated, washed with water and extracted several times with 
dichloromethane. The organic fractions were dried over anhydrous sodium sulfate and the 
solvent removed in vacuo. The crude residue obtained was purified by column 
chromatography on silica gel and the product was eluted with hexane-dichloromethane (7:3). 
4-Benzyloxy-4'-phenylferrocene was obtained as golden flakes (0.16 g, 39%), mp 161-162 DC 
(lit.1S 164-167 DC); (Found: M+ 368.0863. C23H2oFeO requires M+ 368.08635). Vmax (KBr}1 cm-
1 
3447, 1653, 1526, 1455, 1384, 1245, 1103, 1029, 828, 753, 701 and 495; 1H NMR OH (300 
MHz; solvent COCh): 7.47 - 7.28 (7H, m, CsHs and CSH4), 6.93 (2H, dd, J ::: 8.7 Hz, CSH4), 
5.05 (2H, s, OCH2), 4.57 (2H, t, J::: 1.6 Hz, CSH4), 4.29 (2H, t, J::: 1.6 Hz, CSH4), 4.04 (5H, s, 
CsHs); 13C NMR Oc (75 MHz; solvent COCI3): 137.49 (CSH4), 131.96 (CSH4), 128.98 (CSH4), 
128.35 (CSH4), 127.92 (CSH4), 127.60 (CSH4), 115.14 (CSH4), 96.80 (OCH2), 70.47 (CSH4). 
69.94 (CsHs), 68.96 (CSH4) and 66.56 (CSH4); mIz (EI) 368 (M+, 68%), 277 (100), 249 (14). 
121 (30),91 (9) and 56 (6). 
7.2.7 4-Nitrophenylferrocene 17 
A cold aqueous (50 ml) solution of sodium nitrite (8.01 g, 0.12 mol) 
was added slowly to a cold (0 DC) solution of dilute hydrochloric acid 
(100 ml, 2 M) and 4-nitroaniline (15.00 g, 0.11 mol) in a 2-necked 
round-bottom flask. The mixture was stirred at this temperature for at least 30 minutes. The 
diazonium salt that formed was added to a cold solution of ferrocene (18.50 g, 0.10 mol) in 













overnight and nitrogen gas was formed as the reaction progressed. The two-layer reaction 
mixture was then poured into a separating funnel and the aqueous layer was extracted with 
diethyl ether. The organic fractions were combined, washed with water, dried over anhydrous 
sodium sulfate and the solvent removed in vacuo. The crude dark residue obtained was 
initially passed over a silica gel flash column to remove decomposed material, followed by 
column chromatography over deactivated alumina. The product was eluted as a dark red 
band with diethyl ether. 4-Nitrophenytferrocene was obtained as dark red-black crystals (3.10 
g, 21%), mp 108-110 °C (lit.17 108-111 °C); (Found: M+ 307.0293. C1sH13FeN02 requires M+ 
307.0293). Vmax (KBr)1 cm-1 3019, 1594, 1509, 1340, 1106, 1003,847,816 and 474; 1H NMR 
OH (300 MHz; solvent CDCh): 8.14 (2H, d, J:::: 8.5 Hz, CSH4), 7.56 (2H, d, J:::: 8.5 Hz, CSH4), 
4.74 (2H, t, J::: 1.8 Hz, CSH4) , 4.47 (2H, t, J:::: 1.8 Hz, CSH4) , 4.16 (5H, s, CsHs); 13C NMR Oc 
(75 MHz; solvent CDCh): 134.97 (CsH",), 129.7 (CsH",), 126.33 (CSH4), 124.22 (CSH4), 123.88 
(CSH4), 71.00 (CSH4), 70.44 (CsH",) and 68.31 (CsHs); mIz (EI) 308 (M+, 20%), 261 (47), 244 
(9),186 (17), 152 (7), 139 (21) and 121 (17). 
7.2.8 4-Ferrocenylaniline 18 
The hydrogenation of 4-nitrophenytferrocene (3.54 g, 11.53 mmol) to 
4-aminophenylferrocene was catalysed by 10 % palladiuml carbon 
(0.15 g) in tetrahydrofuran (200 ml) in a Parr hydrogenation reactor 
(400 atm). The product was purified by column chromatography on 
silica gel and eluted with dichloromethane. 4-Ferrocenylaniline was obtained as an orange-
brown solid (0.99 g, 31%), mp 157-159 °C (lit. 159-160 °C); (Found: M+ 277.05682. 
C1sH1sFeN requires M+ 277.05539). Vmax (KBr}1 cm-
1 3436, 3356, 3102, 1653, 1622, 1529, 
1452, 1288, 1103, 1012, 820,640,531 and 507; 1H NMR OH (300 MHz; solvent CDCh): 7.30 
(2H, d, J = 8.5 Hz CSH4). 6.65 (2H, d, J:::: 8.5 Hz, CsH",), 4.54 (2H, t, J:::: 1.8 Hz, CSH4) , 4.24 
(2H, t, J :::: 1.8 Hz, CsH",), 4.03 (5H, s, CsHs) , 3.62 (2H, s, NH2); 13C NMR Oc (75 MHz; solvent 
CDCh): 144.94 (CsH",), 129.40 (CsH",), 127.54 (CSH4), 115.59 (CSH4), 96.51 (CsH",), 86.95 
(CSH4), 68.58 (CSH4) and 66.20 (CsHs); mlz (EI) 277 (M+, 100%), 211 (7). 156 (22) and 121 
(8). 
7.2.9 4-Phenylimine-4' -pyridine 19,20 
Pyridine-4-carboxaldehyde (1.15 g, 1.10 ml, 10.74 mmol) was added 
to a solution of aniline (1.0 g, 0.98 ml, 10.74 mmol) in methanol (40 
ml) with 4A molecular sieves (3 g). The reaction mixture was heated 













concentrated. The concentrate was cooled to 0 °C to precipitate the product, which was 
collected via vacuum filtration. The product was obtained as cream crystalline flakes (1.52 g, 
77%), mp 60-66 °C. Vmax (KBr)1 cm-
1 3052, 2883,1651,1621,1595,1494,1226,1186,1166, 
1075, 1023, 1000,821 and 500;1H NMR BH (400 MHz; solvent CDCls): 8.74 (2H, dd, CSH4N), 
8.44 (1 H, s, N=CH), 7.75 (2H, dd, CSH4N), 7.42 (2H, t, CeHs), 7.31 (2H, d, CeHs), 7.25 (1 H, t, 
CeHs); 1SC NMR Be (101 MHz; solvent CDCls): 158.12 (N==C), 151.21 (CSH4N), 150.81 
(CSH4N), 143.05 (CeHs), 129.51 (CSH4N), 127.21 (CeHs), 122.47 (CeHs) and 121.12 (CeHs). 
1.2.10 4-Pyridyl im ine-4' -phenylferrocene21 
Pyridine-4-carboxaldehyde (0.12 g, 1.08 mmol) was added 
to a solution of 4-ferrocenylaniline (0.20 g, 0.72 mmol) in 
methanol (20 ml) with 4A molecular sieves (1 g). The 
reaction mixture was heated under reflux overnight. The 
reaction mixture was then filtered and concentrated. The concentrate was cooled to 0 °C to 
precipitate the product. The product was collected via vacuum filtration and obtained as 
maroon crystalline flakes (0.24 g, 90%), mp 195-196 °C; (Found: M+ 366.08140. C22H1sFeN2 
requires M+ 366.08194). Vmax (KBr)1 cm-
1 3506, 1623, 1408, 1105, 846 and 823; 1H NMR BH 
(400 MHz; solvent CDCls): 8.77 (2H, d, J == 5.9 Hz, CsH.4N), 8.54 (1 H, s, N==CH), 7.79 (2H, dd, 
J == 5.9 Hz, CSH4N), 7.55 (2H, dd, J:::: 6.7 Hz, CeH4), 7.22 (2H, d, J:::: 8.5 Hz, CSH4), 4.68 (2H, 
t, J::::: 1.8 Hz, CSH4), 4.36 (2H, t, J:::: 1.8 Hz, CSH4), 4.06 (5H, s, CsHs); 13C NMR Be (101 MHz; 
solvent CDCIs): 156.71 (N==C), 150.80 (CSH4N), 148.61 (CSH4N), 143.26 (CeH4), 139.07 
(CSH4N), 127.00 (CSH4N), 122.38 (CSH4N), 121.48 (CSH4), 69.88 (CsHs), 69.42 (CSH4) and 
66.70 (CSH4); mIz (EI) 366 (M+, 100%),301 (8),245 (9),139 (8),121 (8) and 56 (3). 
1.2.11 4-Pyridylvinyl-4' -phenylferrocene21• 22 
Lithium n-diisopropylamide (1.20 mmol) in tetrahydrofuran 
(30 ml) was prepared in situ at -78°C. A solution of 4-
methylpyridine (30.8 mg, 0.03 ml, 0.33 mmol) in 
tetrahydrofuran (20 ml) was added slowly to the solution, 
after which the reaction mixture was slightly warmed by replacing the -78°C cold bath with 
an ice-bath. The reaction mixture was further stirred at this temperature for an hour. A 
solution of 4-formylphenylferrocene (80.0 mg, 0.28 mmol) in tetrahydrofuran (10 ml) was 
slowly added to the reaction mixture, which was then gradually allowed to warm to room 
temperature overnight. The reaction mixture was concentrated and the residue taken up in 













combined, dried over anhydrous magnesium sulfate and the solvent removed in vacuo. The 
crude intermediate hydroxy species obtained was taken up in toluene (15 ml) and stirred 
under reflux (23.7 hours) with pyridinium toluene-p-sulfonate (27.5 mg, 0.11 mmol) to form 
the alkene. The reaction mixture was concentrated, the residue taken up in chloroform and 
washed successively with water and brine. The organic portions were combined, dried over 
anhydrous magnesium sulfate and the solvent removed in vacuo. The crude residue was 
further purified by column chromatography on silica gel. The product was collected after 
recrystallisation (dichloromethane-hexane) as pink-red crystalline flakes (23.9 mg, 24%), mp 
228-230 aC. 1H NMR BH (300 MHz; solvent CDCb): 8.59 (2H, d, J::::: 5.9 Hz, C5H4N), 7.48 (4H, 
dd, J = 8.4 Hz, CeH4), 7.36 (1H, d, J::::: 16.1 Hz, CH=CH). 7.26 (2H. d. J::::: 5.8 Hz, C5H4N). 
7.04 (1 H, d, J ::::: 16.1 Hz, CH:::::CH), 4.68 (2H, t, J ::::: 1.9 Hz, CSH4), 4.36 (2H, t, J ::::: 1.8 Hz, 
C5H4), 4.05 (5H, s, C5H5); 13C NMR Be (75 MHz; solvent CDCI3): 150.21 (C5H4N), 133.09 
(C5H4N), 127.12 (CeH4), 126.34 (CeH4), 124.98 (C=C), 120.76 (C=C), 69.70 (CsHs), 69.32 
(C5H4) and 66.52 (Cs~). 
1.2.12 4-ferrocenylpyridine23,24 
Diethyl ether (5 ml) was added to previously dried and weighed ~ i\ 
magnesium (396.0 mg, 16.0 mmol) in a two-necked 50 ml round bottom ~N 
Foe 
flask fitted 'with a condenser and dropping funnel. A solution of 1,2-~
dibromoethane (0.7 ml, 7.9 mmol) and bromoferrocene (792.0 mg, 4.0 
mmol) in diethyl ether (10 ml) was added dropwise. On complete addition, two layers were 
observed with a small amount of unreacted magnesium. A mixture of 4-bromopyridine (462.2 
mg. 2.6 mmol) and cis-(1 ,3-bis(diphenylphosphino)propane)dichloronickel (16.7 mg, 31 jlmol) 
in diethyl ether (10 ml) was added to the freshly prepared Grignard reagent. The reaction 
mixture was heated under reflux under nitrogen for 23 hours, changing to a deep red solution 
over time. Upon cooling the reaction mixture, distilled water was added slowly to destroy any 
active Grignard reagent remaining. The two-layer reaction mixture was poured into a 
separating funnel and the aqueous layer extracted repeatedly with diethyl ether. The organic 
fractions were combined, washed with brine, dried over anhydrous magnesium sulfate and 
the solvent removed in vacuo yielding an orange residue. The residue was purified by column 
chromatography on silica gel. The product was eluted with 5 % methanol in diethyl ether and 
isolated as golden yellow flakes (450 mg, 73%), mp 137-139 °C (1it,23 136-138 °C). Vmax (KBr)1 
cm-1 3104,3069,3033,3047,1612,1569,1478,1436,1348, 1105, 1093, 1033,823 and 486; 
1H NMR BH (300 MHz; solvent CDCI3): 8.45 (2H, d, J::::: 6.0 Hz, C5H4N), 7.51 (2H, dd, J::::: 6.3 













1SC NMR 3c (75 MHz; solvent CDCb): 150.78 (CSH4N), 123.65 (CSH4N), 72.02 (CsHs), 70.46 
(CSH4) and 67.96 (CSH4). 
7.2.13 3-Ferrocenylpyridine23,25 
3-Ferrocenylpyridine was prepared according to the general procedure for 
7.1.12. Magnesium (183.7 mg, 7.55 mmol), 4-bromoferrocene (500.0 mg, 
1.89 mmol), 1,2-dibromoethane (702.0 mg, 0.32 ml, 3.74 mmol), 3-
bromopyridine (194.0 mg, 0.12 ml, 1.23 mmol) and cis-(1,3-
bis(diphenylphosphino)propane)dichloronickel (8.0 mg, 14.7 jJmol) in diethyl ether (25 ml) 
was heated under reflux for 19 hours. The product was obtained as large flat brown crystals 
from dichloromethane-hexane (258.0 mg, 80%), mp 60-62 °C (lit.26 57-59°C). Vmax (KBr)1 cm-1 
3853,3743,1699,1652,1569,1495,1419,1305,1282, 1215, 1103, 1088, 1007,887,808, 
702, 668, 523,498 and 404; 1H NMR 3H (400 MHz; solvent CDCb): 8.75 (1H, br s, CSH4N), 
8.42 (1H, d, J::: 4.3 Hz, CSH4N), 7.73 (1H, dd, J::: 8.0 Hz, CSH4N), 7.21 (1H, dd, J::: 6.3 Hz, 
CSH4N), 4.67 (2H, t, J::: 1.8 Hz, CSH4). 4.37 (2H, t, J::: 1.8 Hz, CSH4) , 4.06 (5H, s, CsHs); 1SC 
NMR 3c (101 MHz; solvent CDCls): 145.87 (CSH4N), 145.40 (CSH4N), 131.41 (CSH4N), 121.63 
(C5H4N), 68.05 (C5Hs), 67.85 (C5H4) and 64.87 (C5H4). 
7.2.142-Ferrocenylpyridine27 
2-Ferrocenylpyridine was prepared by the general procedure 7.1.12 via the ~N} 
Grignard reaction. Magnesium (220.6 mg, 9.06 mmol), bromoferrocene Q V 
(600.9 mg, 2.26 mmol), 1,2-dibromoethane (840.0 mg, 0.39 ml, 4.48 mmol), F.e 
2-bromopyridine (200.0 mg, 0.12 ml, 1.28 mmol) and cis-(1,3-
bis(diphenylphosphino)propane)dichloronickel (6.9 mg, 12.8 jJmol) in diethyl ether (27 ml) 
heated under reflux for 44.4 hours. The product was obtained as orange rod-like 
microcrystals from dichloromethane-hexane (218.9 mg, 65%), mp 85-87 °C (lit?7 87-89 °C); 
(Found: M+ 263.0. C15H1SFeN requires M+ 263.1). Vmax (KBr)1 cm-
1 3608, 3565, 2324, 1843, 
1767,1698,1622,1587,1558,1495,1423,1275, 1106,892,824,788,741,667,518,496, 
441 and 403; 1H NMR 3H (300 MHz; solvent CDCb): 8.49 (1H, br s, C5H4N), 7.57 (1H, d, 
C5H4N), 7.41 (1H, dd, J::: 7.8 Hz, C5H4N), 7.06 (1H, t, CSH4N), 4.92 (2H, t, J::: 1.8 Hz, C5H4) , 
4.39 (2H, t, J ::: 1.8 Hz, CSH4) , 4.05 (5H, s, CsHs); 1SC NMR 3c (75 MHz; solvent CDCI3): 
149.30 (C5H4N), 135.87 (CSH4N), 120.45 (C5H4N), 120.04 (CSH4N), 69.87 (C5H4), 69.56 (C5H5) 














7.2.15 4-Ferrocenylphenyl-4' -pyridine28 
4-Ferrocenylphenyl-4'-pyridine was prepared by the general Q-( X ;N 
procedure for 7.1.12 via the Grignard reaction. Magnesium (178.2 ~ -
mg, 7.33 mmol), 4-bromophenylferrocene (625.4 mg, 1.83 mmol), 
1,2-dibromoethane (682.0 mg, 0.31 ml, 3.63 mmol), 4-bromopyridine (188.2 mg, 1.19 mmol) 
and cis-(1 ,3-bis(diphenylphosphino)propane)dichloronickel (7.8 mg, 14.3 jJmol) in diethyl 
ether (36 ml) was heated under reflux for 21.8 hours. The product was obtained as an orange 
powder (134.0 mg, 33%), mp 225-226 aC. Vmax (KBr)! cm-1 3085, 3023, 1645, 1610, 1545, 
1500, 1435, 1401, 1105, 1087, 1000,842,810,656,498 and 409; 1H NMR ()H (400 MHz; 
solvent CDCI3): 8.66 (2H, dd, J = 5.9 Hz, CSH4N), 7.59 (4H, s, CeH4), 7.54 (2H, dd, J = 6.1 Hz, 
CSH4N), 4.70 (2H, t, J = 1.8 Hz, CSH4) , 4.37 (2H, t, J = 1.8 Hz, CSH4), 4.07 (5H, s, CsHs); 13C 
NMR ()c (101 MHz; solvent CDCI3): 150.45 (CSH4N), 127.09 (CeH4). 126.86 (CeH4), 121.35 
(CSH4N). 66.83 (CSH4), 69.56 (CSH4) and 69.92 (CsHs). 
7.2.16 4-Ferrocenylphenyl-3' -pyridine 
4-Ferrocenylphenyl-3'-pyridine was prepared by the general _ N 
procedure for 7.1.12 via the Grignard reaction. Diethyl ether (5 ml) ~N~ ~-
was added to previously dried and weighed magnesium (179.4 mg, $. 
7.38 mmol) in a two-necked 50 ml round bottom flask fitted with a 
condenser and dropping funnel. A solution f 1,2-dibromoethane (682.0 mg, 0.31 ml, 3.63 
mmol) and 4-bromophenylferrocene (625.3 mg, 1.83 mmol) in diethyl ether (10 ml) was 
added dropwise. On complete addition. two layers were observed with a small amount of 
unreacted magnesium. A mixture of 3-bromopyridine (188.2 mg, 0.11 ml, 1.19 mmol) and cis-
(1,3-bis(diphenylphosphino)propane)dichloronickel (7.8 mg, 14.3 jJmol) in diethyl ether (15 
ml) was added to the freshly prepared Grignard reagent. The reaction mixture was heated 
under reflux under nitrogen for 20.5 hours, changing to a bright orange solution over time. 
Upon COOling the reaction mixture, distilled water was added slowly to destroy any active 
Grignard reagent remaining. The two-layer reaction mixture was poured into a separating 
funnel and the aqueous layer extracted repeatedly with diethyl ether. The organic fractions 
were combined, washed with brine, dried over anhydrous magnesium sulfate and the solvent 
removed in vacuo yielding an orange residue, which was subjected to column 
chromatography on silica gel. The product was eluted with 5 % methanol in diethyl ether and 
isolated as an orange solid (156.0 mg, 39%), mp 144-147 °C; (Found: C, 74.44 %. H, 5.06, N, 
3.79; M+ 339 .. 1. C21H17FeN requires C, 74.3 %, H, 5.1, N, 4.1; M+ 339.1) Vmax (KBr)/ cm-1 













668,498 and 409; 1H NMR OH (400 MHz; solvent CDCh): 8.89 (1H, br s, CSH4N), 8.58 (1H. d, 
J = 4.8 Hz, CSH4N), 7.89 (1H, dt, J::: 1.8 and 11.7 Hz, CSH4N). 7.58 (2H. d, J::: 8.4 Hz, CSH4). 
7.52 (2H, d. J = 8.8 Hz, CSH4), 7.36 (1H, dd, J:: 12.4 Hz, CSH4N). 4.69 (2H. t. J:: 1.8 Hz, 
CSH4), 4.36 (2H. t, J ::: 2.2 Hz, CSH4), 4.07 (5H, s, CsHs); 13C NMR Oc (101 MHz; solvent 
CDCIs): 148.16 (CSH4N). 139.98 (CSH4N), 133.81 (CSH4N). 126.96 (CSH4), 126.65 (CSH4), 
123.51 (CSH4N), 69.61 (CsHs), 69.14 (CSH4) and 66.51 (CSH4); mIz (EI) 340 (24%), 339 (M+, 
100),218 (M+ - Cp-Fe, 18), 189 (4),169 (4),121 (Cp-Fe, 31) and 56 (Fe, 15). 
7.2.174-ferrocenylphenyl-2'-pyridine 
4-Ferrocenylphenyl-2'-pyridine was prepared by the general ~ 
procedure for 7.1.12 via the Grignard reaction. Diethyl ether (5 ml) ~ \. jj -
was added to previously dried and weighed magnesium (129.0 mg, ~ 
5.28 mmol) in a two-necked 50 ml round bottom flask fitted with a condenser and dropping 
funnel. A solution of 1.2-dibromoethane (490.0 mg, 0.24 ml, 2.61 mmol) and 4-
bromophenylferrocene (450.0 mg, 1.32 mmol) in diethyl ether (10 ml) was added dropwise. 
On complete addition, two layers were observed with a small amount of unreacted 
magnesium. A mixture of 2-bromopyridine (136.0 mg, 82.0 1-11, 0.86 mmol) and cis-(1,3-
bis(diphenylphosphino)propane)dichloronickel (5.6 mg. 10.3 I-Imol) in diethyl ether (16 ml) 
was added to the freshly prepared Grignard reagent. The reaction mixture was heated under 
reflux under nitrogen for 20.1 hours, changing to a bright orange-red solution over time. Upon 
cooling the reaction mixture, distilled water was added slowly to destroy any active Grignard 
reagent remaining. The two-layer reaction mixture was poured into a separating funnel and 
the aqueous layer extracted repeatedly with diethyl ether. The organic fractions were 
combined, washed with brine, dried over anhydrous magnesium sulfate and the solvent 
removed in vacuo yielding an orange residue, which was subjected to column 
chromatography on silica gel. The product was eluted with 5 % methanol in diethyl ether and 
isolated as a bright orange-red solid (112.0 mg, 38 %), mp 37-39 °C; (Found: C, 74.54 %, H, 
5.25, N, 4.10; M+ 339.1. C21 H17FeN requires C, 74.3 %, H, 5.0, N, 4.1; M+ 339.1). Vmax (KBr)/ 
cm-1 1585,1467,1434,1105,818,782,492,441,418,411 and 404; 1H NMR OH (400 MHz; 
solvent CDCh): 8.69 (1H, dd, J:: 4.8 Hz, CSH4N), 7.93 (2H, ddt J::: 8.4 Hz, CSH4). 7.74 (2H, 
dd, J::: 6.2 Hz, CSH4N), 7.57 (2H, dd, J::: 8.8 Hz, CSH4), 7.21 (1H, dd, J:: 6.6 Hz, CSH4N), 
4.71 (2H. t, J::: 1.8 Hz, CSH4), 4.35 (2H, t, J:: 2.2 Hz, CSH4), 4.05 (5H, S, CsHs); 13C NMR Oc 
(101 MHz; solvent CDCb): 149.60 (CSH4N), 136.58 (CSH4N), 126.22 (CSH4), 126.77 (CSH4), 
121.70 (CSH4N), 120.05 (CSH4N). 69.60 (CsHs), 69.12 (Cs~) and 66.49 (CSH4); mIz (FAB) 340 












1.2.18 1, 1°.Bis(2-pyridyl)ferrocene29• 3CI 
n-Butyllithium (6.23 ml, 9.97 mmoi, 1.6 M in hexanes) was added 
slowly to a solution of N,N,N',N'-tetramethylethyienediamine (1.16 g, 
1.50 ml, 9.97 mmol) in hexane (5 ml). The mixture was stirred under 
nitrogen for at least 10 minutes at room temperature to allow 
butyllithium-TMEDA to form. A solution of ferrocene (0.743 g, 4.0 
Experimental Details 
mmol) in hexane (35 ml) was added slowly and the mixture further stirred at room 
temperature for 6 hours. Hexane was then removed and the residue taken up in 
tetrahydrofuran (30 ml) and cooled to 0 °C. A cold solution of zinc chloride (1.09 g, 8.0 mmol) 
in tetrahydrofuran (20 ml) was added to the dark solution, which was further stirred at room 
temperature for at least an hour. Meanwhile Superhydride® (0.40 ml, 0.40 mmol, 1 M in 
tetrahyd rofu ran) was added to a suspension of dichlorobis(triphenylphosphine)palladium 
(0.140 g, 0.20 mmol) in tetrahydrofuran (10 ml), forming a dark solution that was added via 
cannula to the ferrocene reaction mixture. 2-Bromopyridine (1.58 g, 0.95 ml, 9.97 mmol) was 
added dropwise to the reaction mixture. An aqueous solution of sodium hydroxide (25 ml, 2.5 
M) was added after 25 hours. The two-layer reaction mixture was poured into a separating 
funnel. The aqueous phase was extracted repeatedly with dichloromethane. The organic 
fractions were combined and dried over anhydrous magnesium sulfate. The solvent was 
removed in vacuo and the residue further purified by column chromatography on alumina. 
Elution with diethyl ether yielded a yellow band of 2-ferrocenylpyridine (575.5 mg, 55%). 
Elution with dichloromethane yielded an orange band of the product. The product was 
obtained as a pinkish-red powder (114.0 mg, 10%), mp 180-182 °C (lit.29 179-180 °C). Vmax 
(KBr)/ cm-1 3568,2323,1773,1700,1636,1617,1586,1562,1507, 1457, 1425, 1100, 1025, 
984, 668, 420 and 405; 1H NMR OH (300 MHz; solvent CDCb): 8.35 (2H, d, J :::: 5.3 Hz, 
CSH4N), 7.67 (2H, t, J:::: 7.8 Hz, CSH4N), 7.50 (2H, dd, J:::: 6.7 Hz, CSH4N). 7.08 (2H, dd, J :::: 
11.6 Hz, CSH4N), 4.91 (4H, t, J:::: 1.8 Hz, CSH4), 4.36 (4H, t, J:::: 1.8 Hz, CSH4); 13C NMR Oc (75 
MHz; solvent CDCb): 156.97 (CSH4N), 136.51 (CSH4N), 131.90 (CSH4N). 128.39 (CSH4N), 
120.30 (C5H4N). 71.48 (CSH4) and 68.73 (CSH4). 
1.2.19 1,1" -Bis(4-pyridyl)ferrocene 
1 , 1'-Bis( 4-pyridyl)ferrocene was prepared according to the general 
procedure for 7.2.18. n-Butyllithium (6.23 ml, 9.97 mmol, 1.6 M in 
hexanes) was added slowly to a solution of N,N,N',N'-
tetramethylethylenediamine (1.16 g, 1.50 ml, 9.97 mmol) in hexane (5 













room temperature to allow butyllithium-TMEDA to fonn. A solution of ferrocene (0.742 g, 4.0 
mmol) in hexane (35 ml) was added slowly and the mixture further stirred at room 
temperature for 6 hours. Hexane was then removed and the residue taken up in 
tetrahydrofuran (30 ml) and cooled to 0 °C. A cold solution of zinc chloride (1.09 g, 8.0 mmol) 
in tetrahydrofuran (20 ml) was added to the dark solution, which was further stirred at room 
temperature for at least an hour. Meanwhile Superhydride® (0.40 ml, 0.40 mmol, 1.0 M in 
tetrahydrofuran) was added to a suspension of chlorobis(triphenylphosphine)palladium (0.140 
g, 0.20 mmol) in tetrahydrofuran (10 ml), fonning a dark solution that was added via cannula 
to the ferrocene reaction mixture. 4-Bromopyridine (1.576 g, 9.97 mmol) was added dropwise 
to the reaction mixture. An aqueous solution of sodium hydroxide (25 ml, 2.5 M) was added 
after 25 hours. The two-layer reaction mixture was poured into a separating funnel. The 
aqueous phase was extracted repeatedly with dichloromethane. The organic fractions were 
combined and dried over anhydrous magnesium sulfate. The solvent was removed in vacuo 
and the residue further purified by column chromatography on alumina. Elution with diethyl 
ether yielded an orange band of 4-ferrocenylpyridine. Elution with dichloromethane yielded an 
orange band of the product. The product was obtained as a yellow crystalline material (204.1 
mg, 15%). Vmax (KBr)1 cm,1 3083, 3029, 2353, 2320, 1941, 1695, 1634, 1606, 1557, 1538, 
1505, 1456, 1418, 1284, 1225, 1118, 1091, 1036,818,677,646,525,500 and 480; 1H NMR 
OH (400 MHz; solvent CDCI3): 8.39 (4H, d, J ::: 6.0 Hz, CSH4N), 7.06 (4H, d, J ::: 5.0 Hz, 
CSH4N), 4.55 (4H, t, J::: 1.8 Hz, CSH4), 4.34 (4H, t, J ::: 1.9 Hz, CSH4); 13C NMR Oc (101 MHz; 
solvent CDCI3): 149.69 (CSH4N), 120.18 (CSH4N), 72.24 (CSH4) and 68.45 (CSH4). 
7.2.20 4-Formylphenylferrocene 14 
A mixture of iodoferrocene (1.95 g, 6.24 mmol), 4-fonnylbenzene 
boronic acid (1.87 g, 12.48 mmol), barium hydroxide (2.76 g, 8.74 
mmol) and paliadium(lI) acetate (0.35 g, 1.56 mmol) in degassed 
ethanol (90 %, 200 ml) was initially stirred under nitrogen for 10 
Q-( j-CHO 
~ 
minutes, followed by vigorous shaking on an automatic shaker for 30 minutes. The reaction 
mixture was heated under reflux while stirring under nitrogen for 54.3 hours. The reaction 
mixture was then concentrated and the residue taken up in diethyl ether and washed with 
water. The combined organic fractions were dried over anhydrous sodium sulfate, the solvent 
removed in vacuo and the crude residue subjected to column chromatography on silica gel. 
The product was obtained by elution with hexane-dichloromethane (1: 1) as a red crystalline 
solid (0.91 g, 50%), mp 136-137 °C; (Found: M+ 290.0384. C17H14FeO requires M+ 290.0393). 
Vmax (KBr)1 cm'1 3096, 2730,1700,1653,1601,1565,1520,1422,1385, 1304, 1280, 1261, 













solvent CDCb): 9.97 (1H, s, CHO), 7.80 (2H, d, J ::: 8.4 Hz CeH4), 7.59 (2H, d, J::: 8.2 Hz, 
CeH4), 4.74 (2H, t, J ::: 1.9 Hz, CSH4), 4.44 (2H, t, J ::: 1.9 Hz, CSH4), 4.05 (5H, s, CsHs); 13C 
NMR Sc (75 MHz; solvent CDCb): 191.71 (CHO), 147.34 (C-CHO), 134.02 (Fc-CeH4), 129.98 
(CsH4-CHO), 82.82 (CSH4), 70.18 (CSH4), 69.93 (CsHs) and 67.09 (CSH4); mIz (EI) 290 (M+, 
100%),261 (5),225 (2), 202 (3),169 (2),145 (9),141 (8),139 (5),121 (23) and 115 (5). 
7.2.21 4-Formyl-4' -biphenylferrocene31 
A mixture of 4-bromophenylferrocene (1.00 g, 2.93 mmol), 
formyl benzene boronic acid (0.88 g, 5.86 mmol), barium 
hydroxide (1.29 g, 4.10 mmol) and paUadium(ll) acetate (0.16 




initially stirred at room temperature under nitrogen, followed by vigorous shaking on an 
automatic shaker for at least 30 minutes. The reaction mixture was heated under reflux while 
stirring under nitrogen for 33.2 hours. The reaction mixture was filtered, the filtrate 
concentrated and the crude residue taken up in diethyl ether which was washed several times 
with distilled water. The organic fractions were combined, washed with water, dried over 
anhydrous sodium sulfate and the solvent removed in vacuo. The crude residue was 
subjected to column chromatography on silica gel and the product was eluted with 
dichloromethane-hexane (7:3). The product was obtained as an orange-red crystalline solid 
(0.45 g, 42%), mp 196-199 °C (Ut.31 203-204 0C); (Found: C, 75.4 %, H, 5.0; M+ 366.07002. 
C23H1eFeO requires C, 75.4 %, H, 5.0; M 366.07070). Vmax (KBr)/ cm,1 3147, 3000, 2900, 
2759,1698,1651,1600,1520,1397,1362,1326,1300, 1150, 1097, 1012, 1002, 817, 520 
and 486;1H NMR SH (300 MHz; solvent CDCI3): 10.06 (1H, s, CHO), 7.96 (2H, d, J::: 8.4 Hz, 
Fc-CeH4), 7.79 (2H, d, J::: 7.7 Hz, CeH4-CHO), 7.58 (4H, s, CeH4) , 4.70 (2H, t, J::: 1.8 Hz, 
CsH4), 4.37 (2H, t, J ::::: 1.8 Hz, CsH4) , 4.07 (5H, S, CsHs); 13C NMR Sc (75 MHz; solvent 
CDCb): 191.92 (CHO), 146.93 (C-CHO), 140.16 (CeH4-CHO), 136.89 (CsH4-Fc), 135.00 (Fc-
CeH4), 130.35 (CeH4-CHO), 127.28 (CsH4-CHO), 127.20 (Fc-CeH4-Ph), 126.61 (Fc-CsH4-Ph), 
84.33 (CSH4), 69.72 (CsHs), 69.32 (CSH4) and 66.61 (CSH4); mIz (EI) 367 (36%), 366 (M+, 100) 
and 364 (10). 
7.2.22 N J N' -Ethylenebis( (ferrocenylmethylidene )am i ne )32 
Anhydrous sodium sulfate (276.7 mg, 1.9 mmol) was 
added to a dark red solution of 4-formylferrocene (429.0 
mg, 2.0 mmol) in diethyl ether (10 ml). A solution of 
Q-c = Nr-\N = c-Q 
~ ~ 













reaction mixture, which was further stirred at room temperature for 23 hours. The reaction 
mixture was filtered, the filtrate concentrated and cooled to 0 °c to precipitate the product. 
The product was collected as a yellow crystalline solid via vacuum filtration (0.61 g, 67%). 
Vmax (KBr)1 cm-l 3072,2893,2830,2322,1843,1761,1717,1699,1695, 1668, 1639, 1616, 
1575,1538,1505,1471,1435,1247,1104,1013,818,668, 519, 487,427, 416 and 403; 1H 
NMR liH (400 MHz; solvent CDCI3): 8.15 (2H, br s, N=CH), 4.61 (4H, t, CSH4), 4.32 (4H, t, 
CSH4) , 4.14 (10H, s, CsHs), 3.75 (4H, s, CH2); l3C NMR lie (101 MHz; solvent CDCb): 162.38 
(C=N), 70.43 (CSH4), 69.23 (CsHs), 68.58 (CSH4), 62.34 (CH2). 
7.2.23 N ,N' -Ethylenebis( (4-phenylferrocenylmethylidene )am ine) 
N, N' -Ethylenebis( (4-
phenylferrocenylmethylidene)amine) was 
prepared according to the procedure 
described for 7.1.22. Anhydrous sodium sulfate (69.6 mg, 0.49 mmol) was added to a solution 
of 4-formylphenylferrocene (150.7 mg, 0.52 mmol) in diethyl ether (15 mI). A solution of 
ethylenediamine (40.0 mg, 44 ~I, 0.65 mmol) in diethyl ether (5 ml) was added slowly to the 
reaction mixture, which was then further stirred at room temperature under a nitrogen 
atmosphere for 4 days. The reaction mixture was then filtered, the filtrate concentrated and 
cooled to 0 °C to precipitate the product. The product was then collected as an orange 
powder via vacuum filtration (76.3 mg, 23%), mp 212-215 °C; (Found: M+ 604. C3eH32Fe2N2 
requires M+ 604). Vmax (KBr)1 cm-l 3418, 2322, 1644, 1616, 1606, 1575, 1505, 1423, 1362, 
1279,1104,1017,820,667,604,594,507,458,439 and 411; lH NMR liH (400 MHz; solvent 
CDCb): 8.28 (2H, s, N=CH), 7.62 (4H, dd, J = 8.4 Hz, CeH4), 7.48 (4H, dd, J = 8.4 Hz, CeH4), 
4.67 (4H, t, J == 2.0 Hz, CSH4), 4.35 (4H, t, J == 1.8 Hz, CSH4). 4.03 (10H. s, CsHs), 3.97 (4H, s, 
CH2); l3C NMR oe (101 MHz; solvent CDCb): 162.21 (C==N), 128.10 (CeH4), 125.93 (CeH4), 
69.63 (CsHs), 69.32 (CSH4), 66.58 (CSH4), 61.97 (CH2); mIz (FAB) 604 (M+, 25%), 594 (12), 
399 (11). 290 (10), 261 (11), 245 (72), 223 (52), 179 (17), 136 (41) and 120 (18). 
7.2.24 N,N' -Ethylenebis( (4,4' -diphenylferrocenylmethylidene )am Ine) 
N,N'-Ethylenebis«4,4'-
diphenylferrocenylmethylidene) 
amine) was prepared 
according to the procedure 
described for 7.1.22. Anhydrous sodium sulfate (37.4 mg, 0.26 mmol) was added to a solution 













ethylenediamine (20.0 mg, 23 IJI, 0.34 mmol) in diethyl ether (5 ml) was added slowly to the 
reaction mixture, which was further stirred at room temperature under a nitrogen atmosphere 
for 4 days. The reaction mixture was filtered, the filtrate concentrated and cooled to 0 °C to 
precipitate the product. The product was collected as an orange powder via vacuum filtration. 
It should be noted that complete characterisation of this compound proved difficult as it was 
found to be insoluble in a range of common organic solvents (30.6 mg, 15%), mp 220-222 °C 
dec.; (Found: M+ 756. C4sH4oFe2N2 requires M+ 756). Vmax (KBr)1 cm-
1 3430, 2845, 2324, 1843, 
1642, 1600, 1575, 1569, 1505, 1436, 1403, 1279, 1203, 1104, 1089, 1002, 889, 822, 667, 
516, 482, 467, 415 and 404; mIz (FAB) 757 (M, 42%), 756 (M·, 2), 559 (4), 375 (25), 304 
(10),277 (58),265 (22),241 (31),203 (92),149 (100) and 115 (40). 
1.2.25 Ferrocenyldiphenylphosphine33 
A suspension of ferrocene (1.90 g, 10.2 mmol) and aluminium chloride (1.36 g, 
10.2 mmol) in n-heptane (20 ml) was heated initially to form a clear solution. A 
solution of chlorodiphenylphosphine (2.25 g, 1.85 ml, 10.2 mmol) in n-heptane 
(10 ml) was added slowly to the ferrocene solution at room temperature. The 
reaction mixture was heated under reflux for 20.5 hours. The suspension obtained was 
cooled to room temperature, the yellow-orange supernatant decanted and concentrated in 
vacuo. The black residue remaining from the reaction mixture was extracted several times 
with hot n-heptane and the extract added to the supernatant concentrate. The black residue 
was further washed with hot water, yielding an orange solid, which was extracted with hot 
toluene. Toluene was removed, all fractions combined and extracted with n-heptane at room 
temperature. Removal of n-heptane in vacuo yielded the product as an orange solid (1.43 g, 
47%), mp 120-123 °C (1it,33 122-124 0G). Vmax (KBr)1 cm-
1 3076, 3042, 1476, 1432, 1410, 
1325,1315,1192,1182,1160,1106,1019,1005,840,834, 827, 819, 745, 698, 491, 451, 
434,416 and 404; 1H NMR ~H (300 MHz; solvent CDCh): 7.38-7.32 (10H, m, CsHs), 4.37 (2H, 
br s, CSH4), 4.16 (2H, br S, CSH4), 4.08 (5H, s, CsHs); 13C NMR ~c (75 MHz; solvent CDCh): 
133.53 (CsHs), 131.72 (CsHs), 128.38 (CsHs), 128.08 (CsHs), 72.90 (CSH4), 70.67 (CSH4), 
69.06 (CsHs) 
1.3Rhodium carbonyl complexes 
1.3.1 Dichlorotetracarbonyldirhodium34 
Carbon monoxide was bubbled through a solution of rhodium OC, ..,......CI, ..,......co 
Rh Rh 













heating under reflux for at least 5 hours. The solvent was then removed in vacuo and the 
residue sublimed. The product was obtained as bright red crystals (0.38 g, 26%), mp 123-125 
°C (lit,34 = 126-127 °C). vmaxlcm·
1 (CH2CI2): 2107m (CO), 2091s (CO), 2035s (CO) and 
2003w(CO). 
7.3.2 Bis( carbonyl)chloro(pyridine)rhodium36 
Pyridine (48.8 mg, 50.0 IJI, 0.62 mmol) was added slowly to a solution of the 
rhodium dimer, dichlorotetracarbonyldirhodium (120.0 mg, 0.31 mmol) in 
pentane (10 ml). An orange suspension was observed to form on gradual 
addition of the pyridine. The product was collected via vacuum filtration as 
an orange powder (137.2 mg, 81%). mp 60-63 °C (1it.3S 62-64 °C). vmax/cm·1 (KBr): 2359 • 
2340.2253,2091 (CO), 2016 (CO), 1794, 1653, 1606, 1471, 1381, 1219, 1096,911,762, 
734, 648, 623 and 485; 1H NMR OH (400 MHz; solvent CDCI3): 8.73 (2H, dd, J = 8.1 Hz, 
CSH4N), 7.91 (1 H, t, J = 7.7 Hz, CSH4N), 7.48 (2H, t, J = 6.2 Hz, CSH4N); 13C NMR Oc (101 
MHz; solvent CDCb): 152.48 (CSH4N), 139.34 (CSH4N), and 125.56 (CSH4N). 
7.3.3 Bis( carbonyl)chloro(4-aminopyridine )rhodium36 
Bis(carbonyl)chloro(4-aminopyridine)rhodium was prepared according to 
the procedure described for 7.3.2. 4-Aminopyridine (38.5 mg, 0.33 
mmol) was added to a solution of dichlorotetracarbonyldirhodium (80.4 
mg, 0.16 mmol) in dichloromethane (20 ml). The reaction mixture was 
stirred under nitrogen for 20 minutes and then concentrated in vacuo. Hexane was added to 
precipitate the product. The product was collected by vacuum filtration as a dark yellow 
powder (60.6 mg, 64%), mp 170-172 °C dec. Vmax/cm'1 (KBr): 3455, 3350, 3218, 2352, 2326, 
2076 (CO), 2012 (CO), 1732, 1615, 1575, 1564,1541,1509,1398,1336,1291,1215,1060, 
1031,820,675,653,617,500 and 483; 1H NMR llH (solvent CDCI3): 8.19 (2H, d, J = 6.8 Hz, 
CSH4N), 6.54 (2H, dd, J = 6.9 Hz, CSH4N), 4.65 (2H. br s, NH2); 13C NMR Oc (75 MHz; solvent 
CDCI3): 153.24 (CSH4N) and 120.65 (CSH4N). 
7.3.4 Bis( carbonyl)chloro( 4-phenylimine-4' -pyridine)rhodium 
Bis( carbonyl)chloro( 4-phenylimine-4' -pyridine )rhodium was 
prepared according to the procedure described for 7.3.2. 4-
Phenylimine-4'-pyridine (56.2 mg, 0.31 mmol) was added to a 













mmol) in dichloromethane (10 ml). The reaction mixture was stirred under nitrogen for 20 
minutes and then concentrated in vacuo. Pentane was added to precipitate the product. The 
product was collected by vacuum filtration as a yellow crystalline solid (74.0 mg, 63%). 
vmaJcm-1 (KBr): 3040, 2088 (CO), 2013 (CO) and 1605 (C==N); 1H NMR 8H (300 MHz; solvent 
CD3COCD3): 8.96 (2H, dd, J == 6.8 Hz, CsH"N), 8.81 (1H, s, N==CH), 8.16 (2H, dd, J == 6.8 Hz, 
Cs~N), 7.51-7.44 (2H, tt, J == 15.1 Hz, CsHs), 7.41 (2H, d, J::. 1.5 Hz, CsHs), 7.35 (1H, t, J == 
10.6 Hz, CsHs); 13C NMR 3c (75 MHz; solvent CDCb): 158.42 (N==C), 154.78 (CsH"N), 130.93 
(CsHs), 129.20 (CsH"N), 125.57 (CsHs) and 122.94 (CsHs). 
1.3.5 Bis( carbonyl)chloro(4-pyridylimine-4'-phenylferrocene )rhodium 
Bis( carbonyl)chloro( 4-pyridylimine-4'-
phenylferrocene)rhodium was prepared according to the 
procedure described for 7.3.2. 4-Pyridyiimine-4'-
phenylferrocene (120.1 mg, 0.33 mmol) was added to a 
solution of dichlorotetracarbonyldirhodium (79.9 mg, 0.16 mmol) in dichloromethane (20 ml) 
and further stirred for 25 minutes. The reaction mixture was concentrated in vacuo and 
hexane was added to precipitate the product. The product was collected by vacuum filtration 
as small maroon-red rod-shaped crystals (56.0 mg, 61%), mp 165-175 DC; (Found: C, 51.2%, 
H, 3.1, N, 4.8; M+ 560.0. C2"H1sCIFeN202Rh requires C, 51.4%, H, 3.2, N, 5.0; M+ 560). 
vmax/cm-1 (KBr): 3054, 2359, 2080, 2003,1684, 1643, 1589, 1427, 1326, 1280, 1106, 1014, 
846,823,759,740,704,491 and 414; 1H NMR 3H (300 MHz; solvent CDCI3): 8.81 (2H, d, J == 
6.6 Hz, C5H"N), 8.57 (1H, s, N==CH), 7.93 (2H, d, J::: 6.5 Hz, C5H"N), 7.54 (2H, d, J::: 8.5 Hz, 
CsH,,), 7.27 (2H, d, J = 8.3 Hz, CsH,,), 4.68 (2H, t, J ::: 1.8 Hz, CsH,,), 4.36 (2H, t, J == 1.8 Hz, 
CsH,,), 4.06 (5H, s, CsHs); 13C NMR 3c (75 MHz; solvent CDCI3): 153.18 (N==C), 152.89 
(CsH"N), 147.13 (CsH,,), 145.97 (CsH,,), 140.34 (CsH"N), 126.78 (CsH"N), 123.75 (CsH,,), 
121.65 (CsH,,), 84.01 (Cs~), 69.71 (CsHs), 69.44 (Cs~) and 66.54 (CsH,,); m/z (FAB) 560 
(M+, 8%), 525 (M-CI, 5), 496 (M-CO, 2), 469 (M-CO, 2), 367 (M-Rh, 50), 366 (M-ligand, 90) 
and 287 (M-py, 10). 
1.3.6 Bis(carbonyl)chloro{4-ferrocenylpyridine)rhodium 
4-Ferrocenylpyridine (94.9 mg, 0.36 mmol) was added to a light ~ oc, N j) 
yellow solution of dichlorotetracarbonyldirhodium (70.6 mg, 0.18 Rtr' Foe 
mmol) in anhydrous pentane (10 ml). A red suspension was OC/ 'CI $ 
observed almost immediately with the supernatant turning to a much lighter, almost clear 













mp 128-130 °C; (Found: C, 44.4%, H, 2.6, N, 3.0; M+ 458.7. C17H13CIFeN02Rh requires C, 
44.6%, H, 2.7, N, 3.1; M 458.9). vmaxlcm-
1 (KBr): 3020, 2086 (CO), 2011 (CO), 1615, 1522, 
1435,1382,1107,1034,833 and 482; 1H NMR SH (300 MHz; solvent CDCb): 8.49 (2H, dd, J 
:: 6.7 Hz, CSH4N), 7.39 (2H, dd, J :: 6.7 Hz, CSH4N), 4.76 (2H, t, CSH4), 4.56 (2H, t, CSH4), 4.08 
(5H, s, CsHs); 13C NMR Sc (75 MHz; solvent CDCb): 151.65 (CSH4N), 121.66 (CSH4N), 71.68 
(CSH4), 70.36 (CsHs) and 67.45 (CSH4); mlz (FAB) 459 (M+, 8%), 424 (M-CI, 8), 389 (4), 367 
(M-2CO, 3), 312 (34), 265 (ligand, 100),235 (1) and 200 (1). 
1.4Rhodium cyclooctadiene complexes 
1.4.1 Chloro(I,5-cyclooctadiene)rhodium(l) dimer7 
1,5-Cyclooctadiene (2.65 ml, 3.0 ml, 24.5 mmol) was added to a 
dark red solution of rhodium trichloride trihydrate (2.00 g, 7.6 
mmol) in deoxygenated ethanol-water 5:1 (20 ml). The mixture 
was then heated under reflux overnight while stirring under nitrogen. A yellow suspension 
formed gradually over time. The reaction mixture was then filtered under vacuum and the 
precipitate washed with pentane followed by methanol. The product was obtained after 
recrystallisation as orange-yellow crystals (1.84 g, 49%), mp 142-144 °C dec. (lit,37 140-145 
°C dec.). Vmax (KBr)1 cm-
1 3547,2936,2359, 1696, 1473, 960, 668, 487 and 449;1H NMR SH 
(300 MHz; solvent CDCI3): 4.23 (8H, br s, COD-CH), 2.53-2.47 (8H, m, COD-CH2), 1.75 (8H, 
d, J :: 8.3 Hz, COD-CH2)' 
1.4.2 Chloro(1,5-cyclooctadiene)(pyridine)rhodium38 
Pyridine (39.55 mg, 42 ~I, 0.50 mmol) was added dropwise to an 
orange-yellow solution of chloro(I,5-cyclooctadiene)rhodium(l) dimer 
(123.6 mg, 0.25 mmol) in dichloromethane (15 ml). The reaction 
mixture was then stirred for a further 39 minutes at room temperature 
under nitrogen. The reaction mixture was then concentrated in vacuo and diethyl ether added 
to precipitate the product. The product was collected by vacuum filtration as bright yellow rod-
like crystals (101.0 mg, 62%), mp 230-233 °C (1it,38 229-232 0C). Vmax (KBr)1 cm-1 3567, 2933, 
2359, 1696, 1599, 1484, 1212, 1068,962,695,668,494,458 and 431; 1H NMR SH (300 MHz; 
solvent CDCI3): 8.76 (2H, d, J:: 5.9 Hz, CsHsN), 7.71 (1 H, t, CsHsN), 7.32 (2H, t, CsHsN), 4.18 
(4H,br Sf COD-CH), 2.54-2.49 (4H, m, COD-CH2), 1.85 (4H, d, J :: 8.1 Hz, COD-CH2); 13C 
NMR Sc (75 MHz; solvent CDCI3): 150.58 (CsHsN), 137.01 (CsHsN), 124.54 (CsHsN), 78.51 













1.4.3 (1 ,5-Cyclooctadiene)bis(pyridine)rhodium hexafluorophosphate39 
Pyridine (48.0 mg, 49.5 1-11, 0.61 mmol) was added slowly to a 
solution of chloro(I,5-cyclooctadiene)rhodium(l) dimer (50.1 mg, 
0.10 mmol) in ethanol (5 ml). After stirring the reaction mixture at 
room temperature for a further 15 minutes, a concentrated 
aqueous solution of ammonium hexafluorophosphate was added. A precipitate was observed 
to form and collected by vacuum filtration as yellow crystals (34.7 mg, 67%). Vmax (KBr)/ cm-1 
3568, 3004, 1696, 1602, 1445, 1430, 1216, 1068, 698,668 and 458; 1H NMR (5H (300 MHz; 
solvent CDCI3): 8.79 (4H, dd, J = 6.1 Hz, CsHsN), 7.70 (2H, t, CsHsN), 7.39 (4H, dd, CsHsN), 
4.10 (4H,s, COD-CH), 2.62 (4H, br s, COD-CH2), 1.95 (4H, d, J = 8.1 Hz, COD-CH2); 13C 
NMR (5e (75 MHz; solvent CDCb): 150.39 (CsHsN), 138.32 (CsHsN), 126.01 (CsHsN), 85.00 
(COD) and 30.55 (COD). 
1.4.4 (1,5-Cyclooctadiene)bis(pyridine)rhodium perchlorate39 
A white precipitate was observed to form immediately on 
addition of silver perchlorate (51.3 mg, 0.24 mmol) to a solution 
of chloro(I,5-cyclooctadiene)rhodium(l) dimer (60.0 mg, 0.12 
mmol) in acetone (10 ml). Pyridine (38.5 mg, 40.0 1-11, 0.49 mmol) 
was then added slowly to the supernatant, which was stirred at 
room temperature for a further 20 minutes. The reaction mixture was then concentrated and 
diethyl ether added to precipitate the product. The product was collected by vacuum filtration 
as small yellow crystals (49.1 mg, 87%), mp 193-195 °C (lit. 191-195 °C). Vmax (KBr)/ cm-1 
1692, 1605, 1445, 1430, 1215, 1080, 698, 664 and 457; 1H NMR (5H (300 MHz; solvent 
CDCb): 8.88 (4H, dd, J = 6.1 Hz, CsHsN), 7.71 (2H, t, CsHsN), 7.41 (4H, dd, CsHsN), 4.10 
(4H,s, COD-CH), 2.66 (4H, m, COD-CH2), 1.91 (4H, d, COD-CH2); 13C NMR (5e (75 MHz; 
solvent CDCb): 150.39 (CsHsN), 138.32 (CsHsN), 126.01 (CsHsN), 84.80 (COD) and 30.56 
(COD). 
1.4.5 Chloro(1,5-cyclooctadiene)(4-phenylpyridine)rhodium 
Chloro(1,5-cyclooctadiene)(4-phenylpyridine)rhodium was aD 
prepared according to the procedure followed for 7.4.2. 4- ~ ~ I 
Phenylpyridine (100.8 mg, 0.64 mmol) was added to a solution Q-___ /N ~ I 
of chloro(I,5-cyclooctadiene)rhodium(l) dimer (159.0 mg, 0.32 r::. ,,:Rh, 
~- CI 













stirred for a further 31 minutes. The reaction mixture was then concentrated in vacuo and 
diethyl ether added to precipitate the product. The product was collected via vacuum filtration 
as bright yellow crystals (206.7 mg, 80%); (Found: C, 56.73%, H, 5.15, N, 3.46; M+ 
401.04176. C19H21 CINRh requires C, 56.8%, H, 5.3, N, 3.5; M+ 401.74272). vmax/cm-1 (KBr): 
2990,2931,2880,2825,2367,2324,1772,1674,1607, 1541, 1471, 1429, 1413, 1333, 1215, 
1068,993,961,848,765, 733, 690, 626, 565,486 and 480; 1H NMR OH (300 MHz; solvent 
CDC(3): 8.75 (2H, dd, J = 6.6 Hz, CSH4N), 7.57 (2H, d, J = 5.6 Hz, CSH4N), 7.48 (5H, m, CsHs), 
4.19 (4H, br s, COD-CH), 2.51 (4H, m, COD-CH2), 1.84 (4H, d, J = B.O Hz, COD-CH2);.13C 
NMR oe (75 MHz; solvent CDC(3): 151.03 (CsHsN), 149.63 (CsHsN), 136.59 (CeHs), 129.86 
(CeHs), 129.29 (CeHs), 126.97 (CeH5), 122.46 (CsHsN), 80.05 (COD) and 30.88 (COD); mlz 
(FAB) 401 (M+, 13%),366 (M-CI, 100).346 (3), 310 (4), 258 (M-COD, 9), 211 (42),181 (11), 
156 (38), 136 (8), 103 (Rh, 5) and 77 (5). 
1.4.6 (1 ,5-Cyclooctadiene)bis(4-phenylpyridine)rhodium perchlorate 
(1,5-Cyclooctadiene)bis(4-phenylpyridine)rhodium ~ 
perchlorate was prepared according to the procedure Q~""" /N'\..J'-/ Rh'OD for 7.4.4. A white precipitate was observed to form ~"" 'N 
immediately on addition of silver perchlorate (66.8 mg, ~ J \ J 
0.32 mmol) to a solution of chloro(I,5-cyclooctadiene)rhodium(l) dimer (79.7 mg, 0.16 mmol) 
in acetone (20 ml). 4-phenylpyridine (100.1 mg, 0.64 mmol) was then added slowly to the 
supernatant, which was stirred at room temperature for a further 20 minutes. The reaction 
mixture was then concentrated and diethyl ether added to precipitate the product. The 
product was collected by vacuum filtration as a light yellow powder (117.2 mg, 59%); (Found: 
C, 57.85%, H, 4.92, N, 4.12; M+ 521.2. C30H30CIN204Rh requires C, 58.0%, H, 4.9, N, 4.5; M+ 
521.5). vmax/cm-
1 (KBr): 3056, 2872, 2818, 2370, 2324, 1616, 1575, 1544, 1516, 1483, 1418, 
1398,1221,1095,841,766,733,696,623,565,481 and 437; 1H NMR OH (400 MHz; solvent 
CDCh): 8.88 (4H, d, J = 5.9 Hz, CsH,N), 7.62-7.53 (10H, m, CeHs), 7.46 (4H, d, J = 5.B Hz, 
CSH4N), 4.14 (4H, br s, COD-CH), 2.69 (4H, m, COD-CH2), 1.99 (4H, d, J = 10.3 Hz, COD-
CH2); 13C NMR oe (101 MHz; solvent CD3COCD3): 153.85 (C5HSN), 136.02 (CsHsN), 130.43 
(CSH5N), 129.77 (CsHs), 129.58 (CsHs), 127.58 (CSH5), 127.28 (CsHs), 123.54 (CsHsN), 85.15 
(COD), 30.54 (COD); m/z (FAB) 521 (M+, 10%),465 (3), 413 (M+-COD, 11).398 (6), 366 (90), 













1.4.1 Chloro(1 ,5-cyclooctadiene )(4-phenylimine-4' -pyridine )rhodium 
Chloro(1,5-cyclooctadiene)(4-phenylimine-4'- _ 
pyridine)rhodium was prepared according to the procedure cr."', N~ ~N-o 
followed for 7.4.2. 4-Phenylimine-4'-pyridine (52.4 mg, .29 r ,.:Rh( ~" 
L).· CI 
mmol) was added to a solution of chloro(I,5- ~ 
cyclooctadiene)rhodium(l) dimer (70.6 mg, 0.14 mmol) in dichloromethane (10 ml). The 
reaction mixture was stirred for a further 28 minutes. The reaction mixture was then 
concentrated in vacuo and diethyl ether added to precipitate the product. The product was 
collected via vacuum filtration as fine yellow crystals (85.3 mg, 83%); (Found: C, 44.56%, H, 
2.69, N, 7.26. C2oH22CIN2Rh requires C, 44.6%, H, 2.7, N, 7.4). Vmax (KBr)1 cm-
1 3049, 2948, 
2873,2359,1651,1608,1574,1485,1191,1166,1075, 1055,961,818,668,481,459 and 
406; 1H NMR OH (300 MHz; solvent CDCb): 8.89 (2H, dd, CSH4N), 8.47 (1H, s, N==CH), 7.88 
(2H, d, J == 6.2 Hz, CSH4N), 7.44 (2H, t, CsHs), 7.34 (2H, d, J == 7.2 Hz, CsHs), 7.26 (1H, t, 
CsHs), 4.21 (4H, br s, COD-CH), 2.54-2.48 (4H, m, COD-CH2), 1.82 (4H, d, J == 8.3 Hz, COD-
CH2); 13C NMR Oc (75 MHz; solvent CDCb): 156.85 (N=C), 154.28 (CSH4N), 151.89 (CSH4N), 
144.51 (CsHs), 129.38 (CSH4N), 127.65 (CsHs), 124.24 (CsHs) and 122.06 (CsHs), 85.42 
(COD) and 30.55 (COD). 
1.4.8 (1 ,5-Cycloocladiene)bis(4-phenylimine-4' -pyridine)rhodium perchlorate 
(1 ,5-Cycloocladiene )bis( 4-phenylimine-4'-
pyridine)rhodium perchlorate was prepared 
according to the procedure for 7.4.4. A white 
precipitate was observed to form immediately on 
addition of silver perchlorate (58.9 mg, 0.28 mmol) 
to a solution of chloro(I,5-cyclooctadiene)rhodium(l) dimer (70.6 mg, 0.14 mmol) in acetone 
(15 ml). 4-Phenylimine-4'-pyridine (103.5 mg, 0.57 mmol) was then added slowly to the 
supernatant, which was stirred at room temperature for a further 20 minutes. The reaction 
mixture was then concentrated and diethyl ether added to precipitate the product. The 
product was coll~cted by vacuum filtration as a yellow powder (110.9 mg, 59%), mp == 199°C 
dec.; (Found: C, 55.98%, H, 4.63, N, 8.06; M+ 5751682. C32H32CIN404Rh requires C, 56.5%, 
H, 4.8, N, 8.3; M+ 575.53486). Vmax (KBr)/ cm-1 3583, 2339, 1770, 1738, 1622, 1610, 1109, 
1086, 833, 552 and 445; 1H NMR ~ (300 MHz; solvent CDCI3): 9.01 (4H, d, J ::: 5.6 Hz, 
CSH4N), 8.39 (2H, s, N==CH), 7.86 (4H, d, J::: 5.5 Hz, CSH4N), 7.40 (4H, t, J ::: 7.3 Hz, CsHs), 
7.28 (2H, t, J == 7.3 Hz, CsHs), 7.19 (4H, d, J::: 8.0 Hz, CsHs), 4.15 (4H, br s, COD-CH), 2.71 













158.21 (N==C), 151.12 (CSH4N), 150.89 (CSH4N), 143.15 (CsHs), 129.35 (C5H4N), 127.74 
(CsHs), 124.24 (CsHs) and 121.06 (CsHs), 85.42 (COD) and 30.55 (COD); mIz (FAB) 575.2 
(M+, 10%),546 (4),532 (2), 492 (2),471 (4),439 (4), 409 (5),393 (100),364 (4), 350 (8),284 
(8),211 (47),183 (37),136 (12),89 (17) and 80 (17). 
7.4.9 Chloro( 1,5-cyclooctadiene )(4-pyridylim ine-4' -phenylferrocene )rhodium 
Chloro(1,5-cyclooctadiene(4-pyridylimine-4'- IJ·... /N~~  
~_Rh~N Q 
phenylferrocene )rhodium was prepared according to ~/ ......... Cl ~ J Foe 
the procedure followed for 7.4.2. 4-Pyridylimine-4'- $ 
phenylferrocene (109.0 mg, 0.29 mmol) was added to a solution of chloro(I,5-
cyclooctadiene)rhodium(l) dimer (73.4 mg, 0.15 mmol) in dichloromethane (10 mI). The 
reaction mixture was stirred for a further 34 minutes. The reaction mixture was then 
concentrated in vacuo and hexane added to precipitate the product. The product was 
collected via vacuum filtration as red crystalline flakes (134.1 mg, 75%), mp 200-202 °C; 
(Found: C, 58.29%, H, 4.59, N, 4.40; M+ 612.05019. C30H30CIFeN2Rh requires C, 58.8%, H, 
4.9, N, 4.6; M+ 612.79361). vmax/cm-
1 (KBr): 3056, 2954, 2879, 2356, 2329, 2295,1745,1731, 
1684,1616,1609,1575,1541,1514,1480,1426,1392, 1371, 1106, 1004,977,950,841, 
814, 807,672, 638, 543,495,481 and 434;1H NMR (5H (solvent CDCI3): 8.84 (2H, d, J::: 5.9 
Hz, CSH4N), 8.48 (1H, s, N==CH), 7.77 (2H, dd, J::: 5.9 Hz, CSH4N), 7.51 (2H, dd, J == 6.7 Hz, 
CSH4), 7.22 (2H, d, J::: 8.5 Hz, CSH4), 4.66 (2H, t, J == 1.8 Hz, C5H4), 4.35 (2H, t, J == 1.8 Hz, 
CSH4), 4.19 (4H, br s, COD-CH), 4.03 (5H, s, CSH5), 2.52-2.48 (4H, m, COD-CH2), 1.85 (4H, 
d, J == 8.6 Hz, COD-CH2); 13C NMR (5e (solvent CDCI3): 156.02 (N==C), 151.10 (CSH4N), 126.83 
(CSH4N), 124.13 (CSH4), 121.55 (CSH4), 69.75 (CsHs), 69.40 (CSH4), 66.58 (CSH4), 30.62 
(COD); mIz (FAB) 612 (M+, 1%), 532 (2), 519 (3), 382 (5), 366 (Ligand, 100), 305 (26), 289 
(41),277 (41), 229 (9),176 (27) and 89 (22). 
7.4.10 (1 ,5-Cyclooctadiene)bis(4-pyrldylimine-4'-phenylferrocene)rhodium 
perchlorate 
(1,5-Cyclooctadiene)bis(4-pyridylimine-4'· 
phenylferrocene)rhodium perchlorate was 
prepared according to the procedure for 7.4.4. 
A white precipitate was observed to form 
immediately on addition of silver perchlorate 
(22.6 mg, 0.11 mmol) to a solution of 













Pyridylimine-4'-phenylferrocene (80.0 mg, 0.22 mmol) was then added slowly to the 
supernatant, which was stirred at room temperature for a further 30 minutes. The reaction 
mixture was then concentrated and diethyl ether added to precipitate the product. The 
product was collected by vacuum filtration as a fine dark maroon-red powder (92.8 mg, 81%), 
mp 265-268 °c dec.; (Found: C, 65.97%, H, 5.12, N, 5.78; M+ 943.2. CS2H48Fe2N4RhCI04 
requires C, 66.2%, H, 5.1, N, 5.9; M+ 943.2). vmax/cm·
1 (KBr): 3076, 3063, 2363, 2322, 2295, 
1738,1684,1616,1575,1541,1514,1487,1432,1398, 1120, 1100, 1086, 1065,998,963, 
889,841,821, 760, 726, 678, 617, 549, 501,481 and 434;1H NMR l>H (400 MHz; solvent 
CDCI3): 8.99 (4H, br s, CSH4N), 8.47 (2H, s, N=CH), 7.87 (4H, d, J = 4.4 Hz, CSH4N), 7.49 
(4H, d, J = 8.4 Hz, CSH4), 7.19 (4H, d, J = 8.1 Hz, CSH4), 4.67 (4H, br s, CSH4), 4.36 (4H. br s, 
CSH4), 4.16 (4H, br s, COD-CH), 4.05 (10H, s, CsHs), 2.81-2.66 (4H, m, COD-CH2), 2.02 (4H, 
d, J = 8.8 Hz, COD-CH2); 13C NMR l>c (101 MHz; solvent CDCI3): 153.95 (N=C), 129.84 
(CSH4N), 126.94 (CSH4N), 124.25 (CSH4), 121.66 (CSH4), 80.24 (COD), 69.95 (CsHs), 69.58 
(CSH4), 66.75 (CSH4), 30.71 (COD); mIz (FAB) 943 (M+, 4%), 577 (M-ligand, 93), 366 (ligand, 
100). 
7.4.11 Chloro(1 ,5-cyclooctadiene)(4-ferrocenylpyridine)rhodium 
Chloro(1 ,5-cyclooctadiene(4-ferrocenylpyridine)rhodium was cr.- ~ 
", N 'l Q 
prepared according to the procedure followed for 7.4.2. 4- r .::Rh( - F.e 
Ferrocenylpyridine (74.6 mg, 0.28 mmol) was added to a l:.\- CI ~ 
solution of chloro(I,5-cyclooctadiene)rhodium(l) dimer (69.8 mg, 0.14 mmol) in 
dichloromethane (10 ml). The reaction mixture was stirred for a further 15 minutes. The 
reaction mixture was then concentrated in vacuo and pentane added to precipitate the 
product. The product was collected via vacuum filtration as an orange solid (111.7 mg, 78%), 
mp 167-169 °C; (Found: C, 54.2%, H, 4.6, N, 2.7; M+ 509.0. C23H2sCIFeNRh requires C, 
54.2%, H, 4.0, N, 2.7; M+ 509.0). vmax/cm-
1 (KBr): 3069, 2872, 2832, 2358, 2331, 1739, 1670, 
1615,1568,1544,1516,1475,1436,1398,1338,1286, 1106, 1031,963, 825,809,674and 
503; 1H NMR l>H (300 MHz; solvent CDCI3): 8.51 (2H, dd, J = 6.7 Hz, CSH4N), 7.27 (2H, dd, J = 
7.3 Hz, CSH4N), 4.69 (2H, t, CSH4), 4.47 (2H, t, CSH4), 4.19 (4H, br s, COD-CH), 4.04 (5H, s, 
CsHs), 2.53-2.49 (4H, m, COD-CH2), 1.84 (4H, d, J = 8.1 Hz, COD-CH2); 13C NMR l>c (75 
MHz; solvent CDCh): 150.28 (CSH4N), 121.19 (CSH4N), 79.28 (COD-CH), 70.98 (CSH4), 70.14 
(CsHs), 67.15 (CSH4) and 30.90 (COD-CH2): mIz (FAB) 509 (M+, 3%), 312 (32), 265 (58),167 













7.4.12 [(1 ,5-Cyclooctadiene)bis(4-ferrocenylpyridine)rhodium perchlorate 
(1,5-Cyclooctadiene)bis(4-ferrocenylpyridine)rhodium 
perchlorate was prepared according to the procedure for 
7.4.4. A white precipitate was observed to form 
immediately on addition of silver perchlorate (43.8 mg, 
0.20 mmol) to a solution of chloro(I,5-
cyclooctadiene)rhodium(l) dimer (50.4 mg, 0.10 mmol) in 
acetone (15 ml). 4-Ferrocenylpyridine (106.1 mg, 0.40 mmol) was then added slowly to the 
supernatant, which was stirred at room temperature for a further 21 minutes. The reaction 
mixture was then concentrated and diethyl ether added to precipitate the product. The 
product was collected by vacuum filtration as small red-brown crystalline flakes (162.2 mg, 96 
%), mp 225°C dec.; (Found: C, 54.2%, H, 4.6, N, 3.1; M+ 737.1. C3sH3sFe2N2RhCI04 requires 
C, 54.5%, H, 4.6, N, 3.3; M+ 737.0). vmax/cm'1 (KBr): 3069, 2349, 2322, 1684, 1616, 1608, 
1575, 1544, 1516, 1429, 1397, 1340, 1217, 1122,832,686,677,622.538,481,472 and 
418;1H NMR DH (300 MHz; solvent CDCI3): 8.60 (4H. d, J:: 6.2 Hz, CSH4N), 7.36 (4H. d, J :: 
6.4 Hz, CSH4N), 4.68 (4H, br 5, CSH4), 4.45 (4H, br s, CSH4), 4.12 (4H, br s, COD-CH), 3.98 
(10H, s, CsHs), 2.75-2.68 (4H, m, COD-CH2) and 1.98 (4H. d, J :: 8.8 Hz, COD-CH2); 13C 
NMR Dc (75 MHz; solvent CDCI3): 151.78 (CSH4N), 122.55 (CSH4N), 77.82 (COD-CH), 70.52 
(CsHs), 70.04 (Cs~), 67.36 (CSH4) and 30.62 (COD- H2); mIz (FAB) 737 (M+, 10%),476 (30). 
312 (19), 265 (97),155 (67),137 (56) and 89 (20). 
7.4.13 Chloro(1 ,5-cyclooctadiene)(3-ferrocenylpyridine)rhodium 
Chloro(1 ,5-cyclooctadiene(3-ferrocenylpyridine)rhodium was jJ___ 0 
prepared according to the procedure followed for 7.4.2. 3- ~ _~:Rh(:~ 
Ferrocenylpyridine (78.3 mg, 0.30 mmol) was added to a solution ~- CI dS 
of chloro(I,5-cyclooctadiene)rhodium(l) dimer (73.4 mg, 0.15 ~ 
mmol) in dichloromethane (15 ml). The reaction mixture was stirred for a further 35 minutes. 
The reaction mixture was then concentrated in vacuo and pentane added to precipitate the 
product. The product was collected via vacuum filtration as golden yellow microcrystals 
(134.5 mg, 88%), mp 162-164 °C; (Found: C, 54.20%, H, 4.76, N, 2.68; M+ 509.00799. 
C23H2sCIFeNRh requires C, 54.2%, H, 4.9, N, 2.7; M+ 509.65806). Vmax (KBr)1 cm,1 3616. 
3584,2830,2349,1798,1703, 1634,1615,1422,1105,814,667,439 and 408; 1H NMR OH 
(400 MHz; solvent CDCh): 8.80 (1H. br s, CSH4N), 8.52 (1H, dd, J:: 6.6 Hz, CSH4N), 7.70 (1H, 
dt, J::::: 8.1 Hz, CSH4N), 7.18 (1 H, dd, J == 5.5 Hz. CSH4N), 4.66 (2H, t, J"" 1.8 Hz, CSH4), 4.40 













CH2), 1.85 (4H, d, J::: 8.0 Hz, COD-CH2); 13C NMR Be (101 MHz; solvent CDCI3): 148.41 
(CSH4N), 147.52 (CSH4N), 133.89 (CSH4N), 124.01 (CSH4N), 80.00 (COD), 69.91 (CSH4), 69.81 
(CsHs), 66.70 (CSH4), 30.82 (COD); m/z (FAB) 509 (M+, 3%), 474 (M-CI, 41),365 (M-COD, 4), 
350 (6), 310 (18), 263 (ligand, 100),211 (M-ligand, 18), 154 (6) and 136 (6). 
1.4.14 Chloro(1 ,5-cyclooctadiene)(2-ferrocenylpyridine)rhodium 
Chloro( 1,5-cyclooctadiene(2-ferrocenylpyridine )rhodium was 
prepared according to the procedure followed for 7.4.2. 2- C2\....~ N~ 
I 'Rh..-" .; 
Ferrocenylpyridine (45.0 mg, 0.17 mmol) was added to a solution of ~.,.. 'CI 
chloro(I,5-cyclooctadiene)rhodium(l) dimer (42.2 mg, 0.08 mmol) in .Q 
dichloromethane (10 mI). The reaction mixture was stirred for a 
further 25 minutes. The reaction mixture was then concentrated in vacuo and pentane added 
to precipitate the product. The product was collected via vacuum filtration as an orange-brown 
powder (26.6 mg, 31%), mp 123-125 °C; (Found: C, 54.48%, H, 4.72, N, 2.48; M+ 509. 
C23H2sCIFeNRh requires C, 54.2%, H, 4.9, N, 2.7; M+ 509). Vmax (KBr)1 cm-
1 3616, 3584, 2830, 
2349,1798,1703,1634,1615,1598,1495,1422,1386,1105, 817, 457 and 408; 1H NMR OH 
(400 MHz; solvent CDCI3): 8.50 (1H, d, J::: 4.8 Hz, CSH4N), 7.57 (1H, t, J::: 7.7 Hz, CSH4N), 
7.41 (1 H, d, J::: 8.1 Hz, CSH4N), 7.06 (1 H, t, J::: 4.8 Hz, CSH4N), 4.92 (2H, t, J::: 1.8 Hz, CSH4), 
4.39 (2H, t, J::: 1.8 Hz, CSH4), 4.23 (4H, s, COD-CH), 4.05 (5H, s, CsHs). 2.49 (4H, m, COD-
CH2), 1.74 (4H, d, J ::: 8.4 Hz, COD-CH2); 13C NMR Oc (101 MHz; solvent CDCb): 149.25 
(CSH4N), 145.18 (CSH4N), 136.51 (CSH4N), 120.36 (CSH4N), 120.04 (CSH4N), 78.66 (COD), 
69.78 (CSH4), 68.48 (CsHs), 67.16 (CSH4), 30.79 (COD); m/z (FAB) 510 (M, 9%), 509 (M+, 1), 
473 (M+-CI), 365 (M-COD, 13),303 (7), 263 (2-Fcpy, 2),185 (100) and 115 (20). 
1.4.15 Chloro(1, 5-cyclooctadiene)(4-ferrocenylphenyl-4' -pyridine)rhodium 
Chloro( 1, 5-cyclooctadiene( 4-ferrocenylphenyl-4'-
pyridine)rhodium was prepared according to the procedure rJ·... /N 
~ Rh -
followed for 7.4.2. 4-Ferrocenylphenyl-4'-pyridine (50.0 Q(/ 'CI 
mg, 0.15 mmol) was added to a solution of chloro(I,5-
cyclooctadiene)rhodium(l) dimer (36.3 mg, 0.07 mmol) in dichloromethane (7 ml). The 
reaction mixture was stirred for a further 20 minutes. The reaction mixture was then 
concentrated in vacuo and diethyl ether added to precipitate the product. The product was 
collected via vacuum filtration as a dark red powder (59.9 mg, 70%), mp 213°C dec.; (Found: 
C, 59.62%, H, 5.12, N, 2.48; M+ 585. C2sH2SCIFeNRh requires C, 59.4%, H, 5.0, N, 2.4; M+ 
585). vmax/cm-













1432, 1398, 1338, 1283, 1222, 1106, 1079, 1032, 998, 964, 814, 719, 698, 644, 597, 502, 
475 and 441;1H NMR ~H (300 MHz; solvent COCh): 8.72 (2H, dd, J = 6.6 Hz, CSH4N), 7.59-
7.50 (6H, m, CeH4 and CSH4N), 4.68 (2H, t, J = 1.8 Hz, CSH4), 4.37 (2H, t, J = 1.8 Hz, CSH4), 
4.18 (4H, br s, COD-CH), 4.05 (5H, s, CsHs), 2.54-2.49 (4H, m, COD-CH2), 1.84 (4H, d, J = 
7.9 Hz, COO-CH2); 13C NMR ~c (75 MHz; solvent COCI3): 150.97 (CSH4N), 149.25 (CSH4N), 
142.02 (CeH4), 133.56 (CeH4), 126.92 (CSH4), 126.73 (CSH4), 121.89 (CSH4N), 83.65 (COO-
CH), 69.73 (CsHs), 69.55 (CsH4s), 66.66 (CSH4) and 30.90 (COO-CH2); mIz (FAB) 585 (M+, 
1%),574 (23), 387 (4-Fc(CeH4)py, 3), 339 (3), 273 (2),241 (24),185 (100) and 115 (10). 
1.4.16 (1,5-Cyclooct8diene)bis(4-ferrocenylphenyl-4'·pyridine)rhodium 
perchlorate 
(1 ,5-Cyclooctadiene )bis( 4-ferrocenylphenyI4'-
pyridine)rhodium perchlorate was prepared 
according to the procedure for 7.4.4. A white 
precipitate was observed to form immediately on 
addition of silver perchlorate (42.0 mg, 0.20 
mmol) to a solution of 
chloro(I,5-cyclooctadiene)rhodium(l) dimer (50.0 mg, 0.10 mmol) in acetone (15 ml). 4-
Ferrocenylphenyl4'-pyridine (106.1 mg, 0.40 mmol) was then added slowly to the 
supernatant, which was stirred at room temperature for a further 46 minutes. The reaction 
mixture was then concentrated and diethyl ether added to precipitate the product. The 
product was collected by vacuum filtration as small dark red crystals (164.6 mg, 83%) mp 
110-112 °C; (Found: C, 60.32%, H, 4.72, N, 2.59; M+ 988. CsoH4sCIFe2N204Rh requires C, 
60.7%, H, 4.7, N, 2.8; M+ 988). vmlllJcm-
1 (KBr): 3069, 2879, 2832, 2356, 2322, 2023, 1772, 
1616, 1602, 1589, 1541, 1487, 1432, 1405, 1283, 1215, 1120, 1100, 1004, 889, 814, 760, 
726,624,509,481,475 and 447;1H NMR ~H (300 MHz; solvent COCI3): 8.85 (4H, d, J = 5.0 
Hz, CSH4N), 7.87-7.34 (12H, m, CeH4 and CSH4N), 4.80 (4H, br s, CSH4), 4.50 (4H, br s, CSH4), 
4.31 (4H, br s, COO-CH), 4.14 (10H, s, CsHs), 2.89-2.56 (4H, m, COO-CH2), 2.00 (4H, d, J = 
8.4 Hz, COO-CH2); 13C NMR ~c (75 MHz; solvent COCI3): 150.50 (CSH4N), 142.47 (CSH4N), 
126.87 (CSH4), 126.68 (CSH4), 122.88 (CSH4N), 84.89 (COO-CH), 70.83 (CsHs), 70.56 (CsH4s), 
67.40 (CSH4) and 30.62 (COD-CH2); mlz (FAB) 988 (M+, 10%),851 (3),639 (7), 559 (11), 474 













7.4.17 Chloro(1 ,5-cyclooctadiene)(4-ferrocenylphenyl-3'·pyridine )rhodium 
Chloro( 1 ,5-cyclooctadiene( 4-ferrocenylphenyl-3'-
pyridine)rhodium was prepared according to the procedure 
followed for 7.4.2. 4-Ferrocenylphenyl-3'-pyridine (70.0 
mg, 0.21 mmol) was added to a solution of 
chloro(I,5-cyclooctadiene)rhodium(l) dimer (50.9 mg, 0.10 mmol) in dichloromethane (10 ml). 
The reaction mixture was stirred for a further 31 minutes. The reaction mixture was then 
concentrated in vacuo and diethyl ether added to precipitate the product. The product was 
collected via vacuum filtration as an orange-mustard powder (84.6 mg, 69%), mp 215-217 DC; 
(Found: C, 59.59%, H, 5.00, N, 2.32; M+ 585.0. C29H29CIFeNRh requires C, 59.5%, H, 5.0, N, 
2.4; M+ 585). Vmax (KBr)1 cm·
1 3689, 3671, 2832, 1612, 1395, 1104, 803, 700. 531, 442, 430, 
406 and 404; 1H NMR DH (400 MHz; solvent CDCb): 8.98 (1H, br s, CSH4N), 8.68 (1H, dd, J::: 
6.6 Hz, CSH4N), 7.88 (1 H, dt, J::: 7.3 Hz, CSH4N), 7.58 (2H. d, J::: 8.4 Hz, CeH4), 7.49 (2H, d, J 
::: 8.4 Hz, CeH4), 7.37 (1 H, dd, J::: 5.9 Hz, CSH4N), 4.69 (2H, t, J::: 1.8 Hz, CSH4), 4.37 (2H, t, J 
::: 1.8 Hz, CSH4), 4.22 (4H, br s, COD-CH) 4.07 (5H, s, CsHs), 2.52 (4H, m, COD-CH2), 1.86 
(4H, d, J ::: 8.1 Hz, COD-CH2); 13C NMR Dc (101 MHz; solvent CDCI3): 147.45 (CSH4N), 
147.26 (CSH4N), 133.25 (CSH4N), 125.50 (CeH4), 125.15 (CeH4). 122.77 (CSH4N), 82.26 
(COD), 68.11 (CsHs), 67.74 (CSH4), 65.00 (CSH4) and 29.25 (COD); mIz (FAB) 585 (M+, 1%), 
550 (M-CI, 28),386 (21),339 (3-Fc(CsH4)PY, 100).274 (6).238 (50) and 211 (17). 
7.4.18 Chloro(1 ,5-cyclooctadiene)(4-ferrocenylphenyl·2'·pyridine)rhodium 
Chloro(1,5-cyclooctadiene(4-ferrocenylphenyl-2'-
pyridine)rhodium was prepared according to the procedure 
followed for 7.4.2. 4-Ferrocenylphenyl-2'-pyridine (60.0 mg, 
0.18 mmol) was added to a solution of 
chloro(I,5-cyclooctadiene)rhodium(l) dimer 43.6 mg, 0.09 
mmol) in dichloromethane (10 mI). The reaction mixture was stirred for a further 31 minutes. 
The reaction mixture was then concentrated in vacuo and diethyl ether added to precipitate 
the product. The product was collected via vacuum filtration as an orange powder (42.6 mg, 
40%), mp 90-92 DC; (Found: C, 59.42%, H, 5.12, N, 2.32; M+ 585. C29H29CIFeNRh requires C, 
59.5%, H, 5.0, N, 2.4; M+ 585). Vmax (KBr)1 cm'1 3629, 3568, 2323, 1740, 1700, 1646, 1336, 
1607,1474,783,500 and 409; 1H NMR DH (400 MHz; solvent CDCb): 8.69 (1H, dd, J::: 4.8 
Hz, CSH4N), 7.93 (2H, dd, J::: 8.4 Hz, CSH4), 7.74 (2H, dd, J::: 6.2 Hz, CSH4N), 7.57 (2H, dd, J 
::: 8.8 Hz, CeH4). 7.21 (1H, dd, J::: 6.6 Hz, CSH4N), 4.74 (2H, t, J::: 1.8 Hz, CSH4), 4.23 (2H, t, J 













d, J:::: 8.2 Hz, COD-CH2); 13C NMR Be (101 MHz; solvent COCh): 149.60 (CSH4N), 136.58 
(CSH4N), 126.25 (CaH4), 126.77 (CaH4), 121.70 (CSH4N), 120.05 (CSH4N), 78.67 (COD), 69.63 
(CsHs), 69.12 (CSH4), 66.49 (CSH4), 30.79 (COD); mIz (FAB) 585 (M+, 1%),548 (M-CI, 3),388 
(2-Fc(CaH4)PY. 60), 340 (60), 274 (10), 238 (3) and 115 (10). 
7.4.19 (1, 1'-Bis(2-pyridyl}ferrocene)(1 ,5-cyclooctadiene)rhodium perchlorate40 
(1,1 '-Bis(2-pyridyl)ferrocene)( 1, 5-cyclooctadiene )rhodium 
perchlorate was prepared according to the procedure for 
7.4.4. A white precipitate was observed to form immediately 
on addition of silver perchlorate (48.7 mg, 0.24 mmol) to a 
solution of chloro(I,5-cyclooctadiene)rhodium(l) dimer (58.0 
mg, 0.12 mmol) in acetone (15 ml). 1,1 '-Bis(2-pyridyl)ferrocene (80.0 mg, 0.24 mmol) was 
added to the supernatant, which was stirred at room temperature for a further 35 minutes. 
The reaction mixture was then concentrated and pentane added to precipitate the product. 
The product was collected by vacuum filtration as small dark red crystals (92.6 mg, 70%), mp 
148-150 °C; (Found: C, 59.62%, H, 4.89, N, 2.21; M+ 551.06569. C2sH2sCIFeN204Rh requires 
C, 59.5%, H, 5.0, N, 2.4; M+ 551.28874). Vmax (KBr)/ cm'1 1596, 1555, 1494, 1419, 1283, 
1120,1086,889,814,780,746,692,624,522,447 and 420; 1H NMR BH (400 MHz; solvent 
COCIa): 8.35 (2H. d. J:::: 5.3 Hz, CSH4N), 7.67 (2H. t, J:::: 7.8 Hz, CSH4N). 7.50 (2H, dd, J:::: 6.7 
Hz, CSH4N), 7.08 (2H, dd, J:::: 11.6 Hz, CSH4N), 4.91 (4H, t, J:::: 1.8 Hz, CSH4), 4.50 (4H, s, 
COD-CH), 4.36 (4H, t, J :::: 1.8 Hz, CSH4), 2.81 (COD-CH2), 2.00 (4H, br s, COO-CH2); 13C 
NMR Be (75 MHz; solvent COCI3): 156.97 (CSH4N), 136.51 (CSH4N), 131.90 (CSH4N), 128.39 
(CSH4N), 120.30 (CSH4N), 75.21 (COD), 71.48 (CSH4), 68.73 (CSH4) and 30.02 (COD); mIz 
(FAB) 551 (M+, 14%),443 (M+-COO, 17),387 (7), 341 (Fc(2-pYh, 11),258 (23),189 (19),154 
(37), 115 (58) and 89 (100). 
7.4.20 (1,1'-Bis(4-pyridyl}ferrocene)(1 ,5-cyclooctadiene)rhodium perchlorate 
(1, 1'-Bis(4-pyridyl)ferrocene)(1,5-cyclooctadiene)rhodium [ J ] 
perchlorate was prepared according to the procedure for Foe _ N" ti····~ 
~j~ /R __ )( C104 
7.4.4. A white precipitate was observed to form N -p 
immediately on addition of silver perchlorate (60.9 mg, 
0.29 mmol) to a solution of chloro(I,5-cyclooctadiene)rhodium(l) dimer (72.5 mg, 0.15 mmol) 
in ethanol (15 ml). 1,1 '-Bls(4-pyridyl)ferrocene (100.0 mg, 0.29 mmol) was added to the 
supernatant, which was stirred at room temperature for a further 40 minutes. The reaction 













was coliected by vacuum filtration as small dark red crystals (107.1 mg, 67%), mp 208-210 °C 
dec.; (Found: C, 59.32%, H, 4.86, N, 2.32; M+ 551. C2sH2SCIFeN204Rh requires C, 59.5%, H, 
5.0, N, 2.4; M+ 551). Vmax (KBr)1 cm-
1 3504, 3436, 3361, 2363, 1650, 1595, 1426, 1113, 1086, 
841, 692, 617 and 543; 1H NMR (5H (400 MHz; solvent CDCb): 8.52 (4H, d, J ::::: 5.8 Hz, 
CSH4N), 7.16 (4H, d, J::::: 5.6 Hz, CSH4N), 4.85 (4H, t, J::::: 1.8 Hz, CSH4), 4.52 (4H, t, J::::: 1.8 Hz, 
CSH4), 4.39 (4H, s, COD-CH), 2.89 (4H, m, COD-CH2), 1.98 (4H, br s, COD-CH2); 13C NMR (5c 
(101 MHz; solvent CDCb): 149.69 (CSH4N), 120.18 (CSH4N), 75.18 (COD), 72.24 (CSH4), 
68.45 (Cs~) and 30.21 (COD); mlz (FAB) 551 (M+, 7%), 442 (1), 387 (i), 342 (Fc(4-PYh, 3), 
279 (100), 258 (3), 223 (3), 207 (5),185 (100) and 115 (10). 
7.4.21 Chloro(1,S-cyclooctadiene)(1' ,2' ,3',4' ,S'·pentamethylazaferrocene)rhodium 
Chloro( 1 ,5-cyclooctadiene)( l' ,2' ,3',4' ,5'-
C(... N~ pentamethylazaferrocene)rhodium was prepared according to the r "'Rh/ F. 
procedure followed for 7.4.2. 1',2',3',4',5'-Pentamethylazaferrocene l\.'/ 'CI"/d5( 
(70.0 mg, 0.27 mmol) was added to a solution of /]' 
chloro(I,5-cyclooctadiene)rhodium(l) dimer (67.1 mg, 0.14 mmol) in dichloromethane (10 ml). 
The reaction mixture was stirred for a further 37 minutes. The reaction mixture was then 
concentrated in vacuo and pentane added to precipitate the product. The product was 
collected via vacuum filtration as an orange powder (47.3 mg, 67%), mp 192-193 °C; (Found: 
C, 52.12%, H, 5.98, N, 2.65; M+ 505. C22H31CIFeNRh requires C, 52.4%, H, 6.2, N, 2.8; M+ 
504.75). Vmax (KBr)1 cm-1 2907, 2872, 2832, 1738, 1704, 1650, 1575, 1473, 1446, 1371, 1324, 
1113, 1066, 1018, 943, 869, 814, 767 and 468; 1H NMR (5H (400 MHz; solvent CDCI3): 5.33 
(2H, s, C4H4N), 4.53 (2H, s, C4H4N), 4.16 (2H, s, COD-CH), 3.81 (2H, s, COD-CH), 2.41 (4H, 
s, COD-CH2), 2.08 (15H, s, CH3) and 1.75 (4H, s, COD-CH2); 13C NMR Be (101 MHz; solvent 
CDCb): 88.96 (CsMes), 82.64 (C4H4N), 75.38 (COD), 74.21 (C4H4N), 31.04 (COD), 30.45 
(COD) and 11.50 (CH3); mlz (FAB) 505 (M+, 10%), 466 (2), 402 (2), 341 (3), 290 (4), 258 
(100),244 (8). 226 (4) and 207 (7). 
7.4.22 Chloro(1 ,S-cyclooctadiene)(4-oclyloxystilbene)rhodium41 
Chloro(1,5-cyclooctadiene(4-octyloxystilbene)rhodium 
was prepared according to the procedure followed for rJ· .. /N~~ 
~ Rh - ~ OCH 
7.4.2. 4-0ctyloxystilbene (70.0 mg, 0.23 mmol) was C\/ 'CI \. J S 17 
added to a solution of chloro(I,5-
cyclooctadiene)rhodium(l) dimer (55.8 mg, 0.11 mmol) in dichloromethane (10 ml). The 













concentrated in vacuo and pentane added to precipitate the product. The product was 
collected via vacuum filtration as a light yellow powder (86.3 mg, 67%), mp 89-128 °C (lit. 85-
130°C). 1H NMR OH (400 MHz; solvent CDCI3): 8.60 (2H, d, J::: 6.6 Hz. CSH4N). 7.45 (2H, d, J 
= 8.4 Hz. CaH4). 7.30 (2H, d, J::: 6.6 Hz, CSH4N), 7.26 (1H, d, J = 16.1 Hz, CH=CH), 6.90 (2H, 
d, J = 8.8 Hz, CeH4), 6.78 (1H, d, J = 16.1 Hz, CH=CH), 4.22 (4H, br s, COD-CH), 3.98 (2H, t, 
J = 6.6 Hz, OCH2), 2.50 (4H, m, COD-CH2), 1.83 (4H, d, J = 7.7 Hz, COD-CH2), 1.42 (2H, m, 
CH2), 1.29 (10H, m, CH2 x 5), 0.89 (3H, m, CH3); 13C NMR Oc (101 MHz; solvent CDCb): 
149.10 (CSH4N), 133.41 (C=C), 127.12 (CeH4), 120.42 (C=C), 119.72 (CeH4), 113.34 (CSH4N), 
66.59 (COD), 30.17 (COD), 29.28 (OCH2), 27.70 (CH2 x 5),21.01 (CH2) and 12.43 (CH3). 
7.4.23 (1 ,5-Cyclooctadiene)-1, l' -bis(diphenylphosphino)ferrocene)rhodium 
perch I orate42 
(1,5-Cycloodadiene)-1,1'-bis(diphenylphosphino)ferrocene) 
procedure for 7.4.4. A white precipitate was observed to ~~~~:Rh( ~ CI04 
rhodium perchlorate was prepared according to the [0- ~~9l 
~ P:-O 
form immediately on addition of silver perchlorate (37.4 mg, Ph2 
0.18 mmol) to a solution of chloro(I,5-cyclooctadiene)rhodium(l) dimer (44.5 mg, 0.09 mmol) 
in acetone (15 ml). 1,1'-Bis(diphenylphosphino)ferrocene (100.2 mg, 0.18 mmol) was then 
added slowly to the supernatant, which was stirred at room temperature for a further 35 
minutes. The reaction mixture was then concentrated and diethyl ether added to precipitate 
the product. The product was collected by vacuum filtration as an orange-gold powder (126.2 
mg, 81%), mp 193-195 °C dec.; (Found: M+ 765. C42H.wCIFe04P2Rh requires M+ 765.52). Vmax 
(KBr)1 cm-1 2356,2329,2288,1765,1738,1684,1616,1575,1541, 1514, 1480, 1432, 1398. 
1337, 1310, 1188,1161, 1099, 1038,998,862,821.753,699,624.543,495 and 434; 1H 
NMR OH (300 MHz; solvent CDCls): 7.86 (10H, dd, J:::: 4.4 Hz. CeHs). 7.59 (10 H, d, J::: 4.8 
Hz, CeHs) , 4.41 (4H. s, COD-CH), 4.34 (4H, t, J = 1.8 Hz. CSH4) , 4.28 (4H, t, J ::: 1.8 Hz. 
CSH4) , 2.37 (4H, m. COD-C~), 2.16 (4H, d, J = 8.1 Hz, COD-CH2); 1SC NMR Oc (75 MHz; 
solvent CDCIa): 134.21 (CeHs). 131.75 (CeHs), 129.10 (CeHs), 99.37 (COD-CH), 75.05 (CSH4). 
74.10 (CSH4) and 30.51 (COD-CH2); mJz (FAB) 765 (M+, 20%), 733 (18), 634 (27), 578 (42). 
395 (10). 321 (20).258 (30),185 (100),149 (21) and 115 (10). 
7.4.24 Chloro(1 ,5-cyclooctadiene)(ferrocenyldiphenylphosphine)rhodium 
Chloro( 1,5-cyclooctadiene )(ferrocenyldiphenylphosphine )rhodium 
was prepared according to the procedure followed for 7.4.2. 













a solution of chloro(I,5-cyclooctadiene)rhodium(l) dimer (66.7 mg, 0.13 mmol) in 
dichloromethane (10 ml). The reaction mixture was stirred for a further 36 minutes. The 
reaction mixture was then concentrated in vacuo and pentane added to precipitate the 
product. The product was collected via vacuum filtration as a mustard-yellow powder (107.8 
mg, 65%), mp 156-158 °C; (Found: C, 57.97%, H, 5.13; M+ 616.02563. C30H31CIFePRh 
requires C, 58.4%, H, 5.1; M+ 616.74827). vmax/cm-
1 (KBr): 3062, 2879, 2832, 2356, 2322, 
1772,1684,1616,1609,1575,1541,1514,1480,1426, 1412, 1398, 1385, 1324, 1303, 1161, 
1106,1086,1066,1032,1011,998,984,957,841,814,753, 699, 644, 543, 522, 488, 461 
and 447; 1H NMR OH (300 MHz; solvent CeDe): 7.79 (5H, t, J::: 5.0 Hz, CeHs), 7.03 (5H, d, J ::: 
5.7 Hz, CeHs), 5.89 (4H, br s, COD-CH), 4.89 (2H, br s, CSH4), 4.31 (5H, s, CsHs), 4.14 (2H, br 
s, CSH4), 3.18 (4H, m, COD-CH2), 2.16 (4H, d, J::: 8.4 Hz, COD-CH2); 13C NMR Oc (75 MHz; 
solvent CDCh): 126.86 (CeHs), 126.67 (CeHs), 122.87 (CeHs), 85.01 (COD-CH), 70.86 (CSH4), 
70.82 (CSH4), 67.41 (CsHs) and 29.10 (COD-CH2); 31p NMR op (121 MHz; solvent CeDe): 
25.69 (PPh2); mIz (FAB) 616 (M+, 69%), 581 (M-CI, 100), 579 (47), 551 (10), 501 (17),470 
(12), 433 (16), 393 (32). 370 (FcPPh2, 86). 351 (12). 293 (10), 273 (12), 233 (8), 210 (M-
FcPPh2, 5), 186 (Ferrocene, 8),154 (13) and 136 (12). 
7.4.25 (1 ,5-Cyclooctadiene)bis(ferrocenyldiphenylphosphine)rhodium 
perchlorate 
(1 ,5-Cyclooctadiene )bis(ferrocenyldiphenylphosphine )rhodium 
perchlorate was prepared according to the procedure for 7.4.4. 
A white precipitate was observed to form immediately on 
addition of silver perchlorate (84.1 mg, 0.40 mmol) to a 
solution of chloro(I,5-cyclooctadiene)rhodium(l) dimer (100.0 
mg, 0.20 mmol) in acetone (20 ml). 
C104 
Ferrocenyldiphenylphosphine (300.1 mg, 0.81 mmol) was then added slowly to the 
supernatant, which was stirred at room temperature for a further 40 minutes. The reaction 
mixture was then concentrated and diethyl ether added to preCipitate the product. The 
product was collected by vacuum filtration as a brown crystalline solid (451.8 mg, 99%), 95-
98°C; (Found: C, 59.48%, H, 4.77; M+ 950.9. CS2HsoCIFe204P2Rh requires C, 59.4%, H, 4.8; 
M+ 950.5). vmax/cm-
1 (KBr): 3056, 2356, 2329, 1616, 1575, 1541, 1514, 1480, 1432, 1398, 
1378,1337,1303,1161,1120,1113,1100,1032,998,821, 746, 692, 624, 570,481,461, 
454 and 434; 1H NMR OH (300 MHz; solvent CDCI3): 7.60 (10H. br s, CeHs), 7.07 (10H, br s, 
CeHs), 4.33 (4H, br s, CSH4), 4.15 (4H, br s, CSH4), 4.04 (10H, s, CsHs), 3.59 (4H, br s, COD-













843 (M-COD, 48), 763 (10), 723 (5), 657 (8), 581 (M-FcPPh2, 75), 501 (29), 417 (39), 393 
(79), 386 (98), 370 (FcPPh2, 100), 321 (77), 293 (34), 233 (27), 210 (M-2 FcPPh2, 11), 136 
(43), 115 (45), 89 (82) and 77 (100). 
1.5 Iridium complexes 
1.5.1 Chloro(!,5-cyc!ooctadiene)iridium(l) dimer43 
1,5-Cyclooctadiene (1.47 g. 1.70 ml, 13.61 mmol) was added to a 
dark suspension of iridium trichloride (1.50 g, 4.25 mmol) in 
ethanol/water 5:1 (20 ml). The reaction mixture was heated under 
reflux overnight. The product was observed as an orange-red crystalline suspension with the 
supernatant gradually changing colour from a dark solution to light orange. The product was 
collected by vacuum filtration and washed successively with pentane and methanol (404.5 
mg, 28%), mp 192°C dec .. Vmax (KBr)1 cm,1 1698, 1471,668,530,497 and 444; 1H NMR OH 
(400 MHz; solvent CsDs): 4.32 (8H, s, COD-CH), 2.02 (8H, br s, COD-CH2), 1.25 (8H, d, J ::: 
8.0 Hz, COD-CH2); 13C NMR oe (101 MHz; solvent CsDs): 61.68 (COD) and 31.56 (COD). 
1.5.2 Chloro(1,5-cyclooctadiene)(pyridine)iridium44 
Pyridine (19.0 mg, 19.3 Ill, 0.24 mmol) was added slowly to an orange 
solution of the chloro(I,5-cyclooctadiene)iridium(l) dimer (80.0 mg, 0.12 
mmol) in tetrahydrofuran (15 ml). The solution was observed to change 
to bright yellow on addition of pyridine. The reaction mixture was further stirred under nitrogen 
at room temperature for 23 minutes and then concentrated in vacuo. Pentane was added to 
precipitate the product that was collected via vacuum filtration as a bright yellow powder (76.2 
mg, 77%), mp 137-139 °C dec. (1it.44 136-138 °C dec.). Vmax (KBr)1 cm,1 2365, 2344, 1696, 
1601,1473,1208,1067,1000,668,492,436 and 406;1H NMR OH (400 MHz; solvent CsDs): 
8.29 (2H, d, J ::: 6.4 Hz, CsHsN), 6.56 (1H, t. J ::: 6.3 Hz, CsHsN), 6.27 (2H, t, J ::: 7.2 Hz, 
CsHsN), 3.97 (4H, br s, COD-CH), 2.21-2.18 (4H, m, COD-CH2). 1.47-1.41 (4H dd, J::: 11.8 
Hz, COD-CH2); 13C NMR oe (101 MHz; solvent CsDs): 150.37 (C5H4N), 136.29 (C5H4N), 
124.65 (CSH4N), 68.00 (COD) and 31.95 (COD). 
1.5.3 (1 ,5-Cyclooctadiene)bis(pyridine)iridium perchlorate43,44 
Excess pyridine (94.2 mg, 96 Ill, 1.20 mmol) was added slowly to an orange suspension of 












bright yellow solution was further stirred at room temperature 
under nitrogen for 26 minutes. Silver perchlorate (61.7 mg, 0.30 
mmol) was added to the reaction mixture. A white precipitate of 
silver chloride was observed to precipitate almost immediately. 
The reaction mixture was filtered under vacuum to remove 
Experimental Details 
precipitated silver chloride. The filtrate was then concentrated and left to crystallise at 0 aC. 
The product was collected via vacuum filtration as a crystalline yellow powder (468.8 mg. 
70%). Vmax (KBr)/cm-
1 3568, 3023,1603,1484,1211,1109,1087,762.622,489 and 436; 1H 
NMR OH (300 MHz; solvent CDCI3): 8.80 (4H, br s, CSH4N), 7.76 (2H, t, J::: 7.1 Hz, CSH4N), 
7.51 (4H, br s, CSH4N). 3.84 (4H, s, COD-CH), 2.49 (4H, br s, COD-CH2), 1.82 (4H, d, J::: 7.7 
Hz, COD-CH2); 13C NMR Oc (75 MHz; solvent CDCI3): 149.88 (CSH4N), 138.77 (CSH4N), 
126.92 (CSH4N), 70.74 (COD) and 31.28 (COD). 
1.S.4 Chloro(1,S-cyclooctadiene)(4-phenylpyridine)iridium 
Chloro(1,5-cyclooctadiene)(4-phenylpyridine)iridium was 
prepared according to the procedure followed for 7.5.2. 4-
Phenylpyridine (46.6 mg, 0.30 mmol) was added to a solution 
of chloro(I,5-cyclooctadiene)iridium(1) dimer (100.0 mg, 0.15 
mmol) in tetrahydrofuran (15 ml). The reaction mixture was 
stirred for a further 30 minutes. and then concentrated in vacuo. Pentane was added to 
precipitate the product. The product was collected via vacuum filtration as a yellow crystalline 
solid (111.0 mg, 75%); (Found: C, 46.34%, H, 4.68, N. 2.74; M+ 491.1. C19H21CllrN requires 
C, 46.4%, H, 4.4, N, 2.8; M+ 491.6). Vmax (KBr)1 cm-
1 3674,3646,3627, 1750, 1733, 1634, 
1609, 1483, 1436, 1414, 765 and 408; 1H NMR OH (400 MHz; solvent CaDa): 8.39 (2H, d, J ::: 
5.8 Hz, CSH4N), 7.12 (5H, br s, CaHs), 6.68 (2H, d, J::: 5.9 Hz, CSH4N), 3.53 (4H. s, COD-CH), 
2.23 (4H, m, COD-CH2), 1.49 (4H, d, J::: 11.5 Hz, COD-CH2); 13C NMR Oc (101 MHz; solvent 
CaDa): 150.63 (CSH4N), 129.68 (CaHs), 129.08 (CaHs), 126.97 (CaHs), 122.46 (CSH4N), 68.90 
(COD), 32.03 (COD); mlz (FAB) 491 (M+, 8%), 456 (M-CI, 44), 452 (26), 347 (6), 297 (24), 
295 (22),170 (9),156 (Iigand-W, 100), 115 (5) and 77 (6). 
1.S.S Chloro(1,S-cyclooctadiene)(4-phenylimine-4'-pyridine)iridium 
Chloro(1,5-cyclooctadiene)(4-phenylimine-4'- -0 
pyridine)iridium was prepared according to the procedure Q'"" ........... N~ ~N \. j 
followed for 7.5.2. 4-Phenylimine-4'-pyridine (55.0 mg, ~_/.lr ............ c~ 













cyclooctadiene)iridium(l) dimer (100.0 mg, 0.15 mmol) in tetrahydrofuran (15 ml). The 
reaction mixture was stirred for a further 47 minutes and then concentrated in vacuo. Pentane 
was added to precipitate the product. The product was collected via vacuum filtration as an 
orange powder (87.8 mg, 57%), mp 197-200 °c dec.; (Found: C, 46.08%, H, 4.31, N, 5.19; M+ 
518.0. C2oH2,2CllrN2 requires C, 46.3%, H, 4.2, N, 5.4; M+ 518.2). Vmax (KBr)1 cm-
1 3629, 1700, 
1696, 1653, 1560,668,412 and 410; 1H NMR OH (300 MHz; solvent CDCh): 8.83 (2H, dd, J = 
6.6 Hz, CSH4N), 8.45 (1H, s, N=CH), 7.83 (2H, dd, J = 6.6 Hz, CSH4N), 7.42 (2H, t, J = 7.7 Hz, 
CeHs), 7.33 (2H, d, J = 7.2 Hz, CeHs), 7.27 (1H, t, J = 8.4 Hz, CeHs), 3.78 (4H, br s, COD-CH), 
2.32 (4H, m, COD-CH2), 1.63 (4H, d, J = 7.4 Hz, COD-CH2); 13C NMR oe (75 MHz; solvent 
CDCb): 157.98 (N=C), 154.28 (CSH4N), 151.89 (CSH4N), 144.51 (CsHs), 129.38 (CSH4N), 
127.65 (CeHs), 123.24 (CeHs), 122.06 (CsHs), 85.12 (COD) and 30.32 (COD); mlz (FAB) 518 
(M+, 8%), 479 (M-CI, 55), 452 (7), 399 (15), 373, (M-COD, 11), 335 (7), 295 (28), 195 (7), 183 
(Ligand-W, 100), 149 (19),79 (py, 13) and 77 (47). 
7 .5.6 Chloro(1,5-cyclooctadiene)(4-ferrocenylpyridine)iridium 
Chloro(1,5-cyclooctadiene)(4-ferrocenylpyridine)iridium was jJ._ N~ 
prepared according to the general procedure followed for 7.5.2. '< .~:::Ir( I~-Foe 
4-Ferrocenylpyridine (78.3 mg, 0.30 mmol) was added to a C\ CI $ 
solution of chloro(I,5-cyciooctadiene)iridium(l) dimer (100.1 mg, 0.15 mmol) in tetrahydrofuran 
(12 mI). The reaction mixture was stirred for a further 40 minutes and then concentrated in 
vacuo. Pentane was added to precipitate the product. The product was collected via vacuum 
filtration as an orange-brown solid (92.4 mg, 51%), mp 179-182 °C dec.; (Found: C, 45.91%, 
H, 4.23, N, 2.27; M+ 598.1. C23H2SCIFeirN requires C, 46.1 %, H, 4.2, N, 2.3; M+ 598.2). Vmax 
(KBr)1 cm-1 3568, 2317,1845,1700,1636,1614,1499,1457,668 and 411; 1H NMR OH (400 
MHz; solvent CeDe): 8.38 (2H, d, J = 5.9 Hz, CSH4N), 6.66 (2H, d, J = 6.1 Hz, CSH4N), 4.21 
(2H, t, J = 1.8 Hz, CSH4), 4.05 (2H, t, J = 1.8 Hz, CSH4), 3.67 (5H, s, CsHs), 2.24 (4H, m, COD-
CH2), 1.29 (4H, d, J = 8.1 Hz, COD-CH2); 13C NMR Oc (101 MHz; solvent CeDe): 149.97 
(CSH4N), 121.40 (CSH4N), 70.99 (CSH4), 70.24 (CsHs), 67.28 (CSH4), 67.26, (COD), 32.08 
(COD); mIz (FAB) 598 (M+, 10%), 578 (16), 564 (M-CI, 43), 454 (6), 440 (26), 400 (29), 363 
(7),297 (14), 263 (ligand, 100), 198 (11),121 (54) and 77 (44). 
7.5.7 (1 ,5-Cyclooctadiene)bis(ferrocenylpyridine)iridium perchlorate 
(1,5-Cyclooctadiene)bis(ferrocenylpyridine)iridium perchlorate was prepared according to the 
procedure for 7.5.3. 4-Ferrocenylpyridine (0.18 g, 0.69 mmol) was added slowly to an orange 













mI). The bright red solution was further stirred at room 
temperature under nitrogen for 24 minutes. Silver 
perchlorate (0.07 g, 0.34 mmol) was added to the reaction 
mixture. A white precipitate of silver chloride was observed 
to precipitate almost immediately. The reaction mixture 
was filtered under vacuum to remove precipitated silver chloride, the filtrate concentrated and 
left to crystallise at 0 °C. The product was collected via vacuum filtration as a fine pink-red 
powder (0.29 g, 94%), mp 170-174 °C dec.; (Found: C, 49.21%, H, 3.82, N, 2.67; M+ 
826.13734. C3sH3sCIFe21rN204 requires C, 49.3%, H, 4.1, N, 3.0; M+ 826.615494). Vmax (KBr)/ 
cm,1 3584, 2349, 1728, 1703, 1634, 1615, 1486, 1435, 1429, 1404, 1122,667,43 and 408; 
1H NMR 5H (400 MHz; solvent CDCb): 8.78 (4H, d, J == 5.9 Hz, CSH4N), 7.75 (4H, d, J == 6.1 
Hz, CSH4N), 5.17 (4H, t, J == 1.8 Hz, CSH4), 4.75 (4H, t, J == 1.8 Hz, CSH4), 4.19 (10H, s, CsHs), 
2.77 (4H, m, COD-CH2), 1.29 (4H, d, J == 8.1 Hz, COD-CH2); 13C NMR 5e (101 MHz; solvent 
CaDa): 150.58 (CSH4N), 122.69 (CSH4N), 72.38 (CSH4), 70.02 (CsHs), 67.47, (COD), 67.08 
(CSH4), 31.89 (COD); mIz (FAB) 827 (33), 826 (M+, 9%), 608 (7), 580 (13), 440 (16), 400 (18), 
263 (ligand, 100), 154 (25) and 77 (13). 
1.5.8 Bis( carbonyl)chloro(4-pyridylim ine-4' -phenylferrocene )iridium 
4-Pyridylimine-4'-phenylferrocene (87.2 mg, 0.24 OC N~ _ 
mmol) was added to an orange solution of the iridium '1/ I~N-G-9 
dimer (80.0 mg, 0.12 mmol) in dichloromethane (10 OC/ 'CI .6-
ml). The reaction mixture was further stirred under 
nitrogen for at least 10 minutes. Carbon monoxide was then bubbled through the reaction 
mixture for 15 minutes. The reaction mixture was concentrated in vacuo and hexane added to 
precipitate the product. The product was collected via vacuum filtration as a fine maroon 
powder (81.0 mg, 52%), mp 151-167 °C; (Found: C, 44.40%, H, 2.66, N, 3.95; M+ 650. 
C24H1sCIFelrN202 requires C, 44.3%, H, 2.8, N, 4.3; M+ 649.94). vmaxlcm,1 (KBr): 3447, 2926, 
2067 (CO), 1991 (CO), 1619 (C==N), 1577, 1429, 1103,846,823, and 503; 1H NMR 5H (300 
MHz; solvent CDCI3): 8.88 (2H, d, J == 6.7 Hz, CSH4N), 8.60 (1H, s, N==CH), 8.00 (2H, d, J == 
6.7 Hz, CSH4N), 7.57 (2H, d, J::: 8.5 Hz, CSH4), 7.29 (2H, d, J::: 8.5 Hz, CSH4), 4.69 (2H, t, J == 
1.8 Hz, CSH4), 4.38 (2H, t, J == 1.8 Hz, CSH4) and 4.06 (5H, s, CsHs); 13C NMR 5e (75 MHz; 
solvent CDCb): 154.17 (N==C), 152.19 (CSH4N), 147.61 (CSH4N), 144.76 (CaH4). 139.07 
(CSH4N), 126.89 (CSH4N), 122.38 (CSH4N), 121.49 (CaH4). 69.82 (CsHs), 69.43 (CSH4) and 
66.67 (CSH4); mlz (FAB) 650 (M+, 1%), 559 (M-CI-2CO, 7), 473 (7), 468 (5), 432 (4), 367 












1.6 Palladium complexes 
1.6.1 Dichlorobis(pyridine)palladium 
The reaction mixture was observed to change from a light brown solution 
to opaque yellow on addition of a solution of pyridine (54.0 mg, 55.0 ~I, 
0.68 mmol) , in ethanol (5 ml) to a solution of sodium 
tetrachloropaliadate(lI) (100.0 mg, 0.34 mmol) in (1 :2) ethanoliwater (3 
ml). The reaction mixture was further stirred at room temperature for 24 
Experimental Details 
hours. A precipitate was observed during this time. The product was collected via vacuum 
filtration as a light yellow powder (88.1 mg, 77%). Vmax (KBr)/ cm'1 3629, 1636, 1604, 1474, 
769,668 and 472; lH NMR ()H (400 MHz; solvent CDCh): 8.84 (4H, dd, J:::: 8.1 and 5.1 Hz, 
CsHsN), 7.78 (2H, tt, J:::: 7.7 Hz, CsHsN), 7.34 (4H, t, J:::: 7.7 Hz, CsHsN); 13C NMR ()e (101 
MHz; solvent CDCh): 153.65 (CsHsN), 138.96 (CsHsN), 124.95 (CsHsN) 
1.6.2 Dichlorobis(4-phenylpyridine)palladium 
A light yellow precipitate was observed to occur immediately 
on addition of a solution of 4-phenylpyridine (0.21 g, 1.36 
mmol) in dichloromethane (5 ml) to a solution of sodium 
tetrachloropaliadate(lI) (0.20 g, 0.68 mmol) in (1 :2) 
ethanol/water (6 ml). The reaction mixture was further 
stirred at room temperature for 6 hours. The product was 
collected as a light yellow powder by vacuum filtration (0.27 
g, 83%); (Found: C, 54.52%, H, 3.55, N, 5.58. C!2H1sC12N2Pd requires C, 54.2%, H, 3.7, N, 
5.7). Vmax (KBr)/ cm-
1 3626, 1760, 1699, 1634, 1609, 1480, 667, 503 and 431; 1H NMR ()H 
(solvent CDCI3): 1H NMR ()H (300 MHz; solvent CDCI3): 8.69 (4H, d, J:::: 5.8 Hz, CSH4N), 7.48 
(4H, d, J:::: 5.8 Hz, CSH4N), 7.32 (10H, m, CaHs). 
1.6.3 Dichlorobis(4-ferrocenylpyridine)palladlum 
Dichlorobis( 4-ferrocenylpyridine )palladium was prepared 
according to the procedure for 7.6.2. A red precipitate was 
observed to occur immediately on addition of a solution of 
4-ferrocenylpyridine (0.50 g, 1.9 mmol) in dichloromethane 
(5 ml) to a solution of sodium tetrachloropaliadate(ll) (0.28 













mixture was further stirred at room temperature 8 hours. The product was collected as a red 
powder by vacuum filtration (0.56 g, 84%), mp 250-253 °C dec.; (Found: C, 50.76%, H, 3.52, 
N, 4.02; M+ 703.92108. C30H2sCI2Fe2N2Pd requires C, 51.2%, H, 3.7, N, 4.0; M+ 703.65268). 
Vmax (KBr)/ cm·1 3568, 1700, 1636, 1611, 1499. 1215, 1107, 1039, 825 and 494; 1H NMR OH 
(solvent CDCb): 8.59 (4H, d, J::: 6.7 Hz, CSH4N), 7.30 (4H, br s, CSH4N), 4.72 (4H. s, CSH4). 
4.52 (4H, s, CSH4), 4.07 (10H, s, CsHs); mIz (FAB) 703.9 (M+, 28%), 667 (M-CI, 148),613 (9), 
482 (7), 460 (25), 371 (8), 329 (32), 307 (75), 289 (60), 263 (ligand, 77), 176 (58), 107 (70) 




Dichlorobis(3-ferrocenylpyridine )palladium was prepared 
according to the procedure for 7.6.2. A yellow precipitate 
was observed to occur immediately on addition of a ~ Pd 
~N/ 'CI 
solution of 3-ferrocenylpyridine (0.30 g, 1.2 mmol) in ~ I " 
dichloromethane (5 ml) to a solution of sodium ~ 
tetrachloropaliadate(lI) (0.17 g, 0.59 mmol) in (1 :2) ethanol-water (6 ml). The reaction mixture 
was further stirred at room temperature for 6 hours. The product was collected as a fine 
mustard-yellow crystalline powder by vacuum filtration (0.35 g, 84%), mp 148-150 °C dec.; 
(Found: C, 50.86%, H, 3.64, N, 3.92; M+ 703.92108. CsoH26CbFe2N2Pd requires C, 51.2%, H, 
3.7, N, 4.0; M+ 703.65268). VmllX (KBr)/ cm·
1 3626, 1699, 1634, 1615, 1495, 1106, 815, 667 
and 498; 1H NMR OH (300 MHz; solvent CDCI3): 8.91 (2H, br s, CSH4N), 8.62 (2H, d, J :: 5.1 
Hz, CSH4N), 7.75 (2H, d, J::: 6.9 Hz, CSH4N), 7.20 (2H, t, J::: 6.6 Hz, CSH4N), 4.73 (4H. br s, 
CSH4), 4.46 (2H, br s, CSH4), 4.18 (10H, s, CsHs); 13C NMR Oc (75 MHz; solvent CDCb): 
151.13 (CSH4N), 149.76 (CSH4N), 138.31 (CSH4N), 135.05 (CSH4N). 124.20 (CSH4N), 70.37 
(CSH4), 70.28 (CsHs) and 67.16 (CSH4); mIz (FAB) 706 (55), 704 (M+, 74%), 702 (30), 669 (M-
CI, 15),633 (M-CI, 8), 581 (7),511 (13),371 (30),369 (M-ligand, 39), 263 (ligand, 100), 198 
(29), 154 (38), 136 (37) and 89 (11). 
1.6.5 Dichlorobis(2-ferrocenylpyridine)palladium45 
Dichlorobis(2-ferrocenylpyridine)palladium was prepared according to the procedure for 7.6.2. 
A brown two-layer solution was observed on addition of a solution of 2-ferrocenylpyridine 
(0.50 g, 1.9 mmol) in dichloromethane (5 ml) to a solution of sodium tetrachloropaliadate(lI) 
(0.28 g, 0.95 mmol) in (1 :2) ethanol-water (6 ml). The reaction mixture was further stirred at 
room temperature for 7.5 hours. The two-layer reaction mixture was separated and the 












collected as dark red microcrystals by vacuum filtration (0.52 g, 78%), mp 
108-110 °C; (Found: C, 51.56%, H, 3.78, N, 4.07; M+ 703.92108. 
C3QH26CI2Fe2N2Pd requires C, 51.2%, H, 3.7, N, 4.0; M+ 703.65268). Vmax 
(KBr)/ cm,1 3626, 1760, 1703, 1634, 1605, 1495, 1435, 1106,815, 667 
and 408; 1H NMR OH (300 MHz; solvent CDCI3): 9.25 (2H, d, J::: 12.8 Hz, 
CSH4N), 8.56 (2H, br s, CSH4N), 7.47 (2H, d, J::: 7.7 Hz, CSH4N), 7.16 (2H, 
d, J::: 8.1 Hz, CSH4N), 4.92 (4H, t, J::: 1.8 Hz, CSH4), 4.39 (4H, t, J::: 1.8 
Hz, CSH4), 4.16 (10H, s, CsHs); 13C NMR Oc (75 MHz; solvent CDCb): 
Experimental Details 
157.51 (CSH4N)152.22 (CSH4N), 139.08 (CSH4N), 125.67 (CSH4N), 119.68 (CSH4N), 70.94 
(CSH4), 70.12 (CSH4) and 67.84 (CsHs); mlz (FAB) 704 (M+, 22%), 666 (M+-CI, 3), 631 (M-CI, 
17),565 (5), 510 (4),370 (18),368 (M-ligand, 19),279 (35), 263 (ligand, 100), 198 (25), 154 
(35), 136 (27) and 89 (13). 
7.6.6 Dichlorobls(4-ferrocenylphenyl-4'·pyrldine)palladium 
Dichlorobis(4-ferrocenylphenyl-4'-
pyridine)palladium was prepared 
according to the procedure for 7.6.2. 
4-Ferrocenylphenyl-4'-pyridine (49.5 mg, 
0.15 mmol) in dichloromethane (5 ml) was added to a solution of sodium 
tetrachloropaliadate(lI) (21.5 mg, 0.07 mmol) in (1 :2) ethanollwater (3 ml). The reaction 
mixture was further stirred at room temperature for 8 hours. The product was collected as 
red-brown microcrystals by vacuum filtration (49.1 mg, 82%), mp 224-226 °C dec.; (Found: C, 
59.25%, H, 4.38, N, 2.85; M+ 856.1. C42H34CI2Fe2N2Pd requires C, 58.9%, H, 4.0, N, 3.3; M+ 
855.8). Vmax (KBr)/ cm-1 3585, 1750, 1699, 1634, 1615, 1495, 1456, 8189, 667 and 406; 1H 
NMR SH (300 MHz; solvent CDCI3): 8.84 (4H, d, J::: 4.1 Hz, CSH4N), 7.56 (8H, br s; CaH4), 
7.54 (4H, d, J::: 6.1 Hz, CSH4N), 4.72 (4H, t, J::: 1.8 Hz, CSH4), 4.41 (4H, t, J::: 1.8 Hz, CSH4), 
4.08 (10H, s, CsHs); 13C NMR Oc (75 MHz; solvent CDCb): 153.10 (CSH4N), 127.04 (CaH4), 
126.75 (CaH4), 122.03 (CSH4N), 69.72 (CSH4), 69.59 (CSH4) and 66.67 (CsHs); mIz (FAB) 856 














1.1.1 Chloro(1 ,5-cyclooctadiene)(4-pyridylimine-4'·phenylferrocene)platinum 
chloride 
4-Pyridylimine-4'-phenylferrocene (23.1 mg, 
0.06 mmol) was added to a solution of [r?"" ~N~ ~] 
dichloro(1,5-cyclooctadiene)platinate (23.8 mg, ~ .... Pt'CI N~ CI 
0.06 mmol) in pentane (6 ml). The reaction ~ 
mixture was stirred at room temperature for 2 days after which a purple precipitate was 
observed. The product was collected via vacuum filtration as purple crystalline flakes (18.3 
mg, 39%), mp 200-202 °C; (Found: C, 48.76%, H, 3.87, N, 3.39; M+ 704.10948. 
C30H30CI2FeN2Pt requires C, 48.6%, H, 4.1, N, 3.8; M+ 704.97134). Vmax (KBr)/ cm-
1 3503, 
1685, 1624, 1577, 1473, 1406,847,668,552 and 418; 1H NMR 5H (300 MHz; solvent CDC(3): 
8.74 (2H, d, J:::: 5.9 Hz, CsH,N), 8.52 (1H, s, N=CH), 7.76 (2H, dd, J:::: 5.9 Hz, CSH4N), 7.52 
(2H, dd, J:::: 8.6 Hz, CSH4), 7.22 (2H, d, J:::: 8.3 Hz, CSH4), 5.59 (4H, br s, COD-CH), 4.66 (2H, 
t, J:::: 1.8 Hz, CSH4), 4.34 (2H, t, J:::: 1.8 Hz, CSH4), 4.04 (5H, s, CsHs), 2.72-2.67 (4H, m, COD-
CH2) and 2.27-2.23 (4H, d, J :::: 8.3 Hz, COD-CH2); 13C NMR 5e (75 MHz; solvent CDC(3): 
153.71 (N=C), 150.85 (CSH4N), 148.54 (CSH4N), 143.24 (CSH4), 139.07 (CSH4N), 126.72 
(CSH4N), 122.38 (CSH4N), 121.49 (CSH4), 69.89 (CsHs), 69.39 (CSH4) and 66.69 (CSH4) mIz 
(FAB) 704 (M+, 1%),519 (3), 460 (8), 410 (6), 366 (ligand, 68), 277 (95), 229 (20), 176 (24), 
149 (25), 91 (37) and 77 (100). 
1.1.2 Dichlorobis(pyridine)platlnum4S 
A solution of pyridine (95.0 mg, 0.10 ml, 1.20 mmol) in ethanol (5 ml) was 
added slowly to a solution of potassium tetrachloroplatinate(1I) (0.25 g, 0.60 
mmol) in (1 :2) ethanol/water (6 ml). The reaction mixture was further stirred at 
room temperature for at least 24 hours. A precipitate was observed to form 
during this time. The product was collected as a white powder via vacuum 
filtration (0.18 g, 72%), mp 227-229 aC. Vmax (KBr)/ cm-1 3608, 3087, 3023, 2322, 2317,1843, 
1634,1616,1607,1575,1557,1482,1436,1242,1207, 1156, 1075,790,767,697,427,410 
and 404; 1H NMR 5H (300 MHz; solvent CDCls): 8.76 (2H, d, CsHsN), 7.33 (2H, dd, CsHsN), 














Dichlorobis(4-phenylpyridine)platinum was prepared according to 
the general procedure for 7.7.2. A solution of 4-phenylpyridine (64.7 
mg, 0.42 mmol) in ethanol (2 ml) was added to a solution of 
potassium tetrachloroplatinate(lI) (86.5 mg, 0.21 mmol) in (1 :2) 
Experimental Details 
CI" ;\ X ) 
Pt 0-0 / , 
CI N J \ J 
ethanollwater (3 ml). The reaction mixture was stirred under nitrogen at room temperature for 
2 days. A precipitate was observed to form during this time. The product was collected via 
vacuum filtration as a cream powder (90.8 mg, 75%), mp 235°C dec. (Found: C, 46.19%, H, 
3.26, N, 4.87. C22H1SCI2N2Pt requires C, 45.8%, H, 3.1, N, 4.9). Vmax (KBr)/ cm-
1 3565, 3055, 
2349, 2322, 1662, 1616, 1575, 1505, 1498, 1447, 1393, 1292, 1076, 1014, 842, 729, 693, 
562,497,441,435,416,410 and 404; 1H NMR OH (300 MHz; solvent DMSO-de): 8.61 (4H, d, 
J = 5.8 Hz. CSH4N). 7.86 (8H. m, CeHs), 7.76 (2H. d, J = 8.0 Hz. CeHs). 7.66 (4H, d, J::: 5.8 
Hz, CSH4N); 13C NMR oe (75 MHz; solvent DMSO-de): 149.89 (CSH4N), 129.09 (CeHs), 128.84 
(CeHs), 126.99 (CeHs) and 126.86 (CSH4N). 
7.7.4 Dichlorobis(4-phenyllmine-4'-pyridine)platinum 
Dichlorobis( 4-phenylimine-4 '-pyridine )platinum was prepared 
according to the procedure for 7.7.2. A solution of 4-
phenylimine-4'-pyridine (0.44 g, 2.4 mmol) in ethanol (10 ml) 
was added to a solution of potassium tetrachloroplatinate(lI) 
(0.50 g, 1.2 mmol) in (1 :2) ethanol/water (12 ml). The reaction 
mixture was stirred under nitrogen at room temperature for 2 days. A precipitate was 
observed to form during this time. The product was collected via vacuum filtration as a 
mustard-yellow powder (0.53 g, 70%), mp 145-146 °C; (Found: C, 45.69%, H, 3.12, N, 8.62; 
M+ 630.07145. C24H20CI2N4Pt requires C, 45.7%, H, 3.2, N, 8.9; M+ 630.42326). Vmax (KBr)/ 
cm-1 3611, 3054, 2322, 1662, 1645, 1623, 1616, 1575, 1557, 1495, 1429, 1061, 832, 765, 
692,668,552,435,420,410 and 403; 1H NMR OH (300 MHz; solvent DMSO-de): 9.04 (4H, d, 
J::: 6.6 Hz, CSH4N), 8.66 (2H, s, N=CH), 8.05 (4H, d, J = 7.3 Hz, CeHs), 7.83 (4H, d, J = 5.8 
Hz, CSH4N), 7.44 (2H, dd, J = 7.6 Hz. CeHs). 7.36 (2H. t, CeHs); 13C NMR oe (75 MHz; solvent 
DMSO-de): 156.95 (N=C), 153.70 (CSH4N), 152.12 (CSH4N), 150.10 (CSH4N), 129.02 (CeHs), 
123.84 (CeHs)121.06 (CeHs), and 120.78 (CeHs); mlz (FAB) 630 (M+, 10%),558 (M-2 CI, 27), 













Dichlorobis(4-ferrocenylpyridine)platinum was prepared according to 
the general procedure for 7.7.2. A solution of 4-ferrocenylpyridine 
(15.4 mg, 0.06 mmol) in ethanol (2 ml) was added to a solution of 






ethanol/water (2 ml). The reaction mixture was stirred under nitrogen CI/ '\.~NI ,....--.; 
at room temperature for 24 hours. A precipitate was observed to form --.. ~ 
during this time. The product was collected via vacuum filtration as an o pink-red powder (16.7 mg, 72%), mp 228-230 °C dec.; (Found: C, ~
45.42%, H, 3.54, N, 3.15; M+ 793. C3QH26CI2Fe2N2Pt requires C, 45.5%, H, 3.3, N. 3.5; M+ 
792.27). Vmax (KBr)1 cm-1 3629, 1701, 1696, 1653, 1617, 1521, 1437,833,501,423,416,410, 
406 and 403; 1H NMR OH (300 MHz; solvent CDCI3): 8.56 (4H, d, J::: 5.3 Hz, C5H4N), 7.25 
(4H, br s, C5H4N). 4.69 (4H. br s, C5H4), 4.51 (4H, br s, C5H4), 4.02 (10H, s, C5H5); 13C NMR 
Oc (CDCb): 152.98 (C5H4N). 125.23 (C5H4N), 73.15 (C5H5), 70.64 (C5H4) and 69.96 (C5H4); 
mIz (FAB) 793 (M+, 4%), 521 (96). 398 (12), 342 (20). 279 (52). 263 (4-Fcpy, 24) and 223 
(21). 
1.1.6 Dichlorobis(4-ferrocenylphenyl-4' -pyridine)platinum 
Dichlorobis( 4-ferrocenylphenyl-4' -pyridine )platinum was 
prepared according to the general procedure for 7.6.2. A 
solution of 4-ferrocenylphenyl-4'-pyridine (50.0 mg, 0.15 
mmol) in dichloromethane (5 ml) was added to a solution of 
potassium tetrachloroplatinate(lI) (30.6 mg, 0.07 mmol) in 
(1 :2) ethanol/water (3 ml). The reaction mixture was stirred 
under nitrogen at room temperature for 6 hours. A two-layer reaction mixture was obtained 
with a dark red organic layer and colourless aqueous layer. The layers were separated and 
the solvent removed in vacuo, yielding dark red crystals (43.0 mg, 65%), mp 239-241 °C dec.; 
(Found: C, 53.08%, H, 3.64, N. 2.85; M+ 944.04473. C42H34CbFe2N2Pt requires C, 53.4%, H, 
3.6, N, 3.0; M+ 944.38395). Vmax (KBr)1 cm-1 1601, 1121, 1105, 1073, 1030, 1002,887.854, 
815,524,504,444 and 425; 1H NMR OH (300 MHz; solvent CDCb): 8.89 (4H, dd, J::: 5.9 Hz. 
C5H4N), 7.62 (4H, dd, J::: 6.0 Hz, C5H4N), 7.54 (8H, s, CeH4), 4.70 (4H. t, J::: 1.8 Hz, C5H4). 
4.40 (4H, t, J :::: 1.8 Hz, C5H4) , 4.07 (10H, s, C5H5); 13C NMR Oc (75 MHz; solvent CDCh): 
152.82 (C5H4N), 126.96 (CeH4), 126.80 (CSH4), 122.55 (C5H4N), 69.82 (C5H5), 69.62 (C5H4) 
and 66.73 (C5H4); mIz (FAB) 944 (M+, 5%), 908 (M+-CI, 3), 871 (3), 675 (10), 610 (5), 533 












7.8 Cobaloxime complex 
7.8.1 (Methyl)(4-pyridylimine-4' -phenylferrocene)cobaloxime 
The cobaloxime complex was prepared by a 
general procedure involving displacement of 
pyridine from methylpyridinecobaloxime47. Dowex 
50W-X4 strongly acidic ion-exchange resin (527:6 
mg) was added to a solution of methylpyridine-
cobaloxime (261.7 mg, 0.82 mmol) in methanol-
water 7:1 (80 ml). The mixture was stirred and 
Experimental Details 
heated at 50-55°C for an hour. The orange-red solution was hot-filtered, concentrated and 
left to crystallise. The orange-red crystals of {Co}(Me)(H20) (112.7 mg, 0.44 mmol, 54% yield) 
were then dehydrated by heating to 60°C in vacuo in order to remove the coordinated water 
molecule and form the light-sensitive dimer [{Co}(Me)]2 (105.2 mg, 0.44 mmol) as dark red 
needles. 4-Pyridylimine-4'-phenylferrocene (61.4 mg, 0.17 mmol) was added to a suspension 
of the dimer (40.0 mg, 0.08 mmol) in dichloromethane (12 ml). The dark red solution was 
further stirred under nitrogen for 22.6 hours. The reaction mixture was concentrated and 
hexane added to precipitate the product that was collected via vacuum filtration. The product 
was obtained as small maroon crystalline flakes (67.6 mg, 67%), mp 249-251 °C; (Found: C, 
61.48%, H, 5.12, N, 13.52; M+ 604.14481. C31H33CoFeNs requires C, 61.6%, H, 5.5, N, 13.9; 
M+ 604.42263). Vmax (KBr)/ cm-
1 3553, 2361, 1685, 1624, 1617, 1576, 1235 and 511; 1H NMR 
()H (300 MHz; solvent CDCI3): 8.73 (2H, d, J::: 6.6 Hz, C5H4N), 8.50 (1H, s, N=CH), 7.78 (2H, 
d, J = 6.5 Hz, CSH4N), 7.51 (2H, d, J:::: 8.5 Hz, CeH4), 7.20 (2H, d, J::: 8.6 Hz, CSH4), 4.66 (2H, 
t, J = 1.8 Hz, CSH4), 4.35 (2H, t, J::: 1.9 Hz, CSH4), 4.05 (5H, s, CsHs), 2.14 (12H, S, N=C-CH3) 
and 0.86 (3H, s, Co-CH3); 13C NMR ()c (75 MHz; solvent CDCI3): 154.17 (N=C), 151.89 
(CSH4N), 146.01 (CSH4N), 143.26 (CSH4). 139.05 (C5H4N), 127.00 (CSH4N), 122.38 (C5H4N), 
121.48 (CSH4). 69.88 (CSH5), 69.42 (C5H4) and 66.70 (C5H4); mIz (FAB) 604 (M+, 2%), 533 (4), 
366 (56), 305 (20), 277 (43), 227 (24) and 77 (64). 
7.9 Catalytic studies 
7.9.1 Polymerisation of phenylacetylene,",49,32 
A typical polymerisation was carried out in a 2-necked 50 ml round bottom flask. The catalyst 
(0.02 mmol) was added to a solution of phenylacetylene (0.55 g, 0.60 ml, 5.44 mmol) in 













temperature (maintained at 25°C) for 24 hours at atmospheric pressure. During this time a 
yellow precipitate of polyphenylacetylene was formed. The polyphenylacetylene was coliected 
by vacuum filtration, washed with methanol and dried in vacuo. Care was taken not to heat 
the samples as this resulted in some isomerisation of the polymer. Polymers formed were 
analysed by NMR and infrared spectroscopy, thermal analysis and gel permeation 
chromatography. 
7.9.2 Carbonylation of nitrobenzene50•51 ,52 
A typical experiment was conducted in a 200 ml steel autoclave. The autoclave was fitted with 
an overhead stirrer, a thermocouple to monitor the reaction temperature internally, pressure 
gauges to monitor the pressure of the reaction vessel internally and pressure release valves. 
Hydrogen gas was introduced through an inlet valve and samples were removed through a 
separate outlet valve. A mixture of the catalyst (0.29 mmol). iron powder (17.0 mmol, 0.949 
g), iodine (0.68 mmol, 0.173 g), pyridine (10.54 mmol, 0.83 g, 0.85 ml) and nitrobenzene 
(0.14 mol, 16.9 g, 14.2 ml) in ethanol (0.55 mOl, 32.3 ml) (where ethanol served as both 
solvent and reagent) was introduced to the reaction vessel under nitrogen. The mixture was 
initially flushed with carbon monoxide and then heated to either 150 or 180°C and 
pressurised to 4 MPa carbon monoxide pressure while stirring vigorously. The reaction was 
allowed to progress for a total of two hours and monitored by removal of samples at various 
time intervals as the reaction progressed. Samples were analysed by gas chromatography. 
7.9.2.1 Gas chromatography instrument conditions 
Analysis of samples was carried out using gas chromatography. Samples were filtered 
through a 0.4 ~m teflon microfilter prior to injection. Gas chromatography was carried out 
using a Carlo Erba Strumentazione Fractovap 4200 series dual column modular gas 
chromatograph fitted with a Phenomenex Zebron Z8-1 capillary column (30 m x 0.25 mm x 
0.5 ~m). Nitrogen was used as carrier gas (1.7 kg.cm-s). A flame ionisation detector was used 
with a hydrogen flow rate of 0.4 kg.cm-3. Samples were injected into the column with a split 
ratio set at 0.17 min-1• The temperature programme was set with an isothermal run at 120°C 
for the determination of the carbonylation products with injector and detector temperatures set 
at 220 and 240°C respectively. Analysis and identification of these products was carried out 
by comparison of retention times with commercially available or independently prepared 
samples as well as by injection of samples containing added standard solutions. Furthermore, 
quantitative determinations were based on response factors and corresponding peak areas, 













Relative response factor = Response factor of sample I Response factor of reference [7.1] 
'1.9.3 Hydrogenation of 1-hexene and cyclohexene 
A typical experiment was carried out in a Schlenck tube designed to accommodate pressures 
slightly above atmospheric. The catalyst (0.02 mmol) was added to a solution of the alkene 
(1.0 mmol), either cyclohexene or 1-hexene, in dichloromethane (10 ml). Octane (1.0 mmol) 
was added as an intemal standard to aid monitoring of the reaction. Hydrogenation of 
cyclohexene was conducted in a 250 ml reaction vessel and 1-hexene hydrogenation in a 70 
ml reaction vessel. The reaction mixture was degassed by the freeze-thaw method and 
flushed with hydrogen gas several times to ensure maximal introduction and interaction of 
reaction mixture with hydrogen gas. The solution was then stirred vigorously at a constant 
rate under a hydrogen gas atmosphere at atmospheric pressure and room temperature, 
which was maintained at 24°C, for a total of 24 hours. The reaction mixture was monitored by 
removal of samples at various time intervals as the reaction progressed. Samples were 
analysed with gas chromatography. 
'1.9.3.1 Gas chromatography instrument conditions 
Analysis of the samples was carried out using gas chromatography. Samples were filtered 
through a 0.4 J.lm teflon microfilter prior to injection. Gas chromatography was carried out 
using a Carlo Erba Strumentazione Fractovap 4200 series dual column modular gas 
chromatograph fitted with a Phenomenex Zebron Z8-1 capillary column (30 m x 0.25 mm x 
0.5 J.lm). Nitrogen was used as carrier gas (1.7 kg.cm-3). A flame ionisation detector was used 
with a hydrogen flow rate of 0.4 kg.cm-3• Samples were injected into the column with a split 
ratio set at 0.17 min-1• The temperature programme was set with an isothermal run at 50°C 
for the determination of samples from both 1-hexene and cyclohexene hydrogenations, with 
injector and detector temperatures set at 220 and 240°C respectively. Analysis and 
identification of hydrogenation products was carried out by comparison of retention times with 
commercially available samples as well as by injection of samples containing added standard 
solutions. Furthermore, quantitative determinations were based on response factors and 
corresponding peak areas as described in Equation 7.1. In all cases an internal standard, 













1.10 Biological studies 
1.10.1 Cytotoxicity determinations 
The cytotoxicity of a range of rhodium, iridium, platinum and palladium complexes was 
determined. Cell lines used for cytotoxicity determinations included WHC01, an oesophageal 
cancer cell line and ME180. a cervical cancer cell line. The cell lines used were prepared in a 
given media with WHC01 cells in DMEM (Dulbecco's Modified Eagle Media), 10 % FCS 
(Foetal Calf Serum, also called Foetal Bovine Serum or FBS) and pen/strep (a mixture of 
penicillin and streptomycin used to prevent bacterial contamination). ME180 cells were 
prepared in a media of McCoy's 5A, 5 % FCS and pen/strep. 
The plating cells used were rinsed and lifted with trypsin, neutralised with an equal volume of 
media and counted using a haemocytometer. An appropriate volume of cell suspension was 
spun down at 10 000 rpm for 5 minutes, supernatant decanted and resuspended at 1 000 
cells/ 90 ~1. Cells were plated in CellStar 96 well plates, with 90 ~II well (4 wells for each 
compound) and incubated at 37°C in an atmosphere of 95 % air and 5 % CO2 for a period of 
24 hours. 
Each compound tested was resuspended in DMSO in a concentration of 25 mg/ml. Dilutions 
were made several times including a dilution of stock into media (once into DMEM and once 
into McCoy's 5A). The respective diluted compounds investigated (10 1-11) were added to each 
well of the well plate with final concentrations of 50, 10 and 1 I-Ig/ml respectively, in 0.2 % 
DMSO followed by addition of 10 1-11 of 2 % DMSO to each of 4 wells, giving a 0.2 % DMSO 
final concentration. Cells were then incubated at 37°C in an atmosphere of 95 % air and 5 % 
CO2 for 48 hours. 
Cell morphology and number were observed and recorded at 24 and 48 hours respectively. 
The media present in the weils was then discarded and methanol (100 1-11> added to each well 
and left to stand for 10 minutes in order to fix the cells. The methanol was discarded and 
crystal violet solution (100 1-11), a protein stain, was added to each well and left to stand for 20 
minutes before rinsing the wells thoroughly with distilled water. Distilled water was introduced 
once more to each well and left to stand for an hour before discarding the water and 
repeating the process. 
The plate was read on a multiwell plate reader at 595 nm. Samples were analysed by 













plotted on a bar chart taking into account solvent control as a reference. The extent of cell 
death was determined relative to the percentage of solvent control. 
7.10.2 Determination of ICso values 
WHC01. the oesophageal cancer cell line, was used for the determination of selected ICoo 
values with a media of DMEM, 10 % FCS and pen/strep. As before, the plating cells were 
rinsed and lifted with trypsin, neutralised with an equal volume of media and counted using a 
haemocytometer. An appropriate volume of cell suspension was spun down at 10 000 rpm for 
5 minutes, supernatant decanted and resuspended at 1000 cellsl 90 J.II. Cells were plated in 
CeliStar 96 well plates, 90 J.II1 well (4 wens for each compound), and incubated at 37°C in an 
atmosphere of 95 % air and 5 % CO2 for 24 hours. 
The compounds investigated were prepared in a series of 11 dilutions from 1 to 50 1-11 with a 
final DMSO concentration of 2 % in media and 0.2 % in each well. The cell morphology and 
number was observed and recorded and MTT reagent (10 1-11) added to each well followed by 
incubation for 4 hours in a TC incubator. A solubilisation solution (100 1-11> was added to each 
well and the cells incubated overnight. The plate was then read on a multiwell plate reader at 
595 nm. Samples were analysed by subtracting the baseline obtained from wells without cells 
and only containing media, and plotted on a bar chart taking into account solvent control as a 
reference. The extent of cell death was determined relative to the percentage of solvent 
control. 
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X-ray crystallographic data is provided in the form of structure factor tables and tables of data 
on diskette, 
II Appendix 1 - X-ray data for complex [3.6] 
II Appendix 2 - X-ray data for complex [3.15] 
II Appendix 3 - X-ray data for complex [3.16] 
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